≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Non-follicular lymphoma

Endpoint Browser PheWeb

C3_NONFOLLICULAR_LYMPHOMA

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — C83
  • Hospital discharge: ICD-9 — 200
  • Hospital discharge: excluded ICD-9 — 200A
  • Cause of death: ICD-10 — C83
  • Cause of death: ICD-9 — 200
  • Cause of death: excluded ICD-9 — 200A

2 out of 7 registries used, show all original rules.

3981

4. Check minimum number of events

None

3981

5. Include endpoints

None

3981

6. Filter based on genotype QC (FinnGen only)

3853

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF4
Parent code in ICD-10
C81-C96
Name in latin
Lymphoma non-Hodgkin diffusum

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

All Female Male
Number of individuals 3853 1608 2245
Unadjusted period prevalence (%) 0.84 0.57 1.03
Median age at first event (years) 67.09 65.59 68.17

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
3981
Matched controls
39810
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
R59.9
ICD-10 Finland
Enlarged lymph nodes, unspecified
22.1
322.8
241
116
R50.9
ICD-10 Finland
Fever, unspecified
4.0
312.0
1184
3853
C82.9
ICD-10 Finland
Follicular lymphoma, unspecified
66.1
311.7
171
27
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
21.3
310.2
235
117
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
+∞
307.7
471
*
9680/3-C77.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph node, NOS
5568.6
307.7
500
*
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
20.1
307.7
737
446
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
39.6
307.7
301
82
A04AA01
ATC
ondansetron; systemic, rectal
8.4
307.7
1139
1807
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
51.8
307.7
1188
324
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
52.5
307.7
773
182
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
9.8
307.7
696
841
L03AA14
ATC
lipegfilgrastim; parenteral
15.5
307.7
362
255
WW500
NOMESCO Finland
Blood transfusion
13.7
307.7
871
799
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
29.2
307.7
468
181
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
6.4
307.7
675
1237
C83.39
ICD-10 Finland
Diffuse non-Hodgkin's large cell lymphoma UNS
+∞
307.7
330
*
PJA10
NOMESCO Finland
Exploration of lymph nodes
30.1
307.7
433
161
H02AB06
ATC
prednisolone; systemic
4.1
307.7
2821
14829
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
40.6
307.7
536
152
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
307.7
2263
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
156.8
307.7
554
41
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.4
307.7
1120
3273
JN6AD
NOMESCO Finland
CT of torso and neck
35.4
307.7
759
263
A04AA02
ATC
granisetron; systemic, transdermal
6.9
307.7
799
1401
C83.00
ICD-10 Finland
Lymphocytic lymphoma
+∞
307.7
386
*
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
9.3
307.7
833
1099
WW300
NOMESCO Finland
Transfer of autologic stem cells
58.2
307.7
215
39
L03AA02
ATC
filgrastim; parenteral
41.3
307.7
1282
453
JN4BD
NOMESCO Finland
Extensive body CT
8.2
307.7
1493
2703
XW000
NOMESCO Finland
Bone marrow biopsy
23.1
307.7
1327
844
JN4AD
NOMESCO Finland
Body CT examination
5.5
307.7
1304
3259
L03AA13
ATC
pegfilgrastim; parenteral
24.3
307.7
1225
716
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
161.0
307.7
3000
742
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
4693.3
307.7
431
*
M04AA01
ATC
allopurinol; systemic
8.5
307.7
1964
4110
ZX120
NOMESCO Finland
Intravenous
5.0
307.7
913
2249
C83.1
ICD-10 Finland
Mantle cell lymphoma
+∞
307.7
533
*
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
155.5
307.7
380
27
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
22.0
307.7
1319
877
1XC02, ,
NOMESCO Finland
71.7
307.7
383
59
C82.1
ICD-10 Finland
Follicular lymphoma grade II
46.3
307.7
272
63
D70.82
ICD-10 Finland
Drug-induced neutropenia
24.0
307.7
463
217
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
14.0
307.7
380
297
A03FA01
ATC
metoclopramide; systemic, rectal
7.6
307.7
2222
5704
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
+∞
307.7
716
*
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
28.2
307.7
434
172
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
63.9
307.7
418
73
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
21.9
299.7
224
108
PJD45
NOMESCO Finland
Excision of inguinal lymph nodes
34.6
291.5
185
56
9680/3-C77.8
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph nodes of multiple regions
2868.3
291.0
278
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
12.5
290.6
293
251
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
11.6
281.5
298
275
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
16.0
271.0
235
155
C82.2
ICD-10 Finland
Follicular lymphoma grade III, unspecified
65.9
255.1
140
22
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
9.6
238.3
289
322
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
11.4
232.1
247
229
H02AB02
ATC
dexamethasone; systemic
3.7
231.5
886
2844
C82.01
ICD-10 Finland
Follicular nodular lymphoma, grade I
56.0
230.0
130
24
212
Kela drug reimbursment
Gout
7.8
220.1
316
433
J05AB11
ATC
valaciclovir; oral
3.4
214.2
958
3385
ZX112
NOMESCO Finland
Subcutaneous
8.2
213.2
294
384
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
12.5
212.3
212
178
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
33.0
208.5
134
42
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.3
203.4
959
3490
WZC00
NOMESCO Finland
Treatment plan or consultation
2.7
200.2
1968
10618
WW409
NOMESCO Finland
Other aferesis
52.8
197.7
113
22
Z85.7
ICD-10 Finland
Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues
404.8
194.7
194
5
TPX10
NOMESCO Finland
Implantation of vascular injection port
6.5
193.8
334
556
WF003
NOMESCO Finland
Adjuvant radiotherapy
6.1
191.7
354
631
C82.00
ICD-10 Finland
Follicular nodular non-Hodgkin's lymphoma, ungraded
46.7
185.7
109
24
N02AA05
ATC
oxycodone; systemic
2.8
182.4
1294
5870
H02AB07
ATC
prednisone; oral
3.1
179.7
905
3401
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
39.0
179.5
110
29
EP1AE
NOMESCO Finland
Neck ultrasound examination
4.4
178.9
489
1221
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
5.4
178.7
375
752
D70.89
ICD-10 Finland
Neutropenic splenomegaly
11.1
174.4
188
177
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.0
174.1
544
1500
L01AA02
ATC
chlorambucil; oral
28.9
171.7
115
41
L01CB01
ATC
etoposide; systemic
16.7
161.7
136
84
ZX108
NOMESCO Finland
Inhalation
15.8
159.5
138
90
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
5.9
157.1
296
536
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.4
152.5
2530
16639
JN5JR
NOMESCO Finland
Extensive PET-CT of upper body metabolism (eyebrows to thighs)
30.1
151.5
100
34
TGC00
NOMESCO Finland
Bronchial lavation
6.0
147.9
272
481
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
18.8
144.8
115
63
390
Kela drug reimbursment
Ibrutinib
47.1
141.7
83
18
C81.1
ICD-10 Finland
Nodular sclerosis classical Hodgkin lymphoma
30.4
139.7
92
31
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
20.7
138.2
105
52
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
11.6
137.7
143
127
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
8.7
137.6
178
214
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
5.5
137.3
279
541
A02BC02
ATC
pantoprazole; systemic
2.6
136.3
3115
23059
2008X
ICD-9 Finland
Lymphosarcoma and reticulosarcoma, Other named variants
+∞
133.1
127
*
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
11.0
132.9
143
134
WF049
NOMESCO Finland
Radiotherapy of metastasis
4.5
131.9
344
823
WF004
NOMESCO Finland
Palliative radiotherapy
5.8
130.7
246
444
J01MA12
ATC
levofloxacin; systemic
2.5
128.9
1106
5366
YNB10
NOMESCO Finland
Collection of stem cells for transplant
42.4
125.0
75
18
C96.9
ICD-10 Finland
Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified
69.2
124.6
68
10
XX3DW
NOMESCO Finland
Time consuming IT work
2.8
123.6
716
2858
AAG00
NOMESCO Finland
Stereotactic intracranial biopsy
35.7
122.7
77
22
1512
Kela drug reimbursment
Ibrutinib
43.7
122.5
73
17
Z51.5
ICD-10 Finland
Palliative care
2.9
122.4
678
2641
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
8.1
120.8
164
209
C83.89
ICD-10 Finland
Other types of diffuse non-Hodgkin's lymphoma
+∞
120.4
115
*
WF002
NOMESCO Finland
Radical radiotherapy
3.4
119.1
475
1527
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
11.6
117.7
122
108
9673/3-C42.1
ICD-O-3
Mantle cell lymphoma of bone marrow
+∞
115.2
110
*
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
10.5
114.9
128
126
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
3.6
114.8
408
1217
B72
ICPC
Hodgkin Lymphoma
238.9
113.4
116
5
D69.5
ICD-10 Finland
Secondary thrombocytopenia
21.2
113.0
85
41
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.1
111.1
508
1771
WW402
NOMESCO Finland
Leucoferesis
61.9
109.7
61
10
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
4.2
109.1
307
776
XX9CD
NOMESCO Finland
Very extensive complementary CT
284.0
108.5
110
*
L01EL01
ATC
ibrutinib; oral
59.9
105.5
59
10
A41.9
ICD-10 Finland
Sepsis, unspecified
4.0
104.0
313
831
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
29.2
103.5
69
24
TAB00
NOMESCO Finland
Lumbar puncture
4.1
101.6
296
767
TPX15
NOMESCO Finland
Removal of vascular injection port
15.3
99.2
87
58
9680/3-C71.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of brain, NOS
+∞
98.3
94
*
C83.33
ICD-10 Finland
Primary medical lymphoma with large B cells
+∞
98.3
94
*
D47.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
23.3
98.2
71
31
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
8.1
95.1
129
164
YJ1BD
NOMESCO Finland
Extensive CT examination of abdomen for dose design of radiotherapy
41.3
94.3
57
14
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
16.7
91.8
77
47
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
7.4
89.0
131
183
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
24.2
87.0
62
26
C83.01
ICD-10 Finland
Lymphoplasmacytic lymphoma
+∞
85.7
82
*
WZC30
NOMESCO Finland
Teaching
2.2
85.7
895
4619
C83.0
ICD-10 Finland
Small cell B-cell lymphoma
+∞
84.7
81
*
A07AA02
ATC
nystatin; oral
3.1
82.5
371
1273
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
4.1
80.2
230
588
YJ1AD
NOMESCO Finland
CT examination of abdomen for dose design of radiotherapy
16.1
79.6
68
43
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.9
79.6
1394
8654
9680/3-C42.1
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of bone marrow
+∞
79.4
76
*
2000B
ICD-9 Finland
Lymphosarcoma and reticulosarcoma, Reticulosarcoma[LYMPHOMA MALIGNUM DIFFUSUM]
+∞
79.4
76
*
JN4ED
NOMESCO Finland
Body CT examination with specail preparation
124.1
79.2
85
7
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
3.0
79.1
373
1315
WW200
NOMESCO Finland
Immunization
4.5
78.1
195
448
C83.34
ICD-10 Finland
Anaplastic large cell lymphoma
+∞
77.3
74
*
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
11.0
76.6
82
76
C85.7
ICD-10 Finland
Other specified types of non-Hodgkin lymphoma
201.4
76.5
79
*
B01AB10
ATC
tinzaparin; parenteral
2.4
76.4
603
2752
D38.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Mediastinum
14.0
75.0
69
50
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
3.0
74.3
344
1199
B01AB05
ATC
enoxaparin; parenteral
1.9
72.2
1474
9547
NK6CT
NOMESCO Finland
Bone biopsy with CT guidance
13.6
71.6
67
50
H02AB09
ATC
hydrocortisone; systemic
4.6
71.2
175
397
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
5.2
71.2
150
299
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.9
71.1
1236
7595
D64.9
ICD-10 Finland
Anaemia, unspecified
2.2
70.7
677
3348
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.0
70.6
954
5379
9680/3-C80.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of unknown primary site
700.5
70.3
69
*
J05AB01
ATC
aciclovir; systemic
2.0
70.2
970
5511
9673/3-C77.9
ICD-O-3
Mantle cell lymphoma of lymph node, NOS
+∞
70.0
67
*
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.5
69.5
489
2113
9823/3-C77.9
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of lymph node, NOS
87.3
69.2
77
9
C83.32
ICD-10 Finland
Centroblastic diffuse non-Hodgkin's lymphoma
+∞
68.9
66
*
9680/3-C09.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of tonsil, NOS
+∞
67.9
65
*
C83.35
ICD-10 Finland
T-cell-rich B-cell lymphoma
+∞
67.9
65
*
2009X
ICD-9 Finland
Lymphosarcoma and reticulosarcoma[LYMPHOMA MALIGNUM (NON-HODGKIN) NUD]
+∞
67.9
65
*
GD1AD
NOMESCO Finland
Thorax CT examination
2.7
66.7
405
1629
JN4CD
NOMESCO Finland
Very extensive body CT
3.3
65.8
257
808
TPH04
NOMESCO Finland
Cathetrisation of vein
1.9
65.7
1075
6447
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
3.9
65.7
198
524
JMA10
NOMESCO Finland
Transabdominal total splenectomy
10.2
65.6
74
74
TPJ00
NOMESCO Finland
Biopsy of superficial lymph node
20.2
65.3
50
25
ED1AA
NOMESCO Finland
Mandibular X-ray examination
9.7
64.9
76
80
R16.1
ICD-10 Finland
Splenomegaly, not elsewhere classified
24.5
64.8
46
19
9680/3-C16.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of stomach, NOS
+∞
64.8
62
*
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.2
64.4
611
3002
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
8.3
63.7
84
103
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
10.2
62.9
71
71
9680/3-C77.0
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph nodes of head, face and neck
+∞
61.6
59
*
FM1FN
NOMESCO Finland
Heart function isotope examination
11.4
61.3
64
57
WX408
NOMESCO Finland
General anesthesy, balanced
1.8
61.3
1151
7186
9591/3-C77.0
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of head, face and neck
213.3
61.3
63
*
C83.2
ICD-10 Finland
Mixed small and large cell (diffuse) non-Hodgkin's lymphoma
+∞
59.5
57
*
C83.71
ICD-10 Finland
Burkitt's tumour
+∞
59.5
57
*
R06AE07
ATC
cetirizine; oral
1.7
58.2
1633
11423
C88.0
ICD-10 Finland
Waldenström macroglobulinaemia
16.5
58.2
49
30
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
2.2
57.8
522
2506
EMA10
NOMESCO Finland
Biopsy of tonsil
13.0
56.3
54
42
ZX070
NOMESCO Finland
Intensity modified radiotherapy
4.2
54.2
145
351
ZXF99
NOMESCO Finland
Other r3eason to interrupt procedure
9.3
53.1
64
70
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.4
52.5
410
1848
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.7
52.2
1325
8949
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
4.5
52.1
129
294
9591/3-C77.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph node, NOS
96.4
51.9
57
6
J01MA14
ATC
moxifloxacin; systemic
2.2
51.6
458
2179
9673/3-C77.8
ICD-O-3
Mantle cell lymphoma of lymph nodes of multiple regions
+∞
51.1
49
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
6.2
51.0
87
142
YNB00
NOMESCO Finland
Excision of bone marrow for transplantation
136.8
50.9
54
*
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.8
50.8
942
5807
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
15.5
49.4
43
28
JFB00
NOMESCO Finland
Partial resection of small intestine
4.4
49.4
124
286
9691/3-C77.9
ICD-O-3
Follicular lymphoma, grade 2 of lymph node, NOS
20.7
48.7
37
18
L04.0
ICD-10 Finland
Acute lymphadenitis of face, head and neck
7.0
47.0
72
105
9699/3-C77.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of lymph node, NOS
+∞
47.0
45
*
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
14.6
46.8
42
29
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.1
45.3
476
2414
1AA09, ,
NOMESCO Finland
65.8
45.2
52
8
C83.51
ICD-10 Finland
B-lymphoblastic lymphoma or leukemia
+∞
44.9
43
*
3AA13, ,
NOMESCO Finland
18.2
44.7
36
20
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.0
44.5
558
3018
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.1
44.2
469
2387
KFC00
NOMESCO Finland
Unilateral orchiectomy
7.4
44.1
64
88
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
4.1
44.0
123
308
E83.50
ICD-10 Finland
Hypercalcemia
4.7
43.9
102
221
C83
ICD-10 Finland
Non-follicular lymphoma
+∞
43.8
42
*
B00.2
ICD-10 Finland
Herpesviral gingivostomatitis and pharyngotonsillitis
12.0
43.7
44
37
AA1BD
NOMESCO Finland
Extensive CT of head and brain
3.4
42.6
155
465
C81.0
ICD-10 Finland
Nodular lymphocyte predominant Hodgkin lymphoma
16.8
41.9
35
21
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.9
41.8
567
3145
C83.8
ICD-10 Finland
Other non-follicular lymphoma
+∞
41.7
40
*
GEA20
NOMESCO Finland
Mediastinoscopy with excision of lesion
14.2
41.6
38
27
C03CA01
ATC
furosemide; systemic
1.6
41.1
1509
11031
9689/3-C42.2
ICD-O-3
Splenic marginal zone B-cell lymphoma of spleen
+∞
40.7
39
*
9680/3-C62.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of testis, NOS
+∞
39.6
38
*
ZX131
NOMESCO Finland
Intrathecal
+∞
39.6
38
*
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
6.2
39.6
68
112
ZXE00
NOMESCO Finland
One hour or less
1.6
38.9
1489
10952
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.5
38.9
1926
15010
D48.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other specified sites
6.4
38.8
64
101
2000A
ICD-9 Finland
Lymphosarcoma and reticulosarcoma, Reticulosarcoma[LYMPHOMA MALIGNUM FOLLICULARE]
+∞
38.6
37
*
WX110
NOMESCO Finland
Infiltration anesthesia
1.6
38.4
2651
22212
I88.9
ICD-10 Finland
Nonspecific lymphadenitis, unspecified
9.3
38.3
46
50
D40.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Testis
7.4
38.1
55
75
9591/3-C77.2
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of intra-abdominal lymph nodes
381.1
38.1
38
*
AAA10
NOMESCO Finland
Biopsy through craniotomy
72.6
38.0
43
6
9699/3-C16.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of stomach, NOS
+∞
37.6
36
*
KA1FN
NOMESCO Finland
Isotope renography
6.3
37.3
63
102
JN3AD
NOMESCO Finland
Abdominal CT examination
1.8
37.0
614
3624
GEA00
NOMESCO Finland
Mediastinoscopy
8.8
36.6
46
53
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
3.8
36.5
114
309
WD315
NOMESCO Finland
Multiple therapy of methastized malignancy with biomodifiers
10.1
36.3
41
41
B02.9
ICD-10 Finland
Zoster without complication
2.1
35.8
350
1721
D48.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Retroperitoneum
11.7
35.2
36
31
ZX090
NOMESCO Finland
Other technic of radiotherapy
3.0
34.7
155
527
9680/3-C77.2
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of intra-abdominal lymph nodes
+∞
34.4
33
*
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
3.0
34.2
158
547
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
4.9
34.2
75
155
N05CF01
ATC
zopiclone; oral
1.5
34.1
1312
9592
127
Kela drug reimbursment
Transplant complication
4.2
34.1
90
216
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
65.6
34.0
39
6
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
4.5
33.4
82
186
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
3.1
33.4
145
485
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
5.0
33.3
71
143
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.5
33.3
1409
10503
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
3.8
33.2
101
269
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.5
32.9
1530
11626
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
2.5
32.6
206
839
L01XX52
ATC
venetoclax; oral
11.9
32.5
33
28
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.0
32.5
408
2195
C84.59
ICD-10 Finland
Other and unspecified T-cell lymphomas
37.7
32.4
41
11
C83.59
ICD-10 Finland
Lymphoblastic lymphoma of indeterminate type
+∞
32.3
31
*
TGD00
NOMESCO Finland
Needle biopsy of lung
6.7
31.8
50
75
V03AF03
ATC
calcium folinate; systemic
11.5
31.8
33
29
WX402
NOMESCO Finland
General anaesthesia
1.6
31.3
848
5694
L01XE27
ATC
[U] ibrutinib
39.4
31.2
39
10
J02AC03
ATC
voriconazole; systemic
11.1
31.1
33
30
C71.90
ICD-10 Finland
Malignant tumor in unspecified localization in the brain without histology
10.1
30.9
35
35
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
6.0
30.7
54
91
C88.9
ICD-10 Finland
Malignant immunoproliferative disease, unspecified
110.9
30.7
33
*
Z52.89
ICD-10 Finland
Donor of other organ or tissue
46.6
30.6
37
8
C83.70
ICD-10 Finland
Non-Hodgkin's lymphoma of the Burkitt type
+∞
30.2
29
*
D37.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Small intestine
6.8
30.1
47
70
A79
ICPC
Malignancy NOS
3.5
29.8
105
309
L01BB05
ATC
fludarabine; systemic
28.8
29.8
40
14
399
Kela drug reimbursment
Venetoclax
10.7
29.5
32
30
9591/3-C77.4
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of inguinal region or leg
+∞
29.2
28
*
JMA11
NOMESCO Finland
Laparoscopic total splenectomy
11.6
29.1
30
26
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
4.3
29.0
74
173
9690/3-C77.9
ICD-O-3
Follicular lymphoma, NOS, of lymph node, NOS
40.4
29.0
36
9
N02BE01
ATC
paracetamol; systemic, rectal
1.7
28.9
3474
31767
JAL01
NOMESCO Finland
Laparoscopic biopsy of peritoneum
10.4
28.9
32
31
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
2.9
28.9
139
493
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
3.3
28.8
107
326
TNE20
NOMESCO Finland
Bone marrow aspiration, pelvis
11.2
28.4
30
27
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.5
28.4
1002
7131
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
2.6
28.3
165
646
I80.8
ICD-10 Finland
Phlebitis and thrombophlebitis of other sites
3.7
28.2
88
239
9680/3-C17.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of small intestine, NOS
+∞
28.2
27
*
A41.8
ICD-10 Finland
Other specified sepsis
3.0
27.6
121
407
120
Kela drug reimbursment
Hypogammaglobulinaemia
25.6
27.4
38
15
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
6.4
27.3
45
71
OAA41
NOMESCO Finland
Health check based on individual needs
7.4
27.1
39
53
C83.40
ICD-10 Finland
Immunoblast large cell lymphoma
+∞
27.1
26
*
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
2.9
27.1
127
444
Z51.3
ICD-10 Finland
Blood transfusion (without reported diagnosis)
38.1
27.1
34
9
J02AC01
ATC
fluconazole; systemic
1.5
27.0
1187
8831
EE1AA
NOMESCO Finland
X-ray of upper jaw or palate
8.4
27.0
35
42
9698/3-C77.9
ICD-O-3
Follicular lymphoma, grade 3 of lymph node, NOS
75.7
26.8
30
*
CFA20
NOMESCO Finland
Biopsy of conjunctiva
9.8
26.8
31
32
G62.0
ICD-10 Finland
Drug-induced polyneuropathy
8.2
26.5
35
43
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
2.0
26.2
320
1702
9680/3-C42.2
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of spleen
+∞
26.1
25
*
9679/3-C38.3
ICD-O-3
Mediastinal large B-cell lymphoma of mediastinum, NOS
+∞
26.1
25
*
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
23.3
26.1
37
16
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
3.6
26.0
87
248
D37.00
ICD-10 Finland
Aryepiglottic fold marginal zone
7.5
25.9
37
50
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
5.4
25.7
50
93
1518, ,
Kela drug reimbursment
10.1
25.6
29
29
Z2446
NOMESCO Finland
Social worker
2.1
25.5
253
1248
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
3.2
25.4
104
336
9680/3-C77.4
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph nodes of inguinal region or leg
+∞
25.0
24
*
9699/3-C34.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of lung, NOS
+∞
25.0
24
*
J01DB01
ATC
cefalexin; oral
1.5
25.0
3107
27909
PJ2HT
NOMESCO Finland
Biopsy of deep lymphnode with ultrasound guidance
58.4
25.0
29
5
C80.99
ICD-10 Finland
Malignant tumor without specified localization or histology
9.7
25.0
29
30
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
21.4
24.7
36
17
9680/3-C34.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lung, NOS
251.7
24.7
25
*
9680/3-C49.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues, NOS
251.7
24.7
25
*
TDM10
NOMESCO Finland
Puncture of maxillary antrum
2.6
24.7
151
606
JAH00
NOMESCO Finland
Laparotomy
2.6
24.3
141
551
9699/3-C77.8
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of lymph nodes of multiple regions
+∞
24.0
23
*
OAB38
NOMESCO Finland
Psychosocial guidance and counselling
7.2
23.7
35
49
PA7ST
NOMESCO Finland
Extensive medical infusion to cerebral artery
241.4
23.7
24
*
4701
FHL
Neck lymph node removal
19.6
23.4
35
18
WE300
NOMESCO Finland
Profylactive therapy of malignancy with biomoidiers
47.0
23.3
28
6
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
2.3
23.2
181
811
B02
ICPC
Lymph gland(s) enlarged/painful
5.1
23.0
48
95
C88.4
ICD-10 Finland
Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lyphoma]
+∞
22.9
22
*
9680/3-C22.0
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of liver
+∞
22.9
22
*
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
3.8
22.8
70
188
PA4AC
NOMESCO Finland
Vertebralis angiography with X-ray
9.4
22.6
27
29
1CX01, ,
NOMESCO Finland
19.0
22.5
34
18
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
2.5
22.4
137
550
B03XA02
ATC
darbepoetin alfa; parenteral
2.7
22.2
118
442
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
1.7
22.1
414
2509
ZX121
NOMESCO Finland
Central venous catheter
7.1
22.0
33
47
Z2221
NOMESCO Finland
Medical doctor
1.5
22.0
970
7168
1BC01, ,
NOMESCO Finland
+∞
21.9
21
*
9673/3-C09.9
ICD-O-3
Mantle cell lymphoma of tonsil, NOS
+∞
21.9
21
*
9680/3-C77.3
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph nodes of axilla or arm
+∞
21.9
21
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
4.5
21.7
53
120
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
2.3
21.7
173
783
9699/3-C42.1
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of bone marrow
80.6
21.7
24
*
JAH21
NOMESCO Finland
Staging laparoscopy
80.6
21.7
24
*
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
2.7
21.5
117
443
N02AX02
ATC
tramadol; systemic, rectal
1.4
21.5
1667
13605
JAH01
NOMESCO Finland
Laparoscopy
2.3
21.2
158
694
D43.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified
9.0
21.2
26
29
C82.7
ICD-10 Finland
Other types of follicular lymphoma
50.3
21.1
25
5
R4190
NOMESCO Finland
Nutritional therapy
2.3
20.9
156
686
9680/3-C49.0
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of head, face, and neck
+∞
20.8
20
*
Z51.0
ICD-10 Finland
Radiotherapy session
3.3
20.7
78
240
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
1.9
20.7
262
1409
Z01.8
ICD-10 Finland
Other specified special examinations
1.5
20.7
843
6126
9591/3-C16.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of stomach, NOS
211.1
20.6
21
*
9591/3-C09.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of tonsil, NOS
110.6
20.6
22
*
Z3231
NOMESCO Finland
Registered nurse
1.4
20.5
1036
7837
C84.49
ICD-10 Finland
Peripheral T-cell lymphoma, unspecified cell type
41.9
20.4
25
6
ZXE10
NOMESCO Finland
More than one and less than three hours
1.4
20.4
1334
10558
CAA30
NOMESCO Finland
Biopsy of orbit
22.5
20.3
29
13
C83.52
ICD-10 Finland
T-lymphoblastic lymphoma or leukemia
+∞
19.8
19
*
C83.7
ICD-10 Finland
Burkitt lymphoma
+∞
19.8
19
*
9699/3-C07.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of parotid gland
+∞
19.8
19
*
9690/3-C77.8
ICD-O-3
Follicular lymphoma, NOS, of lymph nodes of multiple regions
+∞
19.8
19
*
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
5.1
19.7
41
81
R50.8
ICD-10 Finland
Other specified fever
5.1
19.7
41
81
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
3.7
19.7
61
165
D73.1
ICD-10 Finland
Hypersplenism
29.1
19.6
26
9
C81.3
ICD-10 Finland
Lymphocyte depleted classical Hodgkin lymphoma
201.0
19.6
20
*
ENA10
NOMESCO Finland
Biopsy of pharynx
7.1
19.5
29
41
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.4
19.4
1235
9712
B01AB04
ATC
dalteparin; parenteral
2.0
19.4
215
1105
N03AX16
ATC
[U] pregabalin
1.5
19.4
851
6264
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
2.7
19.3
105
398
XW4CT
NOMESCO Finland
Biopsy of other inner organ with CT guidance
31.4
19.2
25
8
A05AA02
ATC
ursodeoxycholic acid; oral
3.5
19.2
66
192
EMB10
NOMESCO Finland
Tonsillectomy
2.5
19.2
126
524
PA3AC
NOMESCO Finland
Carotis angiography with X-ray
5.9
19.1
34
58
UJF32
NOMESCO Finland
Coloscopy
1.4
19.1
1046
8011
J01MA02
ATC
ciprofloxacin; systemic
1.4
19.1
1526
12444
EP2AT
NOMESCO Finland
Neck soft tissue cytology with ultrasound guidance
7.2
19.1
28
39
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
2.7
19.0
102
384
D37.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Stomach
4.3
19.0
49
116
J01CA04
ATC
amoxicillin; systemic
1.4
18.9
2924
26410
7856A
ICD-9 Finland
Symptoms involving cardiovascular system, Enlargement of lymph nodes
14.9
18.9
31
21
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
3.0
18.8
83
281
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.4
18.8
1395
11237
C81.2
ICD-10 Finland
Mixed cellularity classical Hodgkin lymphoma
23.8
18.6
26
11
C81.7
ICD-10 Finland
Other classical Hodgkin lymphoma
20.9
18.6
27
13
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
4.0
18.6
52
131
ZX080
NOMESCO Finland
Image guided radiotherapy
2.7
18.6
101
383
C85.0
ICD-10 Finland
Lymphosarcoma
100.5
18.6
20
*
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
3.3
18.6
69
211
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
4.2
18.4
49
119
ZXD10
NOMESCO Finland
Scheduled procedure
1.4
18.4
1376
11089
WPA13
NOMESCO Finland
Palliative consultation
5.1
18.3
38
75
9698/3-C77.8
ICD-O-3
Follicular lymphoma, grade 3 of lymph nodes of multiple regions
44.2
18.2
22
5
B74
ICPC
Malignant neoplasm blood other
13.6
18.2
31
23
GD6AD
NOMESCO Finland
CT of chest and neck
5.6
18.2
34
61
WX002
NOMESCO Finland
Sedation and analgesia
1.5
18.0
740
5370
D11.0
ICD-10 Finland
Benign neoplasm: Parotid gland
2.8
18.0
88
316
Z31.6
ICD-10 Finland
General counselling and advice on procreation
7.3
17.8
26
36
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
18.1
17.8
27
15
C83.6
ICD-10 Finland
Undifferentiated (diffuse) non-Hodgkin's lymphoma
+∞
17.7
17
*
9680/3-C18.0
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of cecum
+∞
17.7
17
*
9680/3-C50.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of breast, NOS
+∞
17.7
17
*
9680/3-C49.2
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of lower limb and hip
+∞
17.7
17
*
C83.5
ICD-10 Finland
Lymphoblastic (diffuse) lymphoma
+∞
17.7
17
*
9591/3-C77.1
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of intrathoracic lymph nodes
+∞
17.7
17
*
9591/3-C42.1
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of bone marrow
66.9
17.7
20
*
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
3.5
17.5
60
174
A07AA09
ATC
vancomycin; oral
3.0
17.4
75
251
9101
FHL
Bone biopsy
17.0
17.4
27
16
WX882
NOMESCO Finland
High dependency care
2.3
17.3
128
561
ELB30
NOMESCO Finland
Excision of submandibular gland
4.7
17.3
39
83
L04AD01
ATC
ciclosporin; systemic
3.0
17.2
77
263
C91.9
ICD-10 Finland
Lymphoid leukaemia, unspecified
12.6
17.1
30
24
J35.1
ICD-10 Finland
Hypertrophy of tonsils
4.1
17.0
46
113
D43.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, unspecified
7.5
17.0
24
32
NK1AT
NOMESCO Finland
Muscle biopsy with ultrasound guidance
7.5
17.0
24
32
UDQ12
NOMESCO Finland
Flexible laryngoscopy
1.9
16.9
218
1180
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
1.8
16.8
284
1670
L04AA06
ATC
mycophenolic acid; systemic
2.8
16.8
81
289
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.5
16.7
627
4465
N03AX14
ATC
levetiracetam; systemic
2.4
16.6
119
515
C82
ICD-10 Finland
Follicular lymphoma
90.5
16.6
18
*
9591/3-C77.3
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of axilla or arm
90.5
16.6
18
*
C80.90
ICD-10 Finland
Malignant tumor without specified localization without histology
7.0
16.5
25
36
9823/3-C77.8
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of lymph nodes of multiple regions
170.7
16.5
17
*
ZX114
NOMESCO Finland
Intramuscular
3.3
16.4
62
192
TQW99
NOMESCO Finland
Other minor procedure on skin
1.9
16.4
221
1214
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
3.7
16.4
51
139
WF099
NOMESCO Finland
Other radiotherapy
4.5
16.3
39
87
372
Kela drug reimbursment
Idelalisib
40.2
16.3
20
5
R4110
NOMESCO Finland
Physiotherapy
1.4
16.3
1036
8102
TGE00
NOMESCO Finland
Needle biopsy of mediastinum
5.3
16.1
32
61
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
2.3
16.0
123
549
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
3.7
15.8
50
138
9699/3-C69.0
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of conjunctiva
+∞
15.6
15
*
JM2AT
NOMESCO Finland
Biopsy of spleen with ultrasound guidance
+∞
15.6
15
*
ZXX04
NOMESCO Finland
Extent of procedure, 4 units
6.0
15.6
27
45
C84.51
ICD-10 Finland
Other and unspecified T-cell lymphomas
26.4
15.6
21
8
C82.0
ICD-10 Finland
Follicular lymphoma grade I
85.4
15.6
17
*
A06AD11
ATC
lactulose; oral
1.5
15.5
621
4470
9680/3-C38.3
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of mediastinum, NOS
160.6
15.5
16
*
9591/3-C77.8
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of multiple regions
160.6
15.5
16
*
TK800
NOMESCO Finland
Hemodialysis
2.5
15.4
97
396
J12.8
ICD-10 Finland
Other viral pneumonia
3.7
15.4
48
131
I42.7
ICD-10 Finland
Cardiomyopathy due to drugs and other external agents
38.2
15.4
19
5
G53.0
ICD-10 Finland
Postzoster neuralgia
3.9
15.4
44
113
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
3.7
15.3
47
127
XX2RW, ,
NOMESCO Finland
3.0
15.1
67
228
TPH07
NOMESCO Finland
Cathetrisation of artery
1.5
15.1
473
3239
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
3.1
15.1
62
202
QX4AT
NOMESCO Finland
Ultrsound guided needle biopsy of skin
5.6
15.1
28
50
PJ2CT
NOMESCO Finland
Biopsy of lymphnode with CT guidance
45.2
15.1
18
*
YN7AD
NOMESCO Finland
CT examination of spine for dose design of radiotherapy
5.1
15.0
31
61
GD6BD
NOMESCO Finland
Extensive CT of chest and neck
10.8
15.0
28
26
R93.8
ICD-10 Finland
Abnormal findings on diagnostic imaging of other specified body structures
4.6
14.9
35
77
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
2.9
14.9
71
252
L04AA01
ATC
[U] ciclosporin
3.2
14.8
59
189
C84.43
ICD-10 Finland
Peripheral T-cell lymphoma, large cell type
56.9
14.8
17
*
B99
ICD-10 Finland
Other and unspecified infectious diseases
2.5
14.8
89
356
D59.1
ICD-10 Finland
Other autoimmune haemolytic anaemias
5.0
14.8
31
62
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
2.0
14.7
165
852
EBA15
NOMESCO Finland
Extraction of multiple teeth
2.0
14.7
167
866
WZC15, ,
NOMESCO Finland
3.6
14.6
47
131
9699/3-C69.6
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of orbit, NOS
+∞
14.6
14
*
ZXD05
NOMESCO Finland
Urgent procedure
1.3
14.5
1050
8349
D10.4
ICD-10 Finland
Benign neoplasm: Tonsil
5.4
14.5
28
52
J94.8
ICD-10 Finland
Other specified pleural conditions
2.6
14.4
83
325
K63.1
ICD-10 Finland
Perforation of intestine (nontraumatic)
3.2
14.4
56
177
WVA20
NOMESCO Finland
Medicine administration
2.2
14.3
117
536
WPB10
NOMESCO Finland
Making a convalescent care decision
4.7
14.2
32
68
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
2.5
14.2
91
375
EB1BA
NOMESCO Finland
Extensive intraoral X-ray examination
5.3
14.2
28
53
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
4.1
14.2
38
93
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
1.8
14.2
231
1345
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
2.3
14.1
106
469
A02BC01
ATC
omeprazole; systemic
1.3
14.0
995
7882
ZXC95
NOMESCO Finland
Use of surgical navigator
3.1
14.0
57
185
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
2.4
13.9
98
422
I50.1
ICD-10 Finland
Left ventricular failure
1.7
13.8
230
1348
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
2.7
13.8
71
263
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.4
13.6
666
4964
9680/3-C17.2
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of ileum
+∞
13.5
13
*
9680/3-C30.0
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of nasal cavity
+∞
13.5
13
*
2002A
ICD-9 Finland
Lymphosarcoma and reticulosarcoma, Burkitt's tumour or lymphoma
+∞
13.5
13
*
9695/3-C77.8
ICD-O-3
Follicular lymphoma, grade 1 of lymph nodes of multiple regions
140.5
13.5
14
*
C10AA07
ATC
rosuvastatin; oral
0.7
13.4
825
10445
R2120
NOMESCO Finland
Counselling and guidance concerning rehabilitation services and social security
3.7
13.3
41
111
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
1.8
13.3
216
1256
L01AA01
ATC
cyclophosphamide; systemic
4.5
13.3
32
72
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
2.2
13.2
105
477
ZXX01
NOMESCO Finland
Extent of proceudre, 1 unit
4.2
13.1
34
81
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
4.0
13.1
37
94
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
3.8
13.1
39
103
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
2.6
13.1
74
287
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
1.7
13.1
262
1613
B37.09
ICD-10 Finland
Unspecified candidal stomatitis
3.2
13.1
50
156
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
2.7
13.0
68
254
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
2.2
13.0
113
532
CKA10
NOMESCO Finland
Biopsy of vitreous body
10.1
12.9
25
25
ZYC01
NOMESCO Finland
Remote contact by phone
1.8
12.9
210
1222
KA1AE
NOMESCO Finland
Kidney ultrasound examination
2.2
12.9
111
520
EP1AE, ,
SPAT
2.8
12.9
65
238
L98.9
ICD-10 Finland
Disorder of skin and subcutaneous tissue, unspecified
2.9
12.9
61
216
YX9AW, ,
NOMESCO Finland
4.0
12.9
36
91
ZXA00
NOMESCO Finland
Right side
1.3
12.8
987
7900
JAL00
NOMESCO Finland
Biopsy of peritoneum
5.1
12.7
26
51
EL4AT
NOMESCO Finland
Salivary gland cytology with ultrasound guidance
4.8
12.6
28
59
CA1BG
NOMESCO Finland
Eye and orbita MRI examination with high intensity magnet
5.5
12.6
24
44
JN5KR
NOMESCO Finland
Very extensive PET-CT of upper body metabolism (eyebrows to thighs)
5.5
12.6
24
44
SAA03
NOMESCO Finland
Extended examination of mouth
1.3
12.5
1216
10043
XF400
NOMESCO Finland
ECG with 12 standard connections
1.4
12.5
608
4523
1DB01, ,
NOMESCO Finland
+∞
12.5
12
*
9680/3-C49.3
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of thorax
+∞
12.5
12
*
9680/3-C41.4
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of pelvic bones, sacrum, coccyx and associated joints
+∞
12.5
12
*
C83.41
ICD-10 Finland
Immunoblastic (diffuse)
+∞
12.5
12
*
9680/3-C49.6
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of trunk, NOS
+∞
12.5
12
*
9691/3-C77.8
ICD-O-3
Follicular lymphoma, grade 2 of lymph nodes of multiple regions
20.1
12.4
18
9
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
3.2
12.4
48
151
9670/3-C77.9
ICD-O-3
Malignant lymphoma, small B lymphocytic, NOS, of lymph node, NOS
130.4
12.4
13
*
R05
ICD-10 Finland
Cough
1.4
12.4
737
5667
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
3.1
12.4
51
167
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.5
12.4
365
2466
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.7
12.3
231
1399
D86.0
ICD-10 Finland
Sarcoidosis of lung
3.1
12.2
51
168
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.4
12.2
650
4907
A03
ICPC
Fever
1.5
12.2
480
3434
YN1AD
NOMESCO Finland
CT examination of extremities for dose design of radiotherapy
9.7
12.2
24
25
L01XX47
ATC
[U] idelalisib
37.6
12.2
15
*
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
4.4
12.1
30
69
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.7
12.1
224
1351
WPA10
NOMESCO Finland
Proactive palliative care treatment plan
3.2
12.0
47
149
PA7RT
NOMESCO Finland
Medical infusion to cerebral artery
21.3
12.0
17
8
R59
ICD-10 Finland
Enlarged lymph nodes
21.3
12.0
17
8
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
2.3
12.0
92
412
C71.99
ICD-10 Finland
Malignant tumor in unspecified localization in the brain other or unspecified histology
13.4
11.9
20
15
WX892
NOMESCO Finland
Monitored bed care
1.6
11.8
295
1920
D73.9
ICD-10 Finland
Disease of spleen, unspecified
30.1
11.6
15
5
A04AA55
ATC
palonosetron, combinations; systemic
2.0
11.6
116
576
N05BA06
ATC
lorazepam; systemic, sublingual
1.7
11.6
196
1153
I42.0
ICD-10 Finland
Dilated cardiomyopathy
2.1
11.6
113
556
C81
ICD-10 Finland
Hodgkin lymphoma
65.1
11.6
13
*
ZX100
NOMESCO Finland
Oral
2.6
11.6
64
246
D37.08
ICD-10 Finland
Tumor of uncertain or unknown nature in other part of lip, oral cavity and pharynx
5.3
11.5
23
44
6BA02, ,
NOMESCO Finland
9.2
11.5
23
25
9688/3-C77.9
ICD-O-3
T-cell/histiocyte rich large B-cell lymphoma of lymph node, NOS
+∞
11.5
11
*
9699/3-C44.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of skin, NOS
+∞
11.5
11
*
9699/3-C08.0
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of submandibular gland
+∞
11.5
11
*
9687/3-C77.9
ICD-O-3
Burkitt lymphoma, NOS, of lymph node, NOS
+∞
11.5
11
*
9680/3-C17.0
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of duodenum
+∞
11.5
11
*
9680/3-C48.0
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of retroperitoneum
+∞
11.5
11
*
H26.3
ICD-10 Finland
Drug-induced cataract
4.0
11.5
32
81
D48.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue
2.5
11.5
73
301
2019X
ICD-9 Finland
Hodgkin's disease, unspecified
120.4
11.4
12
*
B00.19
ICD-10 Finland
Other vesicular dermatitis caused by the herper simplex virus
4.0
11.4
31
77
J01FF01
ATC
clindamycin; systemic
1.3
11.3
919
7392
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
1.4
11.2
509
3736
D31.6
ICD-10 Finland
Benign neoplasm: Orbit, unspecified
10.5
11.2
21
20
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
2.7
11.2
60
227
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
1.8
11.2
151
831
D04.5
ICD-10 Finland
Carcinoma in situ: Skin of trunk
2.8
11.2
54
194
A49.8
ICD-10 Finland
Other bacterial infections of unspecified site
3.2
11.1
43
136
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
1.7
11.1
183
1071
B73
ICPC
Leukaemia
8.6
11.0
23
27
ZX130
NOMESCO Finland
Epidural
5.7
11.0
20
35
J70.2
ICD-10 Finland
Acute drug-induced interstitial lung disorders
5.7
11.0
20
35
YN1BD
NOMESCO Finland
Extensive CT examination of extremities for dose design of radiotherapy
9.2
11.0
22
24
ZXA05
NOMESCO Finland
Left side
1.3
11.0
891
7162
A02BA02
ATC
ranitidine; systemic
1.3
10.9
701
5444
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
3.3
10.9
40
122
9663/3-C77.8
ICD-O-3
Hodgkin lymphoma, nodular sclerosis, NOS, of lymph nodes of multiple regions
43.4
10.9
13
*
B03XA01
ATC
erythropoietin; parenteral
3.0
10.9
46
153
SPAT1153
SPAT
Removal of sutures
1.3
10.8
1171
9771
D80.3
ICD-10 Finland
Selective deficiency of immunoglobulin G [IgG] subclasses
11.9
10.8
19
16
XX1AD
NOMESCO Finland
Other CT-examination
3.3
10.8
39
118
EBA10
NOMESCO Finland
Operative extraction of tooth
1.5
10.8
335
2287
UJF30
NOMESCO Finland
Ileoscopy through colon
1.5
10.8
369
2570
A04AD12
ATC
aprepitant; systemic
2.4
10.7
70
293
C84.41
ICD-10 Finland
Peripheral T-cell lymphoma, medium-sized cell type
60.2
10.6
12
*
HA1AA
NOMESCO Finland
X-ray mammography
1.6
10.6
246
1574
L57.0
ICD-10 Finland
Actinic keratosis
1.4
10.6
451
3274
AAF30
NOMESCO Finland
Implantation of intraventricular injection device
110.3
10.4
11
*
9691/3-C77.0
ICD-O-3
Follicular lymphoma, grade 2 of lymph nodes of head, face and neck
110.3
10.4
11
*
9690/3-C42.1
ICD-O-3
Follicular lymphoma, NOS, of bone marrow
+∞
10.4
10
*
9680/3-C41.2
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of vertebral column
+∞
10.4
10
*
C88.7
ICD-10 Finland
Other malignant immunoproliferative diseases
+∞
10.4
10
*
9690/3-C77.0
ICD-O-3
Follicular lymphoma, NOS, of lymph nodes of head, face and neck
+∞
10.4
10
*
9680/3-C44.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of skin, NOS
+∞
10.4
10
*
S04
ICPC
Lump/swelling localized
1.5
10.4
353
2454
D89.89
ICD-10 Finland
Other specified disorders involving the immune mechanism, not elsewhere classified
32.6
10.3
13
*
R11
ICD-10 Finland
Nausea and vomiting
1.5
10.2
292
1961
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.3
10.1
786
6271
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.3
10.1
914
7443
WX704
NOMESCO Finland
Intubation
1.5
10.1
277
1843
A06AH03
ATC
naloxegol; oral
2.4
10.0
65
271
PJD43
NOMESCO Finland
Excision of aortic lymph nodes
10.0
10.0
19
19
9671/3-C42.1
ICD-O-3
Lymphoplasmacytic lymphoma of bone marrow
40.2
10.0
12
*
ZYC03
NOMESCO Finland
Remote contact, text-based
3.8
9.9
29
76
A40.8
ICD-10 Finland
Other streptococcal sepsis
2.7
9.9
51
190
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
2.2
9.9
83
387
R53
ICD-10 Finland
Malaise and fatigue
1.3
9.9
842
6803
9761/3-C42.0
ICD-O-3
Waldenstrom macroglobulinemia of blood
10.6
9.8
18
17
P01BA02
ATC
hydroxychloroquine; oral
1.6
9.7
257
1695
B99
ICPC
Blood/lymph/spleen disease other
4.1
9.7
26
64
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
2.0
9.6
98
491
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
1.5
9.6
287
1942
2015X
ICD-9 Finland
Hodgkin's disease, Nodular sclerosis[MORBUS HODGKIN, NODULAR SCLEROSIS, NUD]
55.1
9.6
11
*
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
1.8
9.6
140
791
R93.3
ICD-10 Finland
Abnormal findings on diagnostic imaging of other parts of digestive tract
3.7
9.6
29
78
P01AB01
ATC
metronidazole; oral, rectal
1.3
9.6
1249
10628
EP1BG
NOMESCO Finland
MRI examination of soft tissue of neck with high intesity magnet
4.4
9.5
23
52
WX199
NOMESCO Finland
Other local analgesia
1.8
9.5
135
756
I82.88
ICD-10 Finland
Embolism and thrombosis of other specified veins
2.2
9.5
75
341
NK6BN
NOMESCO Finland
Bone dynamic isotope examination
7.1
9.5
22
31
RS220, ,
NOMESCO Finland
2.8
9.4
47
172
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
1.9
9.4
115
614
9705/3-C77.9
ICD-O-3
Angioimmunoblastic T-cell lymphoma of lymph node, NOS
100.3
9.4
10
*
3AX16, ,
NOMESCO Finland
100.3
9.4
10
*
JA3HT
NOMESCO Finland
Tissue sample of abdominal tissue change under UA control
30.1
9.4
12
*
9699/3-C80.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of unknown primary site
+∞
9.4
9
*
9680/3-C11.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of nasopharynx, NOS
+∞
9.4
9
*
9680/3-C64.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of kidney, NOS
+∞
9.4
9
*
9689/3-C42.1
ICD-O-3
Splenic marginal zone B-cell lymphoma of bone marrow
+∞
9.4
9
*
9673/3-C80.9
ICD-O-3
Mantle cell lymphoma of unknown primary site
+∞
9.4
9
*
1CA02, ,
NOMESCO Finland
+∞
9.4
9
*
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
2.2
9.4
75
343
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
12.4
9.3
16
13
9663/3-C77.9
ICD-O-3
Hodgkin lymphoma, nodular sclerosis, NOS, of lymph node, NOS
21.7
9.3
13
6
Z51.88
ICD-10 Finland
Other specified medical care
2.1
9.3
82
389
R93.5
ICD-10 Finland
Abnormal findings on diagnostic imaging of other abdominal regions, including retroperitoneum
2.7
9.3
49
185
D43.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, infratentorial
9.5
9.3
18
19
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
2.7
9.2
48
180
TPH40
NOMESCO Finland
Insertion of a long peripheral venous catheter
3.0
9.2
40
136
AA1AD
NOMESCO Finland
CT of head and brain
1.3
9.1
1142
9657
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
3.6
9.1
29
81
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
2.3
9.1
63
271
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
1.9
9.1
113
608
2390A
ICD-9 Finland
Neoplasm of unspecified nature, Digestive system
4.8
9.1
20
42
NA2CG
NOMESCO Finland
Thoracal spine extensive MRI examination with high intensity magnet
3.0
9.0
39
132
B34.9
ICD-10 Finland
Viral infection, unspecified
2.1
8.9
79
376
D86.2
ICD-10 Finland
Sarcoidosis of lung with sarcoidosis of lymph nodes
3.1
8.9
35
112
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
2.2
8.9
74
344
I89.9
ICD-10 Finland
Noninfective disorder of lymphatic vessels and lymph nodes, unspecified
12.5
8.9
15
12
D72.9
ICD-10 Finland
Disorder of white blood cells, unspecified
4.9
8.8
19
39
D11.70
ICD-10 Finland
Gland sublingual
4.9
8.8
19
39
5702
FHL
Local lymph node removal (eg armpit, groin)
4.5
8.8
21
47
PJ4AT
NOMESCO Finland
Labeling lymphnode with ultrasound guidance
10.7
8.8
16
15
R22.7
ICD-10 Finland
Localized swelling, mass and lump, multiple sites
9.5
8.8
17
18
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
1.8
8.7
128
726
WX720
NOMESCO Finland
Own respiration
1.7
8.7
170
1044
C90.0
ICD-10 Finland
Multiple myeloma
2.4
8.6
55
228
WX302
NOMESCO Finland
Thoracal epidural anesthesy
1.6
8.6
190
1202
XX3AT
NOMESCO Finland
Other labeling with ultrasound guidance
3.7
8.6
26
70
JJ1CE
NOMESCO Finland
Liver, bile duct and pancreas endoscopic ultrasound examination
4.0
8.6
24
61
H05.9
ICD-10 Finland
Disorder of orbit, unspecified
16.3
8.5
13
8
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
1.5
8.5
252
1703
GDA11
NOMESCO Finland
Thoracoscopic biopsy of lung
4.1
8.5
23
57
Z08.9
ICD-10 Finland
Follow-up examination after unspecified treatment for malignant neoplasm
3.8
8.5
25
66
9702/3-C77.9
ICD-O-3
Mature T-cell lymphoma, NOS, of lymph node, NOS
27.6
8.5
11
*
D73.0
ICD-10 Finland
Hyposplenism
27.6
8.5
11
*
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
2.4
8.5
55
230
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.5
8.4
263
1798
9680/3-C25.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of pancreas, NOS
90.3
8.4
9
*
J17.1*B25.0
ICD-10 Finland
Cytomegaloviral pneumonitis
90.3
8.4
9
*
9591/3-C17.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of small intestine, NOS
90.3
8.4
9
*
K11.2
ICD-10 Finland
Sialoadenitis
1.9
8.4
105
566
WPA15
NOMESCO Finland
Palliative care consultation with the patient and loved ones
3.5
8.4
28
81
J01.4
ICD-10 Finland
Acute pansinusitis
3.5
8.4
28
81
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
2.2
8.3
64
288
9680/3-C06.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of mouth, NOS
+∞
8.3
8
*
9690/3-C77.4
ICD-O-3
Follicular lymphoma, NOS, of lymph nodes of inguinal region or leg
+∞
8.3
8
*
9680/3-C16.2
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of body of stomach
+∞
8.3
8
*
C83.4
ICD-10 Finland
Immunoblastic (diffuse) non-Hodgkin's lymphoma
+∞
8.3
8
*
9670/3-C77.0
ICD-O-3
Malignant lymphoma, small B lymphocytic, NOS, of lymph nodes of head, face and neck
+∞
8.3
8
*
9680/3-C49.4
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of abdomen
+∞
8.3
8
*
9688/3-C77.8
ICD-O-3
T-cell/histiocyte rich large B-cell lymphoma of lymph nodes of multiple regions
+∞
8.3
8
*
9680/3-C07.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of parotid gland
+∞
8.3
8
*
I10
ICD-10 Finland
Essential (primary) hypertension
0.8
8.3
2103
22954
CBA10
NOMESCO Finland
Biopsy of eyelid
2.7
8.3
43
161
121
Kela drug reimbursment
Severe hypofunction of sexual glands
2.3
8.3
59
257
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
2.0
8.3
86
435
J01AA02
ATC
doxycycline; systemic
1.2
8.3
2792
26086
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
4.1
8.2
22
54
CA1CM
NOMESCO Finland
Eye and orbita extensive MRI examination with 3 Tesla magnet
7.1
8.2
19
27
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.4
8.2
409
3048
B04
ICPC
Blood symptom/complaint
3.3
8.2
30
92
Z51.4
ICD-10 Finland
Preparatory care for subsequent treatment, not elsewhere classified
2.7
8.1
43
163
C69.60
ICD-10 Finland
Malignant tumor in orbit without histology
33.4
8.1
10
*
Z03.1
ICD-10 Finland
Observation for suspected malignant neoplasm
2.1
8.1
74
358
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.3
8.0
528
4109
R19.8
ICD-10 Finland
Other specified symptoms and signs involving the digestive system and abdomen
2.4
8.0
52
218
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
1.9
7.9
95
506
WPA45
NOMESCO Finland
Continuous drug infusion in palliative care
4.6
7.9
18
39
AA5DR
NOMESCO Finland
Brain metabolism PET with CT
7.8
7.9
17
22
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
2.5
7.8
47
190
D47.7
ICD-10 Finland
Other specified neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue
10.8
7.8
14
13
C91.7
ICD-10 Finland
Other lymphoid leukaemia
9.4
7.8
15
16
B00.11
ICD-10 Finland
Herpes simplex labialis
2.5
7.7
46
185
JAH20
NOMESCO Finland
Staging laparotomy
15.0
7.7
12
8
5701
FHL
Local exploration of lymph nodes (includes biopsy)
15.0
7.7
12
8
QBE99
NOMESCO Finland
Other excision or repair of lesion of skin of trunk
2.1
7.7
66
312
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
2.1
7.7
72
352
ZXC50
NOMESCO Finland
Cryotherapy
1.7
7.7
129
762
I50.9
ICD-10 Finland
Heart failure, unspecified
1.3
7.6
605
4827
WE100
NOMESCO Finland
Profylactic cytostatic therapy
18.4
7.6
11
6
EP3AT
NOMESCO Finland
Neck soft tissue biopsy with ultrasound guidance
11.9
7.6
13
11
JN4DD
NOMESCO Finland
Scout CT scan of torso
8.9
7.5
15
17
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
2.0
7.5
75
375
KBV15
NOMESCO Finland
Cystoscopic change of ureteral stent
3.1
7.4
30
98
9591/3-C62.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of testis, NOS
80.2
7.4
8
*
KA3CT
NOMESCO Finland
Biopsy of kidney under CT guidance
80.2
7.4
8
*
D86.1
ICD-10 Finland
Sarcoidosis of lymph nodes
3.5
7.4
24
68
Z94.1
ICD-10 Finland
Heart transplant status
6.5
7.4
18
28
1AA01, ,
NOMESCO Finland
13.4
7.4
12
9
D46.9
ICD-10 Finland
Myelodysplastic syndrome, unspecified
3.3
7.4
26
78
N17.9
ICD-10 Finland
Acute renal failure, unspecified
1.6
7.4
173
1113
FB1AD
NOMESCO Finland
CT examination of arteria pulmonalis
1.9
7.3
92
498
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
1.7
7.3
119
697
9680/3-C01.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of base of tongue, NOS
+∞
7.3
7
*
20013
ICD-8 Finland
Lymphosarcoma and reticulum-cell sarcoma, Lymphosarcoma loco alio (lymphonodis intrathoracalibus et intra-abdominalibus inclusis)
+∞
7.3
7
*
9670/3-C77.8
ICD-O-3
Malignant lymphoma, small B lymphocytic, NOS, of lymph nodes of multiple regions
+∞
7.3
7
*
D76.1
ICD-10 Finland
Haemophagocytic lymphohistiocytosis
+∞
7.3
7
*
9680/3-C73.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of thyroid gland
+∞
7.3
7
*
9680/3-C49.1
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of upper limb and shoulder
+∞
7.3
7
*
JM1AT
NOMESCO Finland
Cytology of spleen with ultrasound guidance
+∞
7.3
7
*
3AF07, ,
NOMESCO Finland
+∞
7.3
7
*
WYA00
NOMESCO Finland
Screening and health check-up
2.3
7.3
50
215
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
2.6
7.3
39
149
D10.6
ICD-10 Finland
Benign neoplasm: Nasopharynx
6.8
7.3
17
25
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.2
7.3
1492
13214
M80.8
ICD-10 Finland
Other osteoporosis with pathological fracture
3.5
7.3
24
69
D86.9
ICD-10 Finland
Sarcoidosis, unspecified
3.2
7.3
28
89
J12.1
ICD-10 Finland
Respiratory syncytial virus pneumonia
3.2
7.3
28
89
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
1.7
7.2
122
721
XJD02
NOMESCO Finland
Peroral endoscopic ultrasonography
2.5
7.2
42
167
B44.0
ICD-10 Finland
Invasive pulmonary aspergillosis
15.8
7.2
11
7
J94.0
ICD-10 Finland
Chylous effusion
15.8
7.2
11
7
C84.5
ICD-10 Finland
Other mature T/NK-cell lymphomas
15.8
7.2
11
7
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
1.6
7.2
146
906
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
2.5
7.2
43
174
6103
FHL
Staging laparotomy (to study the reticuloendothelial system)
30.1
7.1
9
*
C38.3
ICD-10 Finland
Malignant neoplasm: Mediastinum, part unspecified
20.0
7.1
10
5
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
1.5
7.1
200
1339
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
2.6
7.1
40
157
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
1.4
7.1
290
2091
T80.8
ICD-10 Finland
Other complications following infusion, transfusion and therapeutic injection
8.8
7.0
14
16
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
1.8
7.0
96
534
N06DX01
ATC
memantine; oral
0.6
7.0
149
2307
KA3EB
NOMESCO Finland
Antegrade pyelography
3.1
7.0
28
91
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.8
6.9
517
6458
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
1.4
6.9
323
2381
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
6.3
6.9
17
27
N02AJ06
ATC
codeine and paracetamol; systemic
1.2
6.9
1412
12484
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.3
6.9
485
3804
JF1CG
NOMESCO Finland
Extensive MRI of small bowel
3.7
6.9
21
57
ELB00
NOMESCO Finland
Excision or exploration of lesion of salivary gland
5.8
6.9
18
31
JN6CD
NOMESCO Finland
Very extensive CT of torso and neck
13.8
6.9
11
8
3AA02, ,
NOMESCO Finland
13.8
6.9
11
8
J02AC04
ATC
posaconazole; systemic
13.8
6.9
11
8
R07.0
ICD-10 Finland
Pain in throat
1.6
6.9
171
1115
D64.8
ICD-10 Finland
Other specified anaemias
2.0
6.9
73
374
ZXC40
NOMESCO Finland
Use of ultrasound
3.3
6.8
25
77
R22.2
ICD-10 Finland
Localized swelling, mass and lump, trunk
1.8
6.8
105
606
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.3
6.8
613
4970
Z94.0
ICD-10 Finland
Kidney transplant status
2.6
6.8
38
149
2301
FHL
Lumbar puncture in anesthesia or operating room
40.1
6.8
8
*
9591/3-C80.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of unknown primary site
40.1
6.8
8
*
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
2.4
6.8
42
173
B02
ICD-10 Finland
Zoster [herpes zoster]
1.6
6.7
153
977
A04AA03
ATC
tropisetron; systemic
4.3
6.7
17
40
WW302
NOMESCO Finland
Allogenic transfer of stem cells from relative
16.7
6.7
10
6
9663/3-C77.0
ICD-O-3
Hodgkin lymphoma, nodular sclerosis, NOS, of lymph nodes of head, face and neck
16.7
6.7
10
6
XX9BW
NOMESCO Finland
Submitting image material and/or investigation material to authority or other institution
2.2
6.7
54
249
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
2.0
6.6
67
337
WX725
NOMESCO Finland
Noninvasive ventilation
1.5
6.6
182
1214
ZYY98
NOMESCO Finland
Missed treatment contact, no notification given by patient
4.0
6.6
18
45
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
1.9
6.6
76
401
J70.4
ICD-10 Finland
Drug-induced interstitial lung disorders, unspecified
12.3
6.6
11
9
EL3AT
NOMESCO Finland
Salivary gland biopsy with ultrasound guidance
12.3
6.6
11
9
XX1XW
NOMESCO Finland
Extensive written report from radiologist
1.9
6.6
74
387
XFE00
NOMESCO Finland
Epicardial ultrasonography
1.9
6.6
83
451
SAA04
NOMESCO Finland
Special examination of mouth
1.6
6.5
147
938
EB1AI
NOMESCO Finland
Cone beam imaging of teeth and jaws (one quarter)
2.2
6.5
53
246
XG410
NOMESCO Finland
Flow-volume spirometry
1.6
6.5
133
829
J01.1
ICD-10 Finland
Acute frontal sinusitis
2.3
6.5
45
195
GA3AT
NOMESCO Finland
Pleural cytology with ultrasound guidance
3.6
6.5
20
55
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
1.5
6.5
205
1409
PJD99
NOMESCO Finland
Excision of other lymph nodes
6.2
6.5
16
26
C76.2
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Abdomen
5.7
6.4
17
30
C779, 9715, 3
ICD-O-3
70.0
6.4
7
*
9920/3-C42.1
ICD-O-3
Therapy-related myeloid neoplasm of bone marrow
70.0
6.4
7
*
1XX08, ,
NOMESCO Finland
70.0
6.4
7
*
9591/3-C71.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of brain, NOS
70.0
6.4
7
*
A02BC05
ATC
esomeprazole; systemic
1.2
6.4
1350
11949
C10AX09
ATC
ezetimibe; oral
0.8
6.4
404
5162
201
Kela drug reimbursment
Chronic cardiac insufficiency
1.5
6.4
219
1530
D04.2
ICD-10 Finland
Carcinoma in situ: Skin of ear and external auricular canal
3.0
6.3
26
86
N74
ICPC
Malignant neoplasm nervous system
8.1
6.3
13
16
C07AB07
ATC
bisoprolol; oral
1.2
6.3
1921
17549
NA3DG
NOMESCO Finland
Lumbar spine very extensive MRI examination with high intensity magnet
2.9
6.3
28
97
EMA30
NOMESCO Finland
Biopsy of rhinopharynx
5.9
6.3
16
27
B37.08
ICD-10 Finland
Other candidal stomatitis
2.6
6.3
34
131
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
1.7
6.3
100
583
J35.9
ICD-10 Finland
Chronic disease of tonsils and adenoids, unspecified
9.3
6.3
12
13
J04BA02
ATC
dapsone; oral
3.5
6.3
21
61
NE1DG
NOMESCO Finland
Pelvic, hip and femur very extensive MRI examination with high intensity magnet
3.3
6.3
23
71
WF029
NOMESCO Finland
Radiotherapy of local residive tumor
2.7
6.3
31
114
Z31.8
ICD-10 Finland
Other procreative management
18.0
6.3
9
5
QXA50
NOMESCO Finland
Skin cryotherapy, unspecified location
2.9
6.3
27
92
9680/3-C67.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of bladder, NOS
+∞
6.2
6
*
PJ023
NOMESCO Finland
Adjuvant radiotherapy of mediastinal lymphnodes
+∞
6.2
6
*
C85
ICD-10 Finland
Other and unspecified types of non-Hodgkin lymphoma
+∞
6.2
6
*
9673/3-C16.9
ICD-O-3
Mantle cell lymphoma of stomach, NOS
+∞
6.2
6
*
9673/3-C77.3
ICD-O-3
Mantle cell lymphoma of lymph nodes of axilla or arm
+∞
6.2
6
*
9673/3-C77.0
ICD-O-3
Mantle cell lymphoma of lymph nodes of head, face and neck
+∞
6.2
6
*
9673/3-C77.4
ICD-O-3
Mantle cell lymphoma of lymph nodes of inguinal region or leg
+∞
6.2
6
*
AAF35
NOMESCO Finland
Implantation of reservoir for intraventricular therapy
+∞
6.2
6
*
9680/3-C62.1
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of descended testis
+∞
6.2
6
*
9591/3-C06.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of mouth, NOS
+∞
6.2
6
*
1AD01, ,
NOMESCO Finland
+∞
6.2
6
*
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
1.6
6.2
149
965
P20
ICPC
Memory disturbance
0.8
6.2
363
4688
M01CB01
ATC
sodium aurothiomalate; parenteral
2.3
6.2
44
193
J94.9
ICD-10 Finland
Pleural condition, unspecified
3.1
6.2
25
82
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
1.6
6.2
132
832
M84.4
ICD-10 Finland
Pathological fracture, not elsewhere classified
4.0
6.2
17
43
L04AX01
ATC
azathioprine; systemic
1.6
6.1
119
732
B28
ICPC
Limited function/disability (B)
3.2
6.1
23
72
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
3.3
6.1
22
67
D04.4
ICD-10 Finland
Carcinoma in situ: Skin of scalp and neck
2.4
6.1
40
169
OAB77
NOMESCO Finland
Discussion on exercise habits and instruction concerning use of sports and fitness services
7.7
6.1
13
17
6753
FHL
Transabdominal splenectomy
7.7
6.1
13
17
NK1XE
NOMESCO Finland
Other ultrasound examinnation of muscle or tendon
2.6
6.1
34
133
I82.9
ICD-10 Finland
Embolism and thrombosis of unspecified vein
2.0
6.1
64
327
R81
ICPC
Pneumonia
1.6
6.1
128
803
C95.9
ICD-10 Finland
Leukaemia, unspecified
12.5
6.1
10
8
C69.00
ICD-10 Finland
Malignant tumor of the conjunctiva without histology
12.5
6.1
10
8
N06DA02
ATC
donepezil; oral
0.6
6.1
109
1753
JF1BD
NOMESCO Finland
Very extensive small bowel CT
3.1
6.0
24
78
D44.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Thyroid gland
2.2
6.0
46
208
Z08.2
ICD-10 Finland
Follow-up examination after chemotherapy for malignant neoplasm
10.0
6.0
11
11
D73.5
ICD-10 Finland
Infarction of spleen
6.7
6.0
14
21

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
filgrastim; parenteral
L03AA02 [21603851]
2.3e+00
2.7e+00
4.1e+00
1.0e+50
6.8e+00
6.2e+00
3.3e+00
cases:1.16%
controls:0.12%
cases:1.24%
controls:0.08%
cases:1.57%
controls:0.03%
cases:0.25%
controls:0.00%
cases:14.23%
controls:0.02%
cases:26.48%
controls:0.07%
cases:6.43%
controls:0.24%
46
47
3910
39494
49
33
3907
39508
62
10
3894
39531
10
0
3946
39541
547
7
3297
39465
927
27
2574
38300
176
78
2562
32345
Medical Oncology
90 [38004507]
6.7e-01
1.3e+00
2.9e+00
7.1e+00
5.1e+00
4.7e+00
3.8e+00
cases:8.16%
controls:4.35%
cases:10.79%
controls:3.11%
cases:16.94%
controls:1.11%
cases:53.36%
controls:0.09%
cases:62.75%
controls:1.04%
cases:76.18%
controls:2.88%
cases:70.49%
controls:5.27%
323
1722
3633
37819
427
1230
3529
38311
670
439
3286
39102
2111
36
1845
39505
2412
412
1432
39060
2667
1103
834
37224
1930
1709
808
30714
Demanding antibody therapy of methastized malignancy
WD415 [2001310689]
2.3e+00
2.8e+00
3.3e+00
1.0e+50
6.6e+00
6.1e+00
3.7e+00
cases:0.63%
controls:0.06%
cases:0.81%
controls:0.05%
cases:0.63%
controls:0.02%
cases:2.25%
controls:0.00%
cases:9.70%
controls:0.02%
cases:15.45%
controls:0.04%
cases:3.07%
controls:0.08%
25
25
3931
39516
32
20
3924
39521
25
9
3931
39532
89
0
3867
39541
373
6
3471
39466
541
15
2960
38312
84
25
2654
32398
Follicular lymphoma grade II
C82.1 [45532946]
3.3e+00
3.5e+00
3.9e+00
1.0e+50
4.5e+00
4.0e+00
4.2e+00
cases:2.07%
controls:0.08%
cases:2.30%
controls:0.07%
cases:1.72%
controls:0.04%
cases:1.01%
controls:0.00%
cases:1.80%
controls:0.02%
cases:3.77%
controls:0.07%
cases:4.67%
controls:0.07%
82
30
3874
39511
91
27
3865
39514
68
14
3888
39527
40
0
3916
39541
69
8
3775
39464
132
28
3369
38299
128
24
2610
32399
Chemotherapy session for neoplasm
Z51.1 [45595526]
2.4e+00
2.1e+00
3.6e+00
1.0e+50
5.7e+00
5.4e+00
3.5e+00
cases:0.51%
controls:0.05%
cases:0.38%
controls:0.05%
cases:0.53%
controls:0.02%
cases:2.12%
controls:0.00%
cases:5.12%
controls:0.02%
cases:8.28%
controls:0.04%
cases:2.70%
controls:0.08%
20
18
3936
39523
15
19
3941
39522
21
6
3935
39535
84
0
3872
39541
197
7
3647
39465
290
15
3211
38312
74
26
2664
32397
Simple antiboidy therapy of methastized malignancy
WD405 [2001310688]
1.9e+00
2.3e+00
2.6e+00
—
5.9e+00
5.5e+00
4.0e+00
cases:0.76%
controls:0.11%
cases:1.16%
controls:0.12%
cases:0.76%
controls:0.06%
—
—
cases:15.95%
controls:0.05%
cases:23.31%
controls:0.12%
cases:8.77%
controls:0.18%
30
45
3926
39496
46
48
3910
39493
30
23
3926
39518
—
613
21
3231
39451
816
46
2685
38281
240
59
2498
32364
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
117 [2001600117]
2.6e+00
3.6e+00
—
1.0e+50
8.5e+00
4.6e+00
2.4e+00
cases:3.49%
controls:0.28%
cases:3.46%
controls:0.10%
—
—
cases:3.56%
controls:0.00%
cases:45.08%
controls:0.02%
cases:8.23%
controls:0.09%
cases:4.02%
controls:0.36%
138
111
3818
39430
137
39
3819
39502
—
141
0
3815
39541
1733
6
2111
39466
288
36
3213
38291
110
117
2628
32306
sulfamethoxazole and trimethoprim
J01EE01 [21602961]
1.3e+00
2.4e+00
3.2e+00
1.0e+50
5.8e+00
5.0e+00
3.0e+00
cases:1.85%
controls:0.50%
cases:2.33%
controls:0.21%
cases:1.87%
controls:0.08%
cases:0.81%
controls:0.00%
cases:16.94%
controls:0.06%
cases:29.65%
controls:0.28%
cases:12.45%
controls:0.73%
73
198
3883
39343
92
83
3864
39458
74
30
3882
39511
32
0
3924
39541
651
25
3193
39447
1038
106
2463
38221
341
236
2397
32187
Follicular nodular lymphoma, grade I
C82.01 [2000501221]
3.1e+00
3.2e+00
3.5e+00
1.0e+50
3.8e+00
3.4e+00
3.6e+00
cases:0.96%
controls:0.04%
cases:0.88%
controls:0.04%
cases:0.51%
controls:0.02%
cases:0.25%
controls:0.00%
cases:0.57%
controls:0.01%
cases:1.23%
controls:0.04%
cases:1.90%
controls:0.06%
38
17
3918
39524
35
14
3921
39527
20
6
3936
39535
10
0
3946
39541
22
5
3822
39467
43
16
3458
38311
52
18
2686
32405
pegfilgrastim; parenteral
L03AA13 [21603856]
1.3e+00
1.7e+00
3.1e+00
—
5.7e+00
5.7e+00
2.6e+00
cases:0.91%
controls:0.25%
cases:0.91%
controls:0.17%
cases:0.81%
controls:0.04%
—
—
cases:12.25%
controls:0.05%
cases:26.16%
controls:0.11%
cases:4.05%
controls:0.30%
36
100
3920
39441
36
69
3920
39472
32
15
3924
39526
—
471
18
3373
39454
916
44
2585
38283
111
98
2627
32325
Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
43730-1 [3043849]
1.4e+00
2.5e+00
4.8e+00
1.0e+50
4.9e+00
3.7e+00
2.5e+00
cases:0.78%
controls:0.19%
cases:1.37%
controls:0.11%
cases:2.33%
controls:0.02%
cases:0.53%
controls:0.00%
cases:3.30%
controls:0.03%
cases:5.54%
controls:0.14%
cases:4.53%
controls:0.37%
31
77
3925
39464
54
43
3902
39498
92
8
3864
39533
21
0
3935
39541
127
10
3717
39462
194
54
3307
38273
124
120
2614
32303
Hepatitis B virus core Ab [Presence] in Serum
16933-4 [3021879]
9.8e-01
2.3e+00
6.0e+00
1.0e+50
5.9e+00
2.8e+00
1.7e+00
cases:2.48%
controls:0.94%
cases:3.69%
controls:0.40%
cases:19.74%
controls:0.06%
cases:2.76%
controls:0.00%
cases:10.54%
controls:0.03%
cases:5.74%
controls:0.36%
cases:6.17%
controls:1.18%
98
372
3858
39169
146
157
3810
39384
781
25
3175
39516
109
0
3847
39541
405
13
3439
39459
201
138
3300
38189
169
381
2569
32042
Demanding cystostatic therapy of methastized malignancy
WD125 [2001310680]
1.0e+00
1.5e+00
2.8e+00
—
5.9e+00
5.5e+00
2.5e+00
cases:0.73%
controls:0.26%
cases:1.04%
controls:0.23%
cases:1.29%
controls:0.08%
—
—
cases:19.59%
controls:0.07%
cases:27.36%
controls:0.15%
cases:4.64%
controls:0.38%
29
102
3927
39439
41
92
3915
39449
51
30
3905
39511
—
753
26
3091
39446
958
59
2543
38268
127
123
2611
32300
Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
22246-3 [3017918]
8.1e-01
2.6e+00
5.0e+00
1.0e+50
5.4e+00
3.5e+00
2.1e+00
cases:0.68%
controls:0.31%
cases:1.47%
controls:0.11%
cases:2.15%
controls:0.02%
cases:1.31%
controls:0.00%
cases:2.68%
controls:0.01%
cases:3.11%
controls:0.10%
cases:2.74%
controls:0.35%
27
121
3929
39420
58
45
3898
39496
85
6
3871
39535
52
0
3904
39541
103
5
3741
39467
109
39
3392
38288
75
115
2663
32308
Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
14804-9 [3022250]
9.0e-01
2.3e+00
5.1e+00
—
5.1e+00
3.2e+00
2.5e+00
cases:5.33%
controls:2.25%
cases:11.70%
controls:1.32%
cases:29.40%
controls:0.25%
—
—
cases:24.97%
controls:0.21%
cases:27.19%
controls:1.44%
cases:32.43%
controls:3.74%
211
888
3745
38653
463
523
3493
39018
1163
97
2793
39444
—
960
81
2884
39391
952
550
2549
37777
888
1211
1850
31212
CT of torso and neck
JN6AD [2001310938]
2.0e+00
3.5e+00
—
1.0e+50
4.0e+00
4.9e+00
4.2e+00
cases:0.38%
controls:0.05%
cases:1.24%
controls:0.04%
—
—
cases:1.77%
controls:0.00%
cases:0.86%
controls:0.02%
cases:8.63%
controls:0.07%
cases:11.40%
controls:0.19%
15
21
3941
39520
49
15
3907
39526
—
70
0
3886
39541
33
6
3811
39466
302
26
3199
38301
312
63
2426
32360
Localized enlarged lymph nodes
R59.0 [45534459]
1.8e+00
4.4e+00
6.7e+00
1.0e+50
—
3.3e+00
2.5e+00
cases:1.34%
controls:0.23%
cases:6.22%
controls:0.08%
cases:9.66%
controls:0.01%
cases:1.62%
controls:0.00%
—
—
cases:1.80%
controls:0.07%
cases:2.48%
controls:0.21%
53
92
3903
39449
246
33
3710
39508
382
5
3574
39536
64
0
3892
39541
—
63
27
3438
38300
68
68
2670
32355
Hematology
82 [38004501]
1.3e+00
2.4e+00
3.5e+00
—
4.4e+00
3.8e+00
3.2e+00
cases:4.68%
controls:1.30%
cases:8.70%
controls:0.84%
cases:9.56%
controls:0.31%
—
—
cases:18.57%
controls:0.29%
cases:28.82%
controls:0.89%
cases:28.01%
controls:1.59%
185
514
3771
39027
344
334
3612
39207
378
121
3578
39420
—
714
113
3130
39359
1009
343
2492
37984
767
517
1971
31906
Bone marrow biopsy
XW000 [2001310618]
1.9e+00
3.3e+00
5.4e+00
1.0e+50
—
4.4e+00
3.1e+00
cases:2.43%
controls:0.38%
cases:3.79%
controls:0.14%
cases:3.87%
controls:0.02%
cases:6.77%
controls:0.00%
—
—
cases:7.80%
controls:0.10%
cases:8.18%
controls:0.42%
96
150
3860
39391
150
57
3806
39484
153
7
3803
39534
268
0
3688
39541
—
273
39
3228
38288
224
136
2514
32287
Thrombocytopenia, unspecified
D69.6 [45581327]
1.3e+00
2.5e+00
3.9e+00
1.0e+50
3.9e+00
4.3e+00
2.1e+00
cases:0.40%
controls:0.11%
cases:0.48%
controls:0.04%
cases:0.61%
controls:0.01%
cases:0.35%
controls:0.00%
cases:0.78%
controls:0.02%
cases:4.20%
controls:0.06%
cases:1.46%
controls:0.18%
16
45
3940
39496
19
16
3937
39525
24
5
3932
39536
14
0
3942
39541
30
6
3814
39466
147
23
3354
38304
40
59
2698
32364
Leukocyte morphology finding [Identifier] in Blood
11156-7 [3008757]
1.2e+00
2.2e+00
3.7e+00
1.0e+50
4.4e+00
3.9e+00
2.4e+00
cases:0.53%
controls:0.16%
cases:0.86%
controls:0.09%
cases:1.21%
controls:0.03%
cases:0.33%
controls:0.00%
cases:1.25%
controls:0.02%
cases:3.26%
controls:0.07%
cases:2.59%
controls:0.24%
21
63
3935
39478
34
37
3922
39504
48
12
3908
39529
13
0
3943
39541
48
6
3796
39466
114
25
3387
38302
71
77
2667
32346
Blood transfusion
WW500 [2001310603]
1.1e+00
1.6e+00
3.0e+00
1.0e+50
4.7e+00
4.8e+00
2.6e+00
cases:0.73%
controls:0.24%
cases:0.68%
controls:0.14%
cases:0.76%
controls:0.04%
cases:1.39%
controls:0.00%
cases:3.67%
controls:0.04%
cases:14.80%
controls:0.15%
cases:4.24%
controls:0.32%
29
93
3927
39448
27
55
3929
39486
30
15
3926
39526
55
0
3901
39541
141
14
3703
39458
518
56
2983
38271
116
103
2622
32320
CD3 cells [#/volume] in Blood
8122-4 [3011412]
1.5e+00
2.3e+00
—
1.0e+50
5.4e+00
5.1e+00
3.6e+00
cases:0.58%
controls:0.14%
cases:0.63%
controls:0.07%
—
—
cases:0.88%
controls:0.00%
cases:2.63%
controls:0.01%
cases:7.43%
controls:0.05%
cases:7.20%
controls:0.21%
23
54
3933
39487
25
26
3931
39515
—
35
0
3921
39541
101
5
3743
39467
260
19
3241
38308
197
67
2541
32356
Extensive body CT
JN4BD [2001310899]
6.1e-01
2.0e+00
3.8e+00
—
3.7e+00
3.9e+00
3.5e+00
cases:3.29%
controls:1.82%
cases:4.85%
controls:0.67%
cases:4.73%
controls:0.11%
—
—
cases:3.72%
controls:0.10%
cases:20.42%
controls:0.53%
cases:22.17%
controls:0.85%
130
718
3826
38823
192
264
3764
39277
187
44
3769
39497
—
143
39
3701
39433
715
203
2786
38124
607
274
2131
32149
rituximab
L01FA01 [955167]
1.8e+00
2.7e+00
4.1e+00
—
—
5.4e+00
3.6e+00
cases:0.81%
controls:0.14%
cases:0.96%
controls:0.07%
cases:1.01%
controls:0.02%
—
—
—
—
cases:12.62%
controls:0.07%
cases:4.05%
controls:0.12%
32
54
3924
39487
38
26
3918
39515
40
7
3916
39534
—
—
442
26
3059
38301
111
38
2627
32385
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
1.5e-01
1.2e+00
3.6e+00
5.1e+00
3.7e+00
2.4e+00
1.4e+00
cases:13.57%
controls:11.94%
cases:18.98%
controls:6.87%
cases:33.67%
controls:1.34%
cases:9.35%
controls:0.06%
cases:36.81%
controls:1.39%
cases:45.59%
controls:7.07%
cases:47.30%
controls:18.00%
537
4722
3419
34819
751
2717
3205
36824
1332
531
2624
39010
370
24
3586
39517
1415
548
2429
38924
1596
2709
1905
35618
1295
5837
1443
26586
Complement+Immunoglobulin [Units/volume] in Red Blood Cells
4533-6 [3024403]
1.2e+00
2.1e+00
5.2e+00
1.0e+50
5.3e+00
2.0e+00
1.6e+00
cases:1.34%
controls:0.42%
cases:1.64%
controls:0.20%
cases:3.97%
controls:0.02%
cases:0.61%
controls:0.00%
cases:2.50%
controls:0.01%
cases:1.63%
controls:0.22%
cases:2.99%
controls:0.64%
53
167
3903
39374
65
81
3891
39460
157
9
3799
39532
24
0
3932
39541
96
5
3748
39467
57
84
3444
38243
82
209
2656
32214
Segmented neutrophils/Leukocytes in Blood
26505-8 [3017354]
1.0e+00
2.2e+00
4.1e+00
1.0e+50
4.2e+00
3.6e+00
2.1e+00
cases:0.38%
controls:0.14%
cases:0.73%
controls:0.08%
cases:1.06%
controls:0.02%
cases:0.15%
controls:0.00%
cases:1.22%
controls:0.02%
cases:2.80%
controls:0.08%
cases:2.41%
controls:0.30%
15
54
3941
39487
29
31
3927
39510
42
7
3914
39534
6
0
3950
39541
47
7
3797
39465
98
29
3403
38298
66
98
2672
32325
Follicular lymphoma grade III, unspecified
C82.2 [45542638]
3.8e+00
4.1e+00
1.0e+50
1.0e+50
—
4.8e+00
4.7e+00
cases:0.86%
controls:0.02%
cases:1.21%
controls:0.02%
cases:1.16%
controls:0.00%
cases:0.81%
controls:0.00%
—
—
cases:2.17%
controls:0.02%
cases:2.26%
controls:0.02%
34
8
3922
39533
48
8
3908
39533
46
0
3910
39541
32
0
3924
39541
—
76
7
3425
38320
62
7
2676
32416
Hepatitis C virus Ab [Presence] in Serum
16128-1 [3017143]
6.3e-01
1.9e+00
5.4e+00
1.0e+50
5.7e+00
2.3e+00
1.4e+00
cases:3.13%
controls:1.69%
cases:4.22%
controls:0.67%
cases:19.64%
controls:0.11%
cases:3.51%
controls:0.00%
cases:11.24%
controls:0.04%
cases:6.17%
controls:0.64%
cases:6.98%
controls:1.88%
124
667
3832
38874
167
263
3789
39278
777
42
3179
39499
139
0
3817
39541
432
17
3412
39455
216
244
3285
38083
191
611
2547
31812
Hepatitis B virus surface Ag [Presence] in Serum
5195-3 [3019284]
5.9e-01
1.9e+00
5.5e+00
1.0e+50
5.6e+00
2.3e+00
1.4e+00
cases:3.19%
controls:1.79%
cases:4.70%
controls:0.71%
cases:20.93%
controls:0.10%
cases:3.67%
controls:0.00%
cases:12.15%
controls:0.05%
cases:6.68%
controls:0.73%
cases:8.40%
controls:2.28%
126
709
3830
38832
186
280
3770
39261
828
41
3128
39500
145
0
3811
39541
467
20
3377
39452
234
278
3267
38049
230
740
2508
31683
Immunohistochemistry procedure
117617002 [4035726]
7.7e-01
2.7e+00
5.6e+00
—
4.0e+00
2.5e+00
1.7e+00
cases:3.11%
controls:1.47%
cases:9.33%
controls:0.67%
cases:16.15%
controls:0.07%
—
—
cases:4.34%
controls:0.08%
cases:5.08%
controls:0.44%
cases:7.78%
controls:1.52%
123
580
3833
38961
369
266
3587
39275
639
28
3317
39513
—
167
32
3677
39440
178
167
3323
38160
213
494
2525
31929
Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
72493-0 [43055120]
1.0e+00
1.9e+00
3.9e+00
—
4.2e+00
3.8e+00
2.6e+00
cases:0.81%
controls:0.30%
cases:1.21%
controls:0.19%
cases:2.15%
controls:0.05%
—
—
cases:3.07%
controls:0.05%
cases:7.54%
controls:0.18%
cases:5.92%
controls:0.49%
32
118
3924
39423
48
74
3908
39467
85
18
3871
39523
—
118
19
3726
39453
264
70
3237
38257
162
158
2576
32265
Differential panel, method unspecified - Blood
69738-3 [42870588]
3.6e-01
1.3e+00
3.5e+00
5.2e+00
3.2e+00
2.2e+00
1.5e+00
cases:10.44%
controls:7.51%
cases:15.57%
controls:4.64%
cases:23.31%
controls:0.90%
cases:5.61%
controls:0.03%
cases:18.05%
controls:0.86%
cases:30.51%
controls:4.85%
cases:35.21%
controls:11.00%
413
2968
3543
36573
616
1834
3340
37707
922
354
3034
39187
222
13
3734
39528
694
338
3150
39134
1068
1857
2433
36470
964
3565
1774
28858
Multidisciplinary treatment meeting
WZC20 [2001310890]
4.7e-01
2.0e+00
4.5e+00
1.0e+50
5.1e+00
3.7e+00
1.9e+00
cases:0.78%
controls:0.49%
cases:1.52%
controls:0.21%
cases:1.72%
controls:0.02%
cases:3.92%
controls:0.00%
cases:2.91%
controls:0.02%
cases:7.88%
controls:0.20%
cases:4.57%
controls:0.69%
31
194
3925
39347
60
84
3896
39457
68
8
3888
39533
155
0
3801
39541
112
7
3732
39465
276
78
3225
38249
125
224
2613
32199
Monocytes/Leukocytes in Blood
26485-3 [3019069]
3.3e-01
1.3e+00
3.5e+00
5.3e+00
3.2e+00
2.1e+00
1.5e+00
cases:14.74%
controls:11.06%
cases:20.42%
controls:6.60%
cases:29.73%
controls:1.30%
cases:7.10%
controls:0.04%
cases:22.71%
controls:1.24%
cases:37.73%
controls:6.83%
cases:46.31%
controls:15.91%
583
4375
3373
35166
808
2608
3148
36933
1176
513
2780
39028
281
15
3675
39526
873
490
2971
38982
1321
2619
2180
35708
1268
5159
1470
27264
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
3.3e-01
1.3e+00
3.5e+00
5.3e+00
3.1e+00
2.1e+00
1.5e+00
cases:14.69%
controls:11.05%
cases:20.45%
controls:6.60%
cases:29.58%
controls:1.30%
cases:7.03%
controls:0.04%
cases:22.19%
controls:1.24%
cases:37.48%
controls:6.84%
cases:46.06%
controls:15.88%
581
4369
3375
35172
809
2609
3147
36932
1170
514
2786
39027
278
15
3678
39526
853
490
2991
38982
1312
2622
2189
35705
1261
5150
1477
27273
Hemoglobin [Entitic mass] in Reticulocytes
42810-2 [3029080]
1.0e+00
2.4e+00
4.3e+00
1.0e+50
5.0e+00
2.6e+00
1.8e+00
cases:0.51%
controls:0.18%
cases:0.96%
controls:0.09%
cases:1.11%
controls:0.02%
cases:0.76%
controls:0.00%
cases:2.60%
controls:0.02%
cases:2.09%
controls:0.16%
cases:2.23%
controls:0.39%
20
72
3936
39469
38
35
3918
39506
44
6
3912
39535
30
0
3926
39541
100
7
3744
39465
73
63
3428
38264
61
126
2677
32297
Multiple cystostatic therapy of methastized malignancy
WD115 [2001310679]
1.4e+00
1.8e+00
2.1e+00
—
4.9e+00
5.0e+00
1.9e+00
cases:0.40%
controls:0.10%
cases:0.40%
controls:0.07%
cases:0.28%
controls:0.04%
—
—
cases:3.56%
controls:0.03%
cases:6.60%
controls:0.05%
cases:1.24%
controls:0.18%
16
39
3940
39502
16
27
3940
39514
11
14
3945
39527
—
137
11
3707
39461
231
19
3270
38308
34
58
2704
32365
Basophils/Leukocytes in Blood
30180-4 [3022096]
3.2e-01
1.3e+00
3.5e+00
5.2e+00
3.1e+00
2.1e+00
1.5e+00
cases:14.59%
controls:11.00%
cases:20.25%
controls:6.57%
cases:29.63%
controls:1.29%
cases:7.05%
controls:0.04%
cases:22.09%
controls:1.22%
cases:37.48%
controls:6.84%
cases:45.95%
controls:15.94%
577
4351
3379
35190
801
2596
3155
36945
1172
512
2784
39029
279
16
3677
39525
849
483
2995
38989
1312
2621
2189
35706
1258
5168
1480
27255
Band form neutrophils/Leukocytes in Blood
26508-2 [3004809]
8.4e-01
2.1e+00
3.9e+00
1.0e+50
4.2e+00
3.8e+00
2.1e+00
cases:0.63%
controls:0.27%
cases:1.16%
controls:0.14%
cases:1.67%
controls:0.04%
cases:0.40%
controls:0.00%
cases:2.58%
controls:0.04%
cases:5.54%
controls:0.13%
cases:3.65%
controls:0.44%
25
108
3931
39433
46
56
3910
39485
66
14
3890
39527
16
0
3940
39541
99
15
3745
39457
194
50
3307
38277
100
143
2638
32280
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
3.1e-01
1.3e+00
3.4e+00
5.2e+00
3.1e+00
2.1e+00
1.5e+00
cases:14.81%
controls:11.33%
cases:20.40%
controls:6.79%
cases:29.88%
controls:1.34%
cases:7.10%
controls:0.04%
cases:22.74%
controls:1.28%
cases:37.70%
controls:7.04%
cases:46.42%
controls:16.38%
586
4480
3370
35061
807
2683
3149
36858
1182
528
2774
39013
281
16
3675
39525
874
504
2970
38968
1320
2698
2181
35629
1271
5311
1467
27112
Outpatient Hospital
22 [8756]
3.0e-02
1.1e+00
3.3e+00
6.3e+00
3.5e+00
2.1e+00
6.9e-01
cases:27.35%
controls:26.75%
cases:20.42%
controls:7.88%
cases:21.41%
controls:1.02%
cases:14.28%
controls:0.03%
cases:23.67%
controls:0.91%
cases:35.30%
controls:6.54%
cases:29.47%
controls:17.31%
1082
10579
2874
28962
808
3115
3148
36426
847
402
3109
39139
565
12
3391
39529
910
361
2934
39111
1236
2508
2265
35819
807
5613
1931
26810
Magnesium [Moles/volume] in Serum or Plasma
2601-3 [3012095]
2.3e-01
8.8e-01
3.5e+00
4.7e+00
4.3e+00
2.5e+00
1.2e+00
cases:3.84%
controls:3.09%
cases:3.64%
controls:1.54%
cases:7.68%
controls:0.26%
cases:1.82%
controls:0.02%
cases:12.88%
controls:0.21%
cases:14.91%
controls:1.48%
cases:12.93%
controls:4.44%
152
1220
3804
38321
144
608
3812
38933
304
103
3652
39438
72
7
3884
39534
495
83
3349
39389
522
568
2979
37759
354
1439
2384
30984
IgM [Mass/volume] in Serum or Plasma
2472-9 [3028026]
8.3e-01
2.1e+00
4.8e+00
—
4.5e+00
2.5e+00
2.0e+00
cases:2.55%
controls:1.13%
cases:3.64%
controls:0.47%
cases:6.52%
controls:0.06%
—
—
cases:5.44%
controls:0.06%
cases:5.57%
controls:0.46%
cases:8.84%
controls:1.26%
101
447
3855
39094
144
185
3812
39356
258
22
3698
39519
—
209
24
3635
39448
195
177
3306
38150
242
409
2496
32014
IgG [Mass/volume] in Serum or Plasma
2465-3 [3005719]
9.0e-01
2.0e+00
4.6e+00
—
4.4e+00
2.8e+00
2.2e+00
cases:3.51%
controls:1.46%
cases:4.68%
controls:0.67%
cases:8.59%
controls:0.10%
—
—
cases:7.70%
controls:0.10%
cases:9.88%
controls:0.69%
cases:14.21%
controls:1.75%
139
578
3817
38963
185
266
3771
39275
340
38
3616
39503
—
296
41
3548
39431
346
263
3155
38064
389
568
2349
31855
Monocytes [#/volume] in Blood
26484-6 [3001604]
2.7e-01
1.2e+00
3.4e+00
5.2e+00
3.0e+00
2.0e+00
1.5e+00
cases:14.74%
controls:11.62%
cases:20.32%
controls:7.02%
cases:29.65%
controls:1.41%
cases:6.98%
controls:0.04%
cases:21.70%
controls:1.31%
cases:37.79%
controls:7.34%
cases:49.63%
controls:17.37%
583
4593
3373
34948
804
2777
3152
36764
1173
556
2783
38985
276
16
3680
39525
834
517
3010
38955
1323
2814
2178
35513
1359
5633
1379
26790
Basophils [#/volume] in Blood
26444-0 [3006315]
2.7e-01
1.2e+00
3.4e+00
5.2e+00
3.0e+00
2.0e+00
1.5e+00
cases:14.79%
controls:11.66%
cases:20.42%
controls:7.07%
cases:29.50%
controls:1.41%
cases:6.93%
controls:0.04%
cases:21.57%
controls:1.31%
cases:37.82%
controls:7.39%
cases:49.63%
controls:17.45%
585
4612
3371
34929
808
2794
3148
36747
1167
558
2789
38983
274
16
3682
39525
829
519
3015
38953
1324
2831
2177
35496
1359
5658
1379
26765
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
3.0e-01
1.2e+00
3.3e+00
5.3e+00
3.0e+00
2.0e+00
1.5e+00
cases:14.36%
controls:11.08%
cases:19.36%
controls:6.60%
cases:27.20%
controls:1.30%
cases:6.37%
controls:0.04%
cases:19.69%
controls:1.24%
cases:35.82%
controls:6.95%
cases:45.33%
controls:16.03%
568
4381
3388
35160
766
2609
3190
36932
1076
515
2880
39026
252
14
3704
39527
757
490
3087
38982
1254
2665
2247
35662
1241
5197
1497
27226
Inpatient Hospital
21 [8717]
-2.3e-02
9.9e-01
3.1e+00
6.2e+00
3.6e+00
2.1e+00
6.3e-01
cases:32.36%
controls:32.86%
cases:25.13%
controls:11.08%
cases:25.05%
controls:1.54%
cases:24.32%
controls:0.06%
cases:37.67%
controls:1.69%
cases:46.73%
controls:9.66%
cases:36.01%
controls:23.15%
1280
12992
2676
26549
994
4380
2962
35161
991
610
2965
38931
962
25
2994
39516
1448
667
2396
38805
1636
3702
1865
34625
986
7505
1752
24918
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
2.5e-01
1.2e+00
3.4e+00
5.2e+00
3.0e+00
2.0e+00
1.5e+00
cases:15.17%
controls:12.21%
cases:20.75%
controls:7.28%
cases:29.85%
controls:1.45%
cases:7.08%
controls:0.04%
cases:21.90%
controls:1.38%
cases:38.05%
controls:7.64%
cases:49.71%
controls:17.89%
600
4828
3356
34713
821
2880
3135
36661
1181
573
2775
38968
280
17
3676
39524
842
544
3002
38928
1332
2927
2169
35400
1361
5799
1377
26624
Eosinophils [#/volume] in Blood
26449-9 [3013115]
2.7e-01
1.2e+00
3.4e+00
5.1e+00
3.0e+00
2.0e+00
1.5e+00
cases:15.39%
controls:12.21%
cases:20.70%
controls:7.31%
cases:30.36%
controls:1.47%
cases:7.28%
controls:0.05%
cases:22.79%
controls:1.39%
cases:38.56%
controls:7.60%
cases:49.85%
controls:18.07%
609
4829
3347
34712
819
2892
3137
36649
1201
581
2755
38960
288
19
3668
39522
876
550
2968
38922
1350
2914
2151
35413
1365
5860
1373
26563
ondansetron; oral, parenteral, rectal
A04AA01 [21600493]
1.0e+00
1.4e+00
3.0e+00
—
5.6e+00
3.8e+00
1.6e+00
cases:1.52%
controls:0.54%
cases:1.21%
controls:0.31%
cases:1.37%
controls:0.07%
—
—
cases:13.40%
controls:0.06%
cases:12.60%
controls:0.33%
cases:4.97%
controls:1.00%
60
213
3896
39328
48
121
3908
39420
54
27
3902
39514
—
515
22
3329
39450
441
128
3060
38199
136
324
2602
32099
HIV 1 and 2 tests - Meaningful Use set
75622-1 [46235355]
4.3e-01
1.9e+00
5.4e+00
—
5.5e+00
2.0e+00
1.2e+00
cases:3.36%
controls:2.21%
cases:5.54%
controls:0.90%
cases:22.07%
controls:0.13%
—
—
cases:12.59%
controls:0.06%
cases:6.57%
controls:0.91%
cases:8.73%
controls:2.74%
133
872
3823
38669
219
356
3737
39185
873
53
3083
39488
—
484
23
3360
39449
230
347
3271
37980
239
889
2499
31534
CBC W Ordered Manual Differential panel - Blood
57782-5 [40760892]
3.1e-01
1.3e+00
3.2e+00
5.0e+00
3.2e+00
2.0e+00
1.4e+00
cases:5.79%
controls:4.33%
cases:8.16%
controls:2.43%
cases:11.10%
controls:0.49%
cases:2.68%
controls:0.02%
cases:10.33%
controls:0.47%
cases:16.91%
controls:2.73%
cases:22.53%
controls:6.75%
229
1713
3727
37828
323
959
3633
38582
439
193
3517
39348
106
7
3850
39534
397
187
3447
39285
592
1046
2909
37281
617
2190
2121
30233
Chronic lymphocytic leukaemia of B-cell type
C91.1 [45600564]
1.9e+00
2.3e+00
3.5e+00
1.0e+50
3.1e+00
2.8e+00
2.7e+00
cases:1.31%
controls:0.19%
cases:1.69%
controls:0.17%
cases:1.85%
controls:0.06%
cases:0.96%
controls:0.00%
cases:1.33%
controls:0.06%
cases:2.83%
controls:0.18%
cases:3.62%
controls:0.25%
52
77
3904
39464
67
67
3889
39474
73
22
3883
39519
38
0
3918
39541
51
24
3793
39448
99
68
3402
38259
99
82
2639
32341
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
2.2e-01
1.1e+00
3.0e+00
4.7e+00
3.3e+00
2.3e+00
1.7e+00
cases:16.71%
controls:13.90%
cases:22.70%
controls:9.06%
cases:31.95%
controls:2.26%
cases:10.16%
controls:0.10%
cases:36.89%
controls:2.14%
cases:49.41%
controls:9.09%
cases:58.11%
controls:20.01%
661
5498
3295
34043
898
3582
3058
35959
1264
892
2692
38649
402
39
3554
39502
1418
843
2426
38629
1730
3484
1771
34843
1591
6487
1147
25936
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
1.3e-01
1.0e+00
3.6e+00
5.5e+00
3.5e+00
1.7e+00
8.5e-01
cases:11.70%
controls:10.41%
cases:14.76%
controls:5.88%
cases:27.98%
controls:1.02%
cases:5.97%
controls:0.03%
cases:22.87%
controls:0.91%
cases:26.76%
controls:6.20%
cases:30.72%
controls:15.97%
463
4117
3493
35424
584
2324
3372
37217
1107
402
2849
39139
236
10
3720
39531
879
361
2965
39111
937
2378
2564
35949
841
5177
1897
27246
CD3+CD4+ (T4 helper) cells/cells in Blood
8123-2 [3014037]
1.2e+00
2.1e+00
—
1.0e+50
5.3e+00
4.6e+00
2.9e+00
cases:0.38%
controls:0.12%
cases:0.48%
controls:0.06%
—
—
cases:1.04%
controls:0.00%
cases:2.55%
controls:0.01%
cases:4.48%
controls:0.05%
cases:3.25%
controls:0.18%
15
46
3941
39495
19
24
3937
39517
—
41
0
3915
39541
98
5
3746
39467
157
18
3344
38309
89
58
2649
32365
Reticulocyte production index
31111-8 [3000012]
7.1e-01
2.2e+00
4.6e+00
1.0e+50
4.9e+00
2.6e+00
1.5e+00
cases:0.51%
controls:0.25%
cases:1.01%
controls:0.12%
cases:1.26%
controls:0.01%
cases:0.86%
controls:0.00%
cases:2.24%
controls:0.02%
cases:2.46%
controls:0.19%
cases:2.01%
controls:0.47%
20
99
3936
39442
40
46
3916
39495
50
5
3906
39536
34
0
3922
39541
86
7
3758
39465
86
74
3415
38253
55
154
2683
32269
Generalized enlarged lymph nodes
R59.1 [45563318]
2.6e+00
5.3e+00
1.0e+50
1.0e+50
1.0e+50
4.4e+00
3.4e+00
cases:0.76%
controls:0.06%
cases:3.44%
controls:0.02%
cases:5.92%
controls:0.00%
cases:0.96%
controls:0.00%
cases:1.20%
controls:0.00%
cases:1.03%
controls:0.01%
cases:0.80%
controls:0.03%
30
23
3926
39518
136
7
3820
39534
234
0
3722
39541
38
0
3918
39541
46
0
3798
39472
36
5
3465
38322
22
9
2716
32414
Calcium [Moles/volume] in Serum or Plasma
2000-8 [3015377]
5.4e-02
8.5e-01
3.3e+00
5.2e+00
3.5e+00
1.9e+00
8.8e-01
cases:7.71%
controls:7.33%
cases:7.66%
controls:3.44%
cases:13.40%
controls:0.59%
cases:3.11%
controls:0.02%
cases:16.23%
controls:0.58%
cases:20.91%
controls:3.75%
cases:22.46%
controls:10.73%
305
2899
3651
36642
303
1359
3653
38182
530
234
3426
39307
123
7
3833
39534
624
230
3220
39242
732
1438
2769
36889
615
3480
2123
28943
Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
71668-8 [43055361]
8.9e-01
1.7e+00
3.1e+00
—
4.5e+00
4.1e+00
2.1e+00
cases:0.23%
controls:0.09%
cases:0.23%
controls:0.04%
cases:0.33%
controls:0.02%
—
—
cases:1.40%
controls:0.02%
cases:2.83%
controls:0.05%
cases:1.10%
controls:0.14%
9
37
3947
39504
9
16
3947
39525
13
6
3943
39535
—
54
6
3790
39466
99
19
3402
38308
30
46
2708
32377
Waldenström macroglobulinaemia
C88.0 [45557037]
2.9e+00
3.1e+00
3.4e+00
1.0e+50
—
3.3e+00
2.8e+00
cases:0.35%
controls:0.02%
cases:0.56%
controls:0.03%
cases:0.38%
controls:0.01%
cases:0.35%
controls:0.00%
—
—
cases:0.69%
controls:0.03%
cases:0.69%
controls:0.04%
14
8
3942
39533
22
10
3934
39531
15
5
3941
39536
14
0
3942
39541
—
24
10
3477
38317
19
14
2719
32409
granisetron; oral, parenteral, transdermal
A04AA02 [21600494]
3.8e-01
9.2e-01
2.5e+00
—
6.1e+00
3.8e+00
2.0e+00
cases:0.78%
controls:0.54%
cases:0.76%
controls:0.30%
cases:0.48%
controls:0.04%
—
—
cases:9.65%
controls:0.02%
cases:9.08%
controls:0.22%
cases:3.73%
controls:0.50%
31
213
3925
39328
30
120
3926
39421
19
16
3937
39525
—
371
9
3473
39463
318
84
3183
38243
102
162
2636
32261
Granulocytes/Leukocytes in Blood
30395-8 [3035933]
4.3e-01
1.4e+00
4.1e+00
—
4.2e+00
3.3e+00
2.2e+00
cases:0.86%
controls:0.56%
cases:0.73%
controls:0.17%
cases:1.39%
controls:0.02%
—
—
cases:1.74%
controls:0.03%
cases:2.86%
controls:0.11%
cases:2.59%
controls:0.29%
34
221
3922
39320
29
69
3927
39472
55
9
3901
39532
—
67
10
3777
39462
100
42
3401
38285
71
94
2667
32329
Granulocytes [#/volume] in Blood
30394-1 [3035715]
4.0e-01
1.4e+00
4.1e+00
—
4.5e+00
3.0e+00
2.2e+00
cases:0.76%
controls:0.51%
cases:0.63%
controls:0.15%
cases:1.24%
controls:0.02%
—
—
cases:1.51%
controls:0.02%
cases:1.94%
controls:0.10%
cases:1.97%
controls:0.22%
30
201
3926
39340
25
59
3931
39482
49
8
3907
39533
—
58
7
3786
39465
68
37
3433
38290
54
72
2684
32351
Oncology Clinic/Center
261QX0200X [38004268]
5.4e-01
2.9e+00
6.4e+00
—
4.0e+00
7.5e-01
6.3e-01
cases:11.30%
controls:6.91%
cases:29.17%
controls:2.19%
cases:49.14%
controls:0.16%
—
—
cases:9.29%
controls:0.18%
cases:3.60%
controls:1.72%
cases:11.98%
controls:6.73%
447
2733
3509
36808
1154
866
2802
38675
1944
64
2012
39477
—
357
73
3487
39399
126
661
3375
37666
328
2182
2410
30241
Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
48674-6 [3049539]
2.7e+00
5.0e+00
—
1.0e+50
1.0e+50
4.1e+00
3.1e+00
cases:0.81%
controls:0.06%
cases:4.17%
controls:0.03%
—
—
cases:0.66%
controls:0.00%
cases:1.87%
controls:0.00%
cases:1.37%
controls:0.02%
cases:2.45%
controls:0.11%
32
22
3924
39519
165
12
3791
39529
—
26
0
3930
39541
72
0
3772
39472
48
9
3453
38318
67
35
2671
32388
pH of Serum or Plasma
2753-2 [3018418]
1.7e-01
8.9e-01
2.9e+00
5.4e+00
3.2e+00
1.6e+00
8.8e-01
cases:7.84%
controls:6.71%
cases:9.35%
controls:4.08%
cases:10.59%
controls:0.68%
cases:3.21%
controls:0.02%
cases:13.63%
controls:0.67%
cases:18.42%
controls:4.22%
cases:22.43%
controls:10.69%
310
2653
3646
36888
370
1613
3586
37928
419
267
3537
39274
127
6
3829
39535
524
263
3320
39209
645
1619
2856
36708
614
3467
2124
28956
Immunofixation for Serum or Plasma
25700-6 [3037756]
9.2e-01
2.4e+00
4.5e+00
1.0e+50
4.3e+00
1.7e+00
1.1e+00
cases:1.21%
controls:0.49%
cases:2.15%
controls:0.20%
cases:1.92%
controls:0.02%
cases:0.38%
controls:0.00%
cases:1.12%
controls:0.02%
cases:0.80%
controls:0.15%
cases:2.05%
controls:0.71%
48
193
3908
39348
85
81
3871
39460
76
9
3880
39532
15
0
3941
39541
43
6
3801
39466
28
59
3473
38268
56
231
2682
32192
Intravenous
ZX120 [2001311495]
5.5e-01
1.4e+00
2.6e+00
—
4.4e+00
3.8e+00
1.9e+00
cases:2.07%
controls:1.21%
cases:1.92%
controls:0.49%
cases:1.62%
controls:0.12%
—
—
cases:8.32%
controls:0.11%
cases:14.65%
controls:0.38%
cases:6.28%
controls:0.95%
82
479
3874
39062
76
192
3880
39349
64
47
3892
39494
—
320
42
3524
39430
513
144
2988
38183
172
308
2566
32115
Office Visit
OMOP4822458 [581477]
1.2e-01
8.8e-01
2.9e+00
4.7e+00
3.2e+00
2.2e+00
9.9e-01
cases:9.86%
controls:8.83%
cases:5.76%
controls:2.47%
cases:4.60%
controls:0.27%
cases:1.87%
controls:0.02%
cases:7.39%
controls:0.33%
cases:14.91%
controls:1.98%
cases:14.65%
controls:5.98%
390
3493
3566
36048
228
978
3728
38563
182
108
3774
39433
74
7
3882
39534
284
130
3560
39342
522
760
2979
37567
401
1938
2337
30485
Lymph node Pathology biopsy report
66112-4 [40768795]
2.4e+00
4.3e+00
—
1.0e+50
1.0e+50
4.5e+00
3.5e+00
cases:1.24%
controls:0.11%
cases:3.99%
controls:0.06%
—
—
cases:0.66%
controls:0.00%
cases:2.08%
controls:0.00%
cases:2.91%
controls:0.03%
cases:4.97%
controls:0.15%
49
43
3907
39498
158
22
3798
39519
—
26
0
3930
39541
80
0
3764
39472
102
13
3399
38314
136
50
2602
32373
Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
38917-1 [3042194]
3.4e-01
9.2e-01
3.2e+00
—
4.5e+00
3.8e+00
2.4e+00
cases:0.48%
controls:0.34%
cases:0.51%
controls:0.20%
cases:0.76%
controls:0.03%
—
—
cases:1.59%
controls:0.02%
cases:6.26%
controls:0.16%
cases:5.37%
controls:0.54%
19
136
3937
39405
20
80
3936
39461
30
12
3926
39529
—
61
7
3783
39465
219
60
3282
38267
147
174
2591
32249
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
5.7e-02
8.7e-01
3.1e+00
4.6e+00
3.1e+00
1.8e+00
1.3e+00
cases:23.26%
controls:22.26%
cases:28.34%
controls:14.18%
cases:37.03%
controls:2.67%
cases:9.88%
controls:0.11%
cases:38.84%
controls:2.73%
cases:50.76%
controls:14.67%
cases:61.58%
controls:31.16%
920
8801
3036
30740
1121
5606
2835
33935
1465
1054
2491
38487
391
43
3565
39498
1493
1078
2351
38394
1777
5623
1724
32704
1686
10103
1052
22320
Glucose [Moles/volume] in Cerebral spinal fluid
14744-7 [3020044]
-2.4e-01
1.5e+00
4.1e+00
1.0e+50
5.0e+00
2.8e+00
1.4e+00
cases:0.35%
controls:0.45%
cases:0.58%
controls:0.13%
cases:0.91%
controls:0.02%
cases:0.25%
controls:0.00%
cases:2.13%
controls:0.02%
cases:1.63%
controls:0.10%
cases:1.90%
controls:0.47%
14
177
3942
39364
23
52
3933
39489
36
6
3920
39535
10
0
3946
39541
82
6
3762
39466
57
40
3444
38287
52
154
2686
32269
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
1.2e-01
8.5e-01
3.1e+00
5.2e+00
3.2e+00
1.6e+00
8.2e-01
cases:11.88%
controls:10.64%
cases:13.73%
controls:6.36%
cases:18.35%
controls:1.03%
cases:5.66%
controls:0.03%
cases:19.67%
controls:1.00%
cases:24.79%
controls:6.37%
cases:30.31%
controls:16.11%
470
4209
3486
35332
543
2515
3413
37026
726
409
3230
39132
224
13
3732
39528
756
395
3088
39077
868
2442
2633
35885
830
5222
1908
27201
Bacteria identified in Blood by Culture
600-7 [3023368]
-3.7e-02
7.0e-01
3.0e+00
4.7e+00
3.4e+00
2.1e+00
7.7e-01
cases:5.23%
controls:5.42%
cases:5.46%
controls:2.79%
cases:6.65%
controls:0.37%
cases:2.12%
controls:0.02%
cases:10.46%
controls:0.39%
cases:20.17%
controls:2.89%
cases:18.01%
controls:9.26%
207
2143
3749
37398
216
1102
3740
38439
263
145
3693
39396
84
8
3872
39533
402
152
3442
39320
706
1106
2795
37221
493
3003
2245
29420
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
7.7e-02
8.7e-01
3.1e+00
5.1e+00
3.2e+00
1.5e+00
8.0e-01
cases:12.74%
controls:11.91%
cases:15.52%
controls:7.15%
cases:20.85%
controls:1.22%
cases:6.09%
controls:0.04%
cases:22.22%
controls:1.15%
cases:27.19%
controls:7.46%
cases:33.89%
controls:18.71%
504
4708
3452
34833
614
2828
3342
36713
825
482
3131
39059
241
15
3715
39526
854
452
2990
39020
952
2859
2549
35468
928
6067
1810
26356
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
4.6e-03
8.9e-01
3.4e+00
4.7e+00
3.1e+00
1.9e+00
6.0e-01
cases:6.93%
controls:6.90%
cases:7.31%
controls:3.13%
cases:9.33%
controls:0.34%
cases:1.42%
controls:0.01%
cases:7.18%
controls:0.36%
cases:15.94%
controls:2.72%
cases:14.61%
controls:8.58%
274
2727
3682
36814
289
1238
3667
38303
369
136
3587
39405
56
5
3900
39536
276
141
3568
39331
558
1042
2943
37285
400
2783
2338
29640
Protein [Mass/volume] in Cerebral spinal fluid
2880-3 [3019473]
-1.7e-01
1.4e+00
4.0e+00
1.0e+50
5.0e+00
2.7e+00
1.4e+00
cases:0.40%
controls:0.48%
cases:0.63%
controls:0.15%
cases:0.99%
controls:0.02%
cases:0.33%
controls:0.00%
cases:2.68%
controls:0.02%
cases:1.89%
controls:0.13%
cases:2.08%
controls:0.55%
16
190
3940
39351
25
60
3931
39481
39
7
3917
39534
13
0
3943
39541
103
7
3741
39465
66
51
3435
38276
57
177
2681
32246
Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]
-2.1e-02
9.1e-01
3.5e+00
4.8e+00
3.1e+00
1.7e+00
4.8e-01
cases:9.63%
controls:9.82%
cases:10.21%
controls:4.39%
cases:15.50%
controls:0.55%
cases:2.17%
controls:0.02%
cases:10.12%
controls:0.52%
cases:18.68%
controls:3.96%
cases:19.10%
controls:12.76%
381
3882
3575
35659
404
1735
3552
37806
613
218
3343
39323
86
7
3870
39534
389
204
3455
39268
654
1519
2847
36808
523
4137
2215
28286
Neck ultrasound examination
EP1AE [2001302284]
6.9e-01
2.3e+00
3.6e+00
—
3.1e+00
2.5e+00
2.3e+00
cases:1.37%
controls:0.69%
cases:2.10%
controls:0.22%
cases:1.19%
controls:0.03%
—
—
cases:0.57%
controls:0.03%
cases:2.17%
controls:0.19%
cases:5.22%
controls:0.55%
54
273
3902
39268
83
86
3873
39455
47
13
3909
39528
—
22
10
3822
39462
76
72
3425
38255
143
177
2595
32246
Excision of cervical lymph nodes
PJD41 [2001309632]
2.9e+00
4.3e+00
—
1.0e+50
1.0e+50
3.6e+00
3.6e+00
cases:1.01%
controls:0.06%
cases:2.43%
controls:0.03%
—
—
cases:0.76%
controls:0.00%
cases:0.57%
controls:0.00%
cases:0.69%
controls:0.02%
cases:1.75%
controls:0.05%
40
22
3916
39519
96
13
3860
39528
—
30
0
3926
39541
22
0
3822
39472
24
7
3477
38320
48
16
2690
32407
Fever, unspecified
R50.9 [45582716]
4.3e-01
1.6e+00
3.5e+00
—
4.2e+00
3.2e+00
1.5e+00
cases:2.48%
controls:1.63%
cases:2.60%
controls:0.55%
cases:2.25%
controls:0.07%
—
—
cases:3.43%
controls:0.06%
cases:12.25%
controls:0.55%
cases:8.84%
controls:2.05%
98
644
3858
38897
103
219
3853
39322
89
28
3867
39513
—
132
22
3712
39450
429
211
3072
38116
242
664
2496
31759
Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
1952-1 [3013201]
1.3e+00
3.0e+00
—
1.0e+50
4.6e+00
3.0e+00
2.4e+00
cases:0.48%
controls:0.13%
cases:1.42%
controls:0.07%
—
—
cases:0.30%
controls:0.00%
cases:1.56%
controls:0.02%
cases:1.31%
controls:0.07%
cases:2.30%
controls:0.22%
19
50
3937
39491
56
29
3900
39512
—
12
0
3944
39541
60
6
3784
39466
46
25
3455
38302
63
72
2675
32351
CD8 cells/Lymphocytes in Specimen
80222-3 [21494814]
2.3e+00
2.7e+00
1.0e+50
—
—
5.2e+00
4.1e+00
cases:0.25%
controls:0.03%
cases:0.23%
controls:0.02%
cases:0.53%
controls:0.00%
—
—
—
—
cases:3.77%
controls:0.02%
cases:3.87%
controls:0.07%
10
10
3946
39531
9
6
3947
39535
21
0
3935
39541
—
—
132
8
3369
38319
106
22
2632
32401
Erythrocytes [#/volume] in Cerebral spinal fluid
26454-9 [3027475]
-3.1e-01
1.4e+00
3.9e+00
1.0e+50
5.0e+00
2.6e+00
1.4e+00
cases:0.33%
controls:0.45%
cases:0.53%
controls:0.14%
cases:0.86%
controls:0.02%
cases:0.28%
controls:0.00%
cases:2.55%
controls:0.02%
cases:1.66%
controls:0.12%
cases:2.05%
controls:0.50%
13
177
3943
39364
21
54
3935
39487
34
7
3922
39534
11
0
3945
39541
98
7
3746
39465
58
47
3443
38280
56
162
2682
32261
metoclopramide; oral, parenteral, rectal
A03FA01 [21600484]
3.2e-01
1.1e+00
3.0e+00
—
5.5e+00
3.0e+00
1.4e+00
cases:3.97%
controls:2.92%
cases:3.94%
controls:1.39%
cases:3.39%
controls:0.18%
—
—
cases:32.99%
controls:0.20%
cases:19.31%
controls:1.15%
cases:12.31%
controls:3.50%
157
1156
3799
38385
156
548
3800
38993
134
70
3822
39471
—
1268
77
2576
39395
676
439
2825
37888
337
1134
2401
31289
Cell count panel - Cerebral spinal fluid
34563-7 [3044290]
-2.0e-01
1.2e+00
4.0e+00
1.0e+50
5.1e+00
2.7e+00
1.4e+00
cases:0.30%
controls:0.37%
cases:0.48%
controls:0.15%
cases:0.78%
controls:0.02%
cases:0.28%
controls:0.00%
cases:1.95%
controls:0.01%
cases:1.66%
controls:0.11%
cases:1.75%
controls:0.44%
12
146
3944
39395
19
59
3937
39482
31
6
3925
39535
11
0
3945
39541
75
5
3769
39467
58
43
3443
38284
48
144
2690
32279
Reticulocytes [#/volume] in Blood
14196-0 [3023520]
6.1e-01
1.9e+00
4.1e+00
1.0e+50
4.3e+00
2.1e+00
1.2e+00
cases:2.68%
controls:1.47%
cases:5.03%
controls:0.77%
cases:5.28%
controls:0.09%
cases:2.17%
controls:0.00%
cases:6.92%
controls:0.10%
cases:7.46%
controls:1.01%
cases:9.86%
controls:3.07%
106
583
3850
38958
199
306
3757
39235
209
36
3747
39505
86
0
3870
39541
266
39
3578
39433
261
389
3240
37938
270
994
2468
31429
Leukocytes [#/volume] in Cerebral spinal fluid
26465-5 [3016543]
-3.1e-01
1.4e+00
3.8e+00
1.0e+50
5.0e+00
2.6e+00
1.4e+00
cases:0.33%
controls:0.45%
cases:0.53%
controls:0.13%
cases:0.81%
controls:0.02%
cases:0.28%
controls:0.00%
cases:2.47%
controls:0.02%
cases:1.63%
controls:0.12%
cases:2.01%
controls:0.49%
13
177
3943
39364
21
53
3935
39488
32
7
3924
39534
11
0
3945
39541
95
7
3749
39465
57
46
3444
38281
55
160
2683
32263
Non-Hodgkin lymphoma, unspecified
C85.9 [45561867]
3.8e+00
5.1e+00
1.0e+50
1.0e+50
1.0e+50
—
5.3e+00
cases:0.86%
controls:0.02%
cases:2.81%
controls:0.02%
cases:7.10%
controls:0.00%
cases:1.26%
controls:0.00%
cases:2.91%
controls:0.00%
—
—
cases:2.99%
controls:0.02%
34
8
3922
39533
111
7
3845
39534
281
0
3675
39541
50
0
3906
39541
112
0
3732
39472
—
82
5
2656
32418
Body CT examination
JN4AD [2001310897]
5.7e-01
1.7e+00
3.9e+00
—
3.2e+00
2.7e+00
2.1e+00
cases:1.62%
controls:0.92%
cases:3.49%
controls:0.68%
cases:4.35%
controls:0.09%
—
—
cases:2.08%
controls:0.09%
cases:9.68%
controls:0.73%
cases:15.16%
controls:2.17%
64
364
3892
39177
138
268
3818
39273
172
37
3784
39504
—
80
34
3764
39438
339
279
3162
38048
415
703
2323
31720
Cystostatic therapy of methastized malignancy
WD105 [2001310678]
8.6e-01
1.1e+00
2.3e+00
—
3.8e+00
3.6e+00
2.4e+00
cases:0.56%
controls:0.24%
cases:0.66%
controls:0.22%
cases:0.76%
controls:0.08%
—
—
cases:3.95%
controls:0.09%
cases:8.11%
controls:0.24%
cases:4.49%
controls:0.43%
22
93
3934
39448
26
88
3930
39453
30
31
3926
39510
—
152
35
3692
39437
284
93
3217
38234
123
138
2615
32285
Emergency Room and Inpatient Visit
ERIP [262]
-4.8e-02
6.6e-01
3.0e+00
5.9e+00
2.7e+00
1.4e+00
2.9e-01
cases:4.78%
controls:5.00%
cases:6.34%
controls:3.37%
cases:8.11%
controls:0.45%
cases:5.11%
controls:0.02%
cases:6.43%
controls:0.44%
cases:14.14%
controls:3.99%
cases:16.91%
controls:13.18%
189
1978
3767
37563
251
1333
3705
38208
321
176
3635
39365
202
6
3754
39535
247
173
3597
39299
495
1530
3006
36797
463
4274
2275
28149
Extensive MRI examination of brain with high intensity magnet
AA1CG [2001300116]
-9.1e-02
1.7e+00
3.6e+00
—
4.1e+00
2.7e+00
1.9e+00
cases:0.81%
controls:0.89%
cases:1.37%
controls:0.26%
cases:1.42%
controls:0.04%
—
—
cases:1.33%
controls:0.02%
cases:3.74%
controls:0.27%
cases:4.86%
controls:0.74%
32
350
3924
39191
54
101
3902
39440
56
16
3900
39525
—
51
9
3793
39463
131
104
3370
38223
133
241
2605
32182
Internal Medicine
11 [38004456]
8.2e-02
9.0e-01
2.6e+00
5.4e+00
2.5e+00
1.7e+00
7.4e-01
cases:25.81%
controls:24.27%
cases:20.73%
controls:9.62%
cases:16.25%
controls:1.46%
cases:10.92%
controls:0.06%
cases:16.02%
controls:1.51%
cases:37.16%
controls:9.35%
cases:37.44%
controls:22.20%
1021
9595
2935
29946
820
3805
3136
35736
643
576
3313
38965
432
22
3524
39519
616
595
3228
38877
1301
3583
2200
34744
1025
7199
1713
25224
CD19 cells/cells in Blood
8117-4 [3016228]
1.9e+00
2.7e+00
1.0e+50
—
—
5.2e+00
3.9e+00
cases:0.25%
controls:0.04%
cases:0.23%
controls:0.02%
cases:0.51%
controls:0.00%
—
—
—
—
cases:3.77%
controls:0.02%
cases:3.80%
controls:0.08%
10
15
3946
39526
9
6
3947
39535
20
0
3936
39541
—
—
132
8
3369
38319
104
25
2634
32398
Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
40976-3 [3040853]
3.9e-01
8.3e-01
3.3e+00
—
4.3e+00
3.7e+00
2.4e+00
cases:0.48%
controls:0.33%
cases:0.46%
controls:0.20%
cases:0.78%
controls:0.03%
—
—
cases:1.53%
controls:0.02%
cases:6.28%
controls:0.16%
cases:5.55%
controls:0.52%
19
129
3937
39412
18
79
3938
39462
31
12
3925
39529
—
59
8
3785
39464
220
62
3281
38265
152
170
2586
32253
Metamyelocytes/Leukocytes in Blood
28541-1 [3002179]
6.6e-01
1.5e+00
3.5e+00
—
3.8e+00
2.7e+00
1.7e+00
cases:1.74%
controls:0.91%
cases:3.16%
controls:0.75%
cases:4.90%
controls:0.16%
—
—
cases:5.65%
controls:0.14%
cases:11.88%
controls:0.94%
cases:12.86%
controls:2.67%
69
360
3887
39181
125
295
3831
39246
194
62
3762
39479
—
217
54
3627
39418
416
361
3085
37966
352
867
2386
31556
Myelocytes/Leukocytes in Blood
26498-6 [3017181]
6.7e-01
1.4e+00
3.4e+00
—
3.8e+00
2.7e+00
1.6e+00
cases:2.10%
controls:1.09%
cases:3.44%
controls:0.85%
cases:5.41%
controls:0.19%
—
—
cases:7.05%
controls:0.17%
cases:13.88%
controls:1.06%
cases:13.04%
controls:2.87%
83
430
3873
39111
136
335
3820
39206
214
76
3742
39465
—
271
66
3573
39406
486
405
3015
37922
357
929
2381
31494
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
2.0e-02
1.0e+00
3.1e+00
4.6e+00
2.7e+00
1.4e+00
6.6e-01
cases:6.12%
controls:6.00%
cases:8.52%
controls:3.16%
cases:9.50%
controls:0.48%
cases:2.05%
controls:0.02%
cases:5.36%
controls:0.37%
cases:10.63%
controls:2.83%
cases:14.28%
controls:7.93%
242
2373
3714
37168
337
1249
3619
38292
376
191
3580
39350
81
8
3875
39533
206
147
3638
39325
372
1083
3129
37244
391
2571
2347
29852
Outpatient Visit
OP [9202]
5.2e-02
6.7e-01
1.9e+00
5.0e+00
2.4e+00
2.0e+00
1.6e+00
cases:75.05%
controls:74.07%
cases:70.63%
controls:55.11%
cases:47.80%
controls:11.76%
cases:41.56%
controls:0.50%
cases:58.38%
controls:11.45%
cases:89.72%
controls:54.54%
cases:95.47%
controls:80.77%
2969
29287
987
10254
2794
21793
1162
17748
1891
4650
2065
34891
1644
197
2312
39344
2244
4520
1600
34952
3141
20904
360
17423
2614
26188
124
6235
Exploration of lymph nodes
PJA10 [2001309626]
2.2e+00
4.4e+00
1.0e+50
1.0e+50
1.0e+50
3.0e+00
3.9e+00
cases:0.58%
controls:0.06%
cases:2.20%
controls:0.03%
cases:5.13%
controls:0.00%
cases:0.53%
controls:0.00%
cases:0.34%
controls:0.00%
cases:0.37%
controls:0.02%
cases:1.61%
controls:0.03%
23
25
3933
39516
87
11
3869
39530
203
0
3753
39541
21
0
3935
39541
13
0
3831
39472
13
7
3488
38320
44
11
2694
32412
Phosphate [Moles/volume] in Serum or Plasma
14879-1 [3003458]
-4.3e-02
8.1e-01
2.4e+00
4.4e+00
3.3e+00
1.6e+00
8.8e-01
cases:2.86%
controls:2.98%
cases:3.84%
controls:1.75%
cases:3.79%
controls:0.36%
cases:1.06%
controls:0.01%
cases:8.71%
controls:0.35%
cases:8.68%
controls:1.87%
cases:9.82%
controls:4.32%
113
1178
3843
38363
152
691
3804
38850
150
142
3806
39399
42
5
3914
39536
335
138
3509
39334
304
717
3197
37610
269
1402
2469
31021
CD19 cells [#/volume] in Blood
8116-6 [3010503]
1.7e+00
2.7e+00
1.0e+50
1.0e+50
—
5.1e+00
3.9e+00
cases:0.38%
controls:0.07%
cases:0.40%
controls:0.03%
cases:0.83%
controls:0.00%
cases:0.15%
controls:0.00%
—
—
cases:5.37%
controls:0.03%
cases:5.37%
controls:0.11%
15
27
3941
39514
16
11
3940
39530
33
0
3923
39541
6
0
3950
39541
—
188
13
3313
38314
147
37
2591
32386
Reticulocytes/Erythrocytes in Blood
4679-7 [3027945]
4.7e-01
1.7e+00
3.9e+00
—
4.1e+00
2.0e+00
1.2e+00
cases:3.77%
controls:2.39%
cases:6.34%
controls:1.18%
cases:6.62%
controls:0.14%
—
—
cases:8.09%
controls:0.15%
cases:9.23%
controls:1.34%
cases:12.09%
controls:3.96%
149
946
3807
38595
251
467
3705
39074
262
56
3694
39485
—
311
60
3533
39412
323
514
3178
37813
331
1285
2407
31138
Urate [Moles/volume] in Serum or Plasma
14933-6 [3026493]
2.9e-01
1.2e+00
4.3e+00
—
4.5e+00
1.9e+00
1.1e+00
cases:8.49%
controls:6.51%
cases:9.20%
controls:3.02%
cases:24.32%
controls:0.42%
—
—
cases:25.36%
controls:0.36%
cases:17.62%
controls:3.02%
cases:22.10%
controls:8.71%
336
2576
3620
36965
364
1196
3592
38345
962
165
2994
39376
—
975
143
2869
39329
617
1156
2884
37171
605
2825
2133
29598
Bacterial infection, unspecified
A49.9 [45590816]
1.1e-01
1.1e+00
3.5e+00
—
4.2e+00
3.3e+00
1.3e+00
cases:1.47%
controls:1.31%
cases:1.54%
controls:0.52%
cases:1.39%
controls:0.04%
—
—
cases:4.16%
controls:0.07%
cases:14.14%
controls:0.59%
cases:6.79%
controls:2.01%
58
518
3898
39023
61
204
3895
39337
55
17
3901
39524
—
160
27
3684
39445
495
226
3006
38101
186
652
2552
31771
Otolaryngology
4 [38004449]
3.2e-01
1.3e+00
3.2e+00
4.9e+00
1.9e+00
9.1e-01
7.8e-01
cases:16.05%
controls:12.17%
cases:15.75%
controls:4.65%
cases:16.53%
controls:0.79%
cases:3.87%
controls:0.03%
cases:4.37%
controls:0.70%
cases:10.63%
controls:4.57%
cases:24.21%
controls:12.82%
635
4814
3321
34727
623
1839
3333
37702
654
313
3302
39228
153
12
3803
39529
168
278
3676
39194
372
1753
3129
36574
663
4157
2075
28266
Emergency Room Visit
ER [9203]
4.5e-02
8.8e-01
2.8e+00
4.9e+00
2.4e+00
1.6e+00
5.8e-01
cases:35.84%
controls:34.81%
cases:25.08%
controls:12.17%
cases:21.76%
controls:1.63%
cases:8.19%
controls:0.06%
cases:15.17%
controls:1.53%
cases:38.73%
controls:11.29%
cases:42.37%
controls:29.20%
1418
13765
2538
25776
992
4813
2964
34728
861
643
3095
38898
324
25
3632
39516
583
605
3261
38867
1356
4328
2145
33999
1160
9469
1578
22954
Localized swelling, mass and lump, neck
R22.1 [45592412]
1.3e+00
3.4e+00
5.6e+00
1.0e+50
—
1.9e+00
1.1e+00
cases:1.04%
controls:0.28%
cases:3.61%
controls:0.12%
cases:3.19%
controls:0.01%
cases:0.58%
controls:0.00%
—
—
cases:0.60%
controls:0.09%
cases:1.06%
controls:0.36%
41
111
3915
39430
143
48
3813
39493
126
5
3830
39536
23
0
3933
39541
—
21
35
3480
38292
29
118
2709
32305
Mycobacterium sp identified in Specimen by Organism specific culture
543-9 [3005702]
5.7e-01
1.6e+00
3.9e+00
—
3.4e+00
2.4e+00
1.9e+00
cases:0.68%
controls:0.39%
cases:0.96%
controls:0.19%
cases:1.19%
controls:0.03%
—
—
cases:0.60%
controls:0.02%
cases:1.97%
controls:0.17%
cases:3.07%
controls:0.46%
27
153
3929
39388
38
75
3918
39466
47
10
3909
39531
—
23
8
3821
39464
69
67
3432
38260
84
149
2654
32274
Short blood count panel - Blood
55429-5 [40758558]
1.9e-01
8.1e-01
2.5e+00
4.3e+00
2.9e+00
1.7e+00
1.1e+00
cases:7.25%
controls:6.10%
cases:7.56%
controls:3.51%
cases:9.53%
controls:0.85%
cases:2.93%
controls:0.04%
cases:11.68%
controls:0.74%
cases:16.40%
controls:3.47%
cases:21.66%
controls:8.42%
287
2413
3669
37128
299
1389
3657
38152
377
335
3579
39206
116
17
3840
39524
449
292
3395
39180
574
1329
2927
36998
593
2730
2145
29693
Promyelocytes/Leukocytes in Blood
26524-9 [3021440]
5.6e-01
1.4e+00
3.3e+00
—
3.7e+00
2.6e+00
1.6e+00
cases:1.79%
controls:1.03%
cases:3.24%
controls:0.81%
cases:4.93%
controls:0.19%
—
—
cases:6.19%
controls:0.16%
cases:12.20%
controls:1.02%
cases:12.27%
controls:2.73%
71
408
3885
39133
128
321
3828
39220
195
74
3761
39467
—
238
62
3606
39410
427
390
3074
37937
336
884
2402
31539
Abdominal ultrasound examination
JN3AE [2001305555]
6.0e-01
1.9e+00
3.4e+00
—
2.9e+00
2.3e+00
2.2e+00
cases:3.19%
controls:1.78%
cases:3.21%
controls:0.52%
cases:1.14%
controls:0.04%
—
—
cases:1.04%
controls:0.06%
cases:4.86%
controls:0.52%
cases:11.76%
controls:1.51%
126
704
3830
38837
127
204
3829
39337
45
15
3911
39526
—
40
22
3804
39450
170
201
3331
38126
322
491
2416
31932
prednisolone; oral, parenteral
H02AB06 [21602734]
2.9e-01
7.6e-01
1.9e+00
3.8e+00
3.6e+00
2.2e+00
6.7e-01
cases:14.96%
controls:11.63%
cases:10.74%
controls:5.34%
cases:6.19%
controls:1.02%
cases:2.33%
controls:0.05%
cases:29.66%
controls:1.13%
cases:35.28%
controls:5.46%
cases:22.21%
controls:12.71%
592
4599
3364
34942
425
2111
3531
37430
245
405
3711
39136
92
21
3864
39520
1140
448
2704
39024
1235
2091
2266
36236
608
4121
2130
28302
prednisolone
A07EA01 [21600653]
2.9e-01
7.6e-01
1.9e+00
3.8e+00
3.6e+00
2.2e+00
6.7e-01
cases:15.02%
controls:11.69%
cases:10.79%
controls:5.35%
cases:6.19%
controls:1.03%
cases:2.33%
controls:0.05%
cases:29.68%
controls:1.14%
cases:35.30%
controls:5.47%
cases:22.28%
controls:12.75%
594
4624
3362
34917
427
2115
3529
37426
245
406
3711
39135
92
21
3864
39520
1141
449
2703
39023
1236
2095
2265
36232
610
4135
2128
28288
Mycobacterium sp identified in Specimen
40699-1 [3042631]
6.4e-01
2.0e+00
3.5e+00
—
2.8e+00
2.8e+00
2.0e+00
cases:0.46%
controls:0.24%
cases:0.83%
controls:0.11%
cases:0.58%
controls:0.02%
—
—
cases:0.34%
controls:0.02%
cases:1.74%
controls:0.11%
cases:2.19%
controls:0.30%
18
95
3938
39446
33
43
3923
39498
23
7
3933
39534
—
13
8
3831
39464
61
42
3440
38285
60
97
2678
32326
Extensive CT of torso and neck
JN6BD [2001310939]
6.9e-01
2.5e+00
—
1.0e+50
—
5.0e+00
5.6e+00
cases:0.13%
controls:0.06%
cases:0.33%
controls:0.03%
—
—
cases:0.58%
controls:0.00%
—
—
cases:3.48%
controls:0.02%
cases:4.89%
controls:0.02%
5
25
3951
39516
13
11
3943
39530
—
23
0
3933
39541
—
122
9
3379
38318
134
6
2604
32417
allopurinol; oral, parenteral
M04AA01 [21604131]
3.3e-01
5.4e-01
1.6e+00
4.4e+00
3.8e+00
1.5e+00
9.0e-01
cases:5.11%
controls:3.73%
cases:4.90%
controls:2.92%
cases:3.72%
controls:0.78%
cases:1.87%
controls:0.02%
cases:27.76%
controls:0.82%
cases:12.20%
controls:3.01%
cases:10.30%
controls:4.46%
202
1476
3754
38065
194
1154
3762
38387
147
309
3809
39232
74
9
3882
39532
1067
324
2777
39148
427
1155
3074
37172
282
1447
2456
30976
Bone marrow Pathology biopsy report
33721-2 [3045142]
1.9e+00
3.5e+00
—
1.0e+50
—
4.5e+00
3.1e+00
cases:1.14%
controls:0.16%
cases:2.68%
controls:0.08%
—
—
cases:1.82%
controls:0.00%
—
—
cases:5.20%
controls:0.06%
cases:4.78%
controls:0.22%
45
65
3911
39476
106
33
3850
39508
—
72
0
3884
39541
—
182
23
3319
38304
131
71
2607
32352
Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
13956-8 [3014162]
4.1e-01
1.8e+00
3.7e+00
—
3.5e+00
2.5e+00
1.6e+00
cases:0.91%
controls:0.60%
cases:1.62%
controls:0.27%
cases:1.52%
controls:0.04%
—
—
cases:0.81%
controls:0.03%
cases:3.08%
controls:0.27%
cases:4.64%
controls:0.93%
36
239
3920
39302
64
107
3892
39434
60
15
3896
39526
—
31
10
3813
39462
108
104
3393
38223
127
303
2611
32120
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
1.0e-01
1.0e+00
3.2e+00
4.2e+00
2.5e+00
1.2e+00
8.8e-01
cases:22.55%
controls:20.85%
cases:25.61%
controls:10.89%
cases:29.10%
controls:1.59%
cases:4.15%
controls:0.06%
cases:15.53%
controls:1.47%
cases:29.05%
controls:11.21%
cases:48.65%
controls:28.12%
892
8245
3064
31296
1013
4305
2943
35236
1151
630
2805
38911
164
25
3792
39516
597
582
3247
38890
1017
4298
2484
34029
1332
9117
1406
23306
enoxaparin; parenteral
B01AB05 [21600976]
-1.8e-03
6.4e-01
2.8e+00
3.5e+00
3.3e+00
2.1e+00
7.1e-01
cases:6.47%
controls:6.48%
cases:3.46%
controls:1.85%
cases:3.77%
controls:0.24%
cases:0.43%
controls:0.01%
cases:6.30%
controls:0.25%
cases:11.63%
controls:1.60%
cases:10.23%
controls:5.29%
256
2563
3700
36978
137
732
3819
38809
149
96
3807
39445
17
5
3939
39536
242
99
3602
39373
407
612
3094
37715
280
1716
2458
30707
Thorax extensive CT-examination
GD1BD [2001303621]
9.0e-02
1.6e+00
3.4e+00
1.0e+50
3.4e+00
2.6e+00
2.0e+00
cases:0.88%
controls:0.81%
cases:1.16%
controls:0.24%
cases:0.94%
controls:0.03%
cases:0.48%
controls:0.00%
cases:0.36%
controls:0.01%
cases:1.71%
controls:0.14%
cases:2.56%
controls:0.34%
35
320
3921
39221
46
95
3910
39446
37
12
3919
39529
19
0
3937
39541
14
5
3830
39467
60
52
3441
38275
70
110
2668
32313
oxycodone; oral, parenteral
N02AA05 [21604260]
1.5e-01
8.9e-01
2.5e+00
3.4e+00
3.1e+00
2.3e+00
7.2e-01
cases:1.95%
controls:1.68%
cases:2.83%
controls:1.18%
cases:4.83%
controls:0.42%
cases:0.63%
controls:0.02%
cases:8.77%
controls:0.45%
cases:13.08%
controls:1.42%
cases:7.82%
controls:3.95%
77
666
3879
38875
112
466
3844
39075
191
165
3765
39376
25
8
3931
39533
337
178
3507
39294
458
545
3043
37782
214
1281
2524
31142
Drug-induced neutropenia
D70.82 [2000501376]
1.6e+00
2.5e+00
—
1.0e+50
—
5.7e+00
3.1e+00
cases:0.40%
controls:0.08%
cases:0.40%
controls:0.03%
—
—
cases:0.28%
controls:0.00%
—
—
cases:8.05%
controls:0.03%
cases:2.37%
controls:0.11%
16
33
3940
39508
16
13
3940
39528
—
11
0
3945
39541
—
282
11
3219
38316
65
36
2673
32387
Upper gastrointestinal surgery
106 [44777669]
4.4e-02
1.1e+00
3.1e+00
5.2e+00
2.0e+00
9.5e-01
5.5e-01
cases:11.00%
controls:10.57%
cases:11.73%
controls:4.40%
cases:12.71%
controls:0.68%
cases:3.06%
controls:0.02%
cases:4.79%
controls:0.67%
cases:10.51%
controls:4.35%
cases:18.19%
controls:11.37%
435
4180
3521
35361
464
1739
3492
37802
503
270
3453
39271
121
7
3835
39534
184
265
3660
39207
368
1669
3133
36658
498
3688
2240
28735
Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
80721-4 [21493690]
1.6e+00
2.4e+00
—
1.0e+50
—
5.1e+00
3.7e+00
cases:0.53%
controls:0.10%
cases:0.48%
controls:0.05%
—
—
cases:0.96%
controls:0.00%
—
—
cases:6.17%
controls:0.04%
cases:5.44%
controls:0.14%
21
41
3935
39500
19
18
3937
39523
—
38
0
3918
39541
—
216
16
3285
38311
149
46
2589
32377
Normoblasts [#/volume] in Blood
715-3 [3021589]
2.0e-01
7.9e-01
2.7e+00
4.5e+00
2.4e+00
1.2e+00
9.0e-01
cases:11.40%
controls:9.54%
cases:15.95%
controls:7.90%
cases:21.01%
controls:1.83%
cases:5.54%
controls:0.07%
cases:16.57%
controls:1.70%
cases:24.19%
controls:8.55%
cases:33.64%
controls:17.05%
451
3772
3505
35769
631
3125
3325
36416
831
722
3125
38819
219
26
3737
39515
637
672
3207
38800
847
3276
2654
35051
921
5528
1817
26895
B-cell lymphoma, unspecified
C85.1 [45586056]
3.7e+00
4.5e+00
—
1.0e+50
—
—
4.5e+00
cases:0.51%
controls:0.01%
cases:1.59%
controls:0.02%
—
—
cases:1.29%
controls:0.00%
—
—
—
—
cases:2.15%
controls:0.02%
20
5
3936
39536
63
7
3893
39534
—
51
0
3905
39541
—
—
59
8
2679
32415
Parainfluenza type 1 nucleic acid detection
222341000000100 [44790047]
3.4e-01
6.3e-01
3.2e+00
—
3.8e+00
3.4e+00
2.2e+00
cases:0.23%
controls:0.16%
cases:0.15%
controls:0.08%
cases:0.43%
controls:0.02%
—
—
cases:0.70%
controls:0.02%
cases:2.43%
controls:0.08%
cases:2.41%
controls:0.26%
9
64
3947
39477
6
32
3950
39509
17
7
3939
39534
—
27
6
3817
39466
85
31
3416
38296
66
85
2672
32338
Parainfluenza type 2 nucleic acid detection
222351000000102 [44790048]
3.4e-01
6.3e-01
3.2e+00
—
3.8e+00
3.4e+00
2.2e+00
cases:0.23%
controls:0.16%
cases:0.15%
controls:0.08%
cases:0.43%
controls:0.02%
—
—
cases:0.70%
controls:0.02%
cases:2.43%
controls:0.08%
cases:2.41%
controls:0.26%
9
64
3947
39477
6
32
3950
39509
17
7
3939
39534
—
27
6
3817
39466
85
31
3416
38296
66
85
2672
32338
Parainfluenza type 3 nucleic acid detection
222361000000104 [44790049]
3.4e-01
6.3e-01
3.2e+00
—
3.8e+00
3.4e+00
2.2e+00
cases:0.23%
controls:0.16%
cases:0.15%
controls:0.08%
cases:0.43%
controls:0.02%
—
—
cases:0.70%
controls:0.02%
cases:2.43%
controls:0.08%
cases:2.41%
controls:0.26%
9
64
3947
39477
6
32
3950
39509
17
7
3939
39534
—
27
6
3817
39466
85
31
3416
38296
66
85
2672
32338
Parainfluenza type 4 nucleic acid detection
810871000000102 [44806118]
3.4e-01
6.3e-01
3.2e+00
—
3.8e+00
3.4e+00
2.2e+00
cases:0.23%
controls:0.16%
cases:0.15%
controls:0.08%
cases:0.43%
controls:0.02%
—
—
cases:0.70%
controls:0.02%
cases:2.43%
controls:0.08%
cases:2.41%
controls:0.26%
9
64
3947
39477
6
32
3950
39509
17
7
3939
39534
—
27
6
3817
39466
85
31
3416
38296
66
85
2672
32338
Blasts/Leukocytes in Blood
26446-5 [3025159]
5.8e-01
1.4e+00
3.2e+00
—
3.6e+00
2.4e+00
1.5e+00
cases:1.64%
controls:0.93%
cases:3.01%
controls:0.79%
cases:4.65%
controls:0.19%
—
—
cases:5.20%
controls:0.15%
cases:9.94%
controls:1.03%
cases:11.69%
controls:2.78%
65
367
3891
39174
119
313
3837
39228
184
75
3772
39466
—
200
61
3644
39411
348
395
3153
37932
320
901
2418
31522
Heart transplant status
Z94.1 [45590779]
1.9e+00
2.2e+00
2.0e+00
—
2.0e+00
2.1e+00
2.3e+00
cases:0.25%
controls:0.04%
cases:0.28%
controls:0.03%
cases:0.15%
controls:0.02%
—
—
cases:0.16%
controls:0.02%
cases:0.23%
controls:0.03%
cases:0.26%
controls:0.02%
10
15
3946
39526
11
12
3945
39529
6
8
3950
39533
—
6
8
3838
39464
8
11
3493
38316
7
8
2731
32415
Thymidine kinase [Enzymatic activity/volume] in Serum
44934-8 [3045066]
1.7e+00
3.0e+00
—
1.0e+50
—
4.0e+00
3.9e+00
cases:0.20%
controls:0.04%
cases:0.91%
controls:0.05%
—
—
cases:0.18%
controls:0.00%
—
—
cases:0.94%
controls:0.02%
cases:2.52%
controls:0.05%
8
15
3948
39526
36
18
3920
39523
—
7
0
3949
39541
—
33
7
3468
38320
69
17
2669
32406
CD3-CD16+CD56+ (Natural killer) cells/cells in Blood
8112-5 [3027831]
1.6e+00
2.2e+00
—
1.0e+50
—
5.1e+00
3.6e+00
cases:0.46%
controls:0.09%
cases:0.46%
controls:0.05%
—
—
cases:0.78%
controls:0.00%
—
—
cases:5.77%
controls:0.04%
cases:5.66%
controls:0.16%
18
37
3938
39504
18
20
3938
39521
—
31
0
3925
39541
—
202
14
3299
38313
155
53
2583
32370
Protein electrophoresis panel - Serum or Plasma
24351-9 [3004588]
6.5e-01
2.0e+00
4.3e+00
—
3.5e+00
1.1e+00
9.0e-01
cases:2.91%
controls:1.54%
cases:5.23%
controls:0.72%
cases:6.95%
controls:0.10%
—
—
cases:4.40%
controls:0.14%
cases:2.11%
controls:0.73%
cases:5.11%
controls:2.13%
115
609
3841
38932
207
285
3749
39256
275
39
3681
39502
—
169
54
3675
39418
74
280
3427
38047
140
692
2598
31731
prednisone
A07EA03 [21600655]
7.0e-01
1.2e+00
2.3e+00
—
4.4e+00
2.9e+00
1.1e+00
cases:3.29%
controls:1.65%
cases:1.79%
controls:0.56%
cases:1.16%
controls:0.12%
—
—
cases:9.03%
controls:0.13%
cases:9.11%
controls:0.57%
cases:4.27%
controls:1.49%
130
653
3826
38888
71
222
3885
39319
46
48
3910
39493
—
347
50
3497
39422
319
218
3182
38109
117
482
2621
31941
prednisone; oral
H02AB07 [21602735]
7.0e-01
1.2e+00
2.3e+00
—
4.4e+00
2.9e+00
1.1e+00
cases:3.29%
controls:1.65%
cases:1.79%
controls:0.56%
cases:1.16%
controls:0.12%
—
—
cases:9.03%
controls:0.13%
cases:9.11%
controls:0.57%
cases:4.27%
controls:1.49%
130
653
3826
38888
71
222
3885
39319
46
48
3910
39493
—
347
50
3497
39422
319
218
3182
38109
117
482
2621
31941
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
3.5e-02
7.8e-01
2.8e+00
4.1e+00
2.7e+00
1.3e+00
7.1e-01
cases:33.11%
controls:32.34%
cases:37.89%
controls:21.84%
cases:41.56%
controls:4.32%
cases:14.71%
controls:0.28%
cases:40.89%
controls:4.32%
cases:51.90%
controls:22.53%
cases:62.75%
controls:45.25%
1310
12786
2646
26755
1499
8635
2457
30906
1644
1709
2312
37832
582
111
3374
39430
1572
1704
2272
37768
1817
8636
1684
29691
1718
14670
1020
17753
Supplier / Service Provider
OMOP5117446 [33004]
-7.1e-01
-3.4e-01
1.3e+00
2.0e+00
4.0e+00
3.3e+00
2.8e+00
cases:14.76%
controls:25.99%
cases:6.75%
controls:9.21%
cases:3.11%
controls:0.86%
cases:0.28%
controls:0.04%
cases:4.42%
controls:0.08%
cases:13.82%
controls:0.57%
cases:19.72%
controls:1.54%
584
10278
3372
29263
267
3641
3689
35900
123
341
3833
39200
11
15
3945
39526
170
32
3674
39440
484
219
3017
38108
540
498
2198
31925
Lymphnode ultrasound examination
PJ2AE [2001309620]
1.7e+00
3.8e+00
—
1.0e+50
—
3.8e+00
3.1e+00
cases:0.40%
controls:0.08%
cases:0.68%
controls:0.02%
—
—
cases:0.28%
controls:0.00%
—
—
cases:0.57%
controls:0.01%
cases:0.88%
controls:0.04%
16
30
3940
39511
27
6
3929
39535
—
11
0
3945
39541
—
20
5
3481
38322
24
13
2714
32410
CD3 cells/Lymphocytes in Blood
90304-7 [1175426]
1.5e+00
2.2e+00
—
1.0e+50
—
5.1e+00
3.6e+00
cases:0.46%
controls:0.11%
cases:0.48%
controls:0.05%
—
—
cases:0.81%
controls:0.00%
—
—
cases:5.88%
controls:0.04%
cases:5.73%
controls:0.17%
18
42
3938
39499
19
21
3937
39520
—
32
0
3924
39541
—
206
14
3295
38313
157
56
2581
32367
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
-4.9e-02
6.4e-01
2.9e+00
4.4e+00
2.7e+00
1.3e+00
4.6e-01
cases:14.03%
controls:14.63%
cases:13.75%
controls:7.74%
cases:16.56%
controls:1.11%
cases:3.29%
controls:0.04%
cases:13.84%
controls:1.03%
cases:23.31%
controls:7.81%
cases:30.53%
controls:21.73%
555
5786
3401
33755
544
3062
3412
36479
655
438
3301
39103
130
17
3826
39524
532
408
3312
39064
816
2993
2685
35334
836
7046
1902
25377
Drill biopsy of bone marrow, pelvis
TNE25 [2001307884]
1.9e+00
3.4e+00
1.0e+50
1.0e+50
1.0e+50
3.9e+00
3.0e+00
cases:0.56%
controls:0.08%
cases:0.94%
controls:0.03%
cases:0.96%
controls:0.00%
cases:1.06%
controls:0.00%
cases:0.73%
controls:0.00%
cases:1.17%
controls:0.02%
cases:1.42%
controls:0.07%
22
32
3934
39509
37
13
3919
39528
38
0
3918
39541
42
0
3914
39541
28
0
3816
39472
41
9
3460
38318
39
24
2699
32399
High resolution CT examination of lungs
GD1DD [2001303632]
6.2e-01
1.2e+00
2.5e+00
1.0e+50
3.2e+00
2.8e+00
1.9e+00
cases:1.01%
controls:0.55%
cases:0.71%
controls:0.20%
cases:0.18%
controls:0.02%
cases:0.18%
controls:0.00%
cases:0.31%
controls:0.01%
cases:3.00%
controls:0.19%
cases:3.83%
controls:0.61%
40
217
3916
39324
28
81
3928
39460
7
6
3949
39535
7
0
3949
39541
12
5
3832
39467
105
73
3396
38254
105
199
2633
32224
Radiotherapy of metastasis
WF049 [2001310705]
9.5e-01
1.2e+00
2.6e+00
—
3.6e+00
3.0e+00
1.7e+00
cases:0.38%
controls:0.15%
cases:0.40%
controls:0.12%
cases:0.23%
controls:0.02%
—
—
cases:0.86%
controls:0.02%
cases:2.51%
controls:0.13%
cases:2.15%
controls:0.39%
15
58
3941
39483
16
46
3940
39495
9
7
3947
39534
—
33
9
3811
39463
88
49
3413
38278
59
127
2679
32296
Extensive abdominal CT
JN3BD [2001305556]
1.4e-01
1.2e+00
3.9e+00
1.0e+50
3.6e+00
2.2e+00
1.3e+00
cases:1.64%
controls:1.43%
cases:1.49%
controls:0.43%
cases:1.24%
controls:0.03%
cases:0.63%
controls:0.00%
cases:0.70%
controls:0.02%
cases:2.34%
controls:0.27%
cases:2.96%
controls:0.85%
65
567
3891
38974
59
172
3897
39369
49
10
3907
39531
25
0
3931
39541
27
8
3817
39464
82
105
3419
38222
81
276
2657
32147
Demanding cystostatic therapy of methastized malignancy
WD135 [2001310681]
2.4e+00
—
—
1.0e+50
—
6.1e+00
3.6e+00
cases:0.30%
controls:0.03%
—
—
—
—
cases:0.91%
controls:0.00%
—
—
cases:8.68%
controls:0.02%
cases:1.46%
controls:0.04%
12
11
3944
39530
—
—
36
0
3920
39541
—
304
8
3197
38319
40
13
2698
32410
Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
3255-7 [3016407]
2.2e-01
1.2e+00
3.4e+00
1.0e+50
4.2e+00
1.9e+00
1.4e+00
cases:0.63%
controls:0.51%
cases:0.73%
controls:0.21%
cases:0.94%
controls:0.03%
cases:0.23%
controls:0.00%
cases:1.14%
controls:0.02%
cases:1.37%
controls:0.20%
cases:2.30%
controls:0.60%
25
200
3931
39341
29
85
3927
39456
37
13
3919
39528
9
0
3947
39541
44
7
3800
39465
48
76
3453
38251
63
195
2675
32228
cyclophosphamide
L01AA01 [21601390]
1.8e+00
2.3e+00
—
1.0e+50
—
5.1e+00
2.9e+00
cases:0.35%
controls:0.06%
cases:0.23%
controls:0.02%
—
—
cases:0.15%
controls:0.00%
—
—
cases:4.83%
controls:0.03%
cases:1.02%
controls:0.06%
14
23
3942
39518
9
9
3947
39532
—
6
0
3950
39541
—
169
12
3332
38315
28
19
2710
32404
Procalcitonin [Mass/volume] in Serum or Plasma
33959-8 [3046279]
1.2e-01
9.4e-01
3.8e+00
—
3.9e+00
2.4e+00
9.1e-01
cases:0.63%
controls:0.56%
cases:0.83%
controls:0.33%
cases:1.09%
controls:0.03%
—
—
cases:2.00%
controls:0.04%
cases:3.86%
controls:0.35%
cases:3.36%
controls:1.38%
25
222
3931
39319
33
129
3923
39412
43
10
3913
39531
—
77
17
3767
39455
135
136
3366
38191
92
449
2646
31974
Lumbar puncture
TAB00 [2001300538]
3.0e-01
2.0e+00
—
1.0e+50
5.0e+00
3.3e+00
1.7e+00
cases:0.53%
controls:0.39%
cases:0.71%
controls:0.10%
—
—
cases:0.94%
controls:0.00%
cases:1.77%
controls:0.01%
cases:2.09%
controls:0.08%
cases:1.46%
controls:0.27%
21
155
3935
39386
28
39
3928
39502
—
37
0
3919
39541
68
5
3776
39467
73
31
3428
38296
40
88
2698
32335
CD4 cells/Lymphocytes in Specimen
80223-1 [21494815]
1.5e+00
2.1e+00
—
1.0e+50
—
4.7e+00
3.5e+00
cases:0.53%
controls:0.12%
cases:0.43%
controls:0.05%
—
—
cases:0.20%
controls:0.00%
—
—
cases:5.63%
controls:0.05%
cases:5.95%
controls:0.19%
21
47
3935
39494
17
20
3939
39521
—
8
0
3948
39541
—
197
20
3304
38307
163
63
2575
32360
Enlarged lymph nodes, unspecified
R59.9 [45563319]
2.3e+00
4.9e+00
1.0e+50
1.0e+50
—
3.0e+00
1.7e+00
cases:0.48%
controls:0.05%
cases:1.92%
controls:0.02%
cases:2.58%
controls:0.00%
cases:0.43%
controls:0.00%
—
—
cases:0.26%
controls:0.01%
cases:0.33%
controls:0.06%
19
20
3937
39521
76
6
3880
39535
102
0
3854
39541
17
0
3939
39541
—
9
5
3492
38322
9
19
2729
32404
Very extensive CT examination of mouth and soft tissues of neck
EN1BD [2001302281]
7.1e-01
2.9e+00
—
1.0e+50
1.0e+50
4.8e+00
4.1e+00
cases:0.30%
controls:0.15%
cases:0.61%
controls:0.03%
—
—
cases:0.63%
controls:0.00%
cases:0.36%
controls:0.00%
cases:2.23%
controls:0.02%
cases:2.30%
controls:0.04%
12
59
3944
39482
24
13
3932
39528
—
25
0
3931
39541
14
0
3830
39472
78
7
3423
38320
63
13
2675
32410
IgA [Mass/volume] in Serum or Plasma
2458-8 [3007164]
3.4e-01
1.4e+00
4.0e+00
—
3.6e+00
1.6e+00
9.4e-01
cases:4.63%
controls:3.33%
cases:4.88%
controls:1.27%
cases:6.67%
controls:0.13%
—
—
cases:5.39%
controls:0.15%
cases:5.43%
controls:1.20%
cases:10.19%
controls:4.24%
183
1315
3773
38226
193
503
3763
39038
264
52
3692
39489
—
207
61
3637
39411
190
460
3311
37867
279
1375
2459
31048
Insertion of central venous catheter through external or internal jugular vein
TPH15 [2001309600]
1.7e-01
8.5e-01
2.6e+00
1.0e+50
3.3e+00
3.5e+00
1.5e+00
cases:0.88%
controls:0.75%
cases:0.63%
controls:0.27%
cases:0.43%
controls:0.03%
cases:0.66%
controls:0.00%
cases:0.91%
controls:0.03%
cases:6.03%
controls:0.19%
cases:2.78%
controls:0.62%
35
297
3921
39244
25
107
3931
39434
17
13
3939
39528
26
0
3930
39541
35
13
3809
39459
211
71
3290
38256
76
202
2662
32221
Choriogonadotropin [Units/volume] in Serum or Plasma
19080-1 [3018171]
-5.0e-01
2.0e+00
3.7e+00
—
3.3e+00
1.7e+00
1.1e+00
cases:0.13%
controls:0.21%
cases:0.68%
controls:0.09%
cases:0.61%
controls:0.02%
—
—
cases:0.34%
controls:0.01%
cases:0.40%
controls:0.07%
cases:0.73%
controls:0.25%
5
82
3951
39459
27
36
3929
39505
24
6
3932
39535
—
13
5
3831
39467
14
28
3487
38299
20
82
2718
32341
Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
51435-6 [3029713]
7.0e-01
2.0e+00
4.0e+00
1.0e+50
3.2e+00
1.0e+00
8.7e-01
cases:1.49%
controls:0.75%
cases:2.98%
controls:0.42%
cases:2.70%
controls:0.05%
cases:0.46%
controls:0.00%
cases:1.85%
controls:0.08%
cases:1.14%
controls:0.43%
cases:2.56%
controls:1.09%
59
295
3897
39246
118
166
3838
39375
107
21
3849
39520
18
0
3938
39541
71
30
3773
39442
40
163
3461
38164
70
352
2668
32071
Microscopic observation [Identifier] in Isolate by Gram stain
87975-9 [36305247]
4.9e-01
8.7e-01
3.9e+00
—
3.6e+00
2.1e+00
1.3e+00
cases:0.73%
controls:0.45%
cases:0.48%
controls:0.20%
cases:0.86%
controls:0.02%
—
—
cases:1.17%
controls:0.03%
cases:1.97%
controls:0.25%
cases:2.34%
controls:0.66%
29
178
3927
39363
19
80
3937
39461
34
7
3922
39534
—
45
13
3799
39459
69
95
3432
38232
64
213
2674
32210
Flexible bronchoscopy
UGC12 [2001303610]
4.4e-01
1.7e+00
3.8e+00
1.0e+50
2.5e+00
2.4e+00
1.3e+00
cases:1.42%
controls:0.91%
cases:1.59%
controls:0.28%
cases:1.11%
controls:0.03%
cases:0.13%
controls:0.00%
cases:0.31%
controls:0.03%
cases:2.60%
controls:0.24%
cases:3.21%
controls:0.94%
56
361
3900
39180
63
112
3893
39429
44
10
3912
39531
5
0
3951
39541
12
10
3832
39462
91
92
3410
38235
88
304
2650
32119
Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
35559-4 [3035797]
6.3e-01
2.0e+00
3.9e+00
1.0e+50
3.2e+00
9.8e-01
9.0e-01
cases:1.26%
controls:0.68%
cases:2.60%
controls:0.36%
cases:2.33%
controls:0.05%
cases:0.43%
controls:0.00%
cases:1.59%
controls:0.06%
cases:0.97%
controls:0.37%
cases:2.19%
controls:0.90%
50
268
3906
39273
103
142
3853
39399
92
19
3864
39522
17
0
3939
39541
61
25
3783
39447
34
140
3467
38187
60
293
2678
32130
Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
50796-2 [3029338]
6.5e-01
2.0e+00
3.8e+00
1.0e+50
3.2e+00
1.0e+00
9.3e-01
cases:1.21%
controls:0.64%
cases:2.48%
controls:0.33%
cases:2.07%
controls:0.05%
cases:0.33%
controls:0.00%
cases:1.51%
controls:0.06%
cases:0.94%
controls:0.35%
cases:2.23%
controls:0.89%
48
253
3908
39288
98
132
3858
39409
82
18
3874
39523
13
0
3943
39541
58
25
3786
39447
33
134
3468
38193
61
290
2677
32133
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
-7.4e-02
7.1e-01
2.4e+00
4.3e+00
2.4e+00
1.3e+00
4.1e-01
cases:5.94%
controls:6.37%
cases:6.90%
controls:3.53%
cases:4.98%
controls:0.46%
cases:1.14%
controls:0.02%
cases:5.15%
controls:0.50%
cases:12.08%
controls:3.56%
cases:14.72%
controls:10.32%
235
2517
3721
37024
273
1396
3683
38145
197
181
3759
39360
45
6
3911
39535
198
196
3646
39276
423
1365
3078
36962
403
3345
2335
29078
Bacteria [Presence] in Urine
87829-8 [36304419]
-5.9e-02
7.3e-01
2.4e+00
4.2e+00
2.4e+00
1.3e+00
4.3e-01
cases:5.71%
controls:6.04%
cases:6.72%
controls:3.36%
cases:4.73%
controls:0.44%
cases:1.04%
controls:0.02%
cases:4.84%
controls:0.46%
cases:11.57%
controls:3.29%
cases:13.95%
controls:9.54%
226
2387
3730
37154
266
1328
3690
38213
187
174
3769
39367
41
6
3915
39535
186
182
3658
39290
405
1260
3096
37067
382
3092
2356
29331
Epstein Barr virus Ab [Presence] in Serum
49178-7 [3048929]
5.5e-01
2.4e+00
5.1e+00
1.0e+50
—
2.5e+00
1.5e+00
cases:0.66%
controls:0.38%
cases:1.64%
controls:0.16%
cases:2.05%
controls:0.01%
cases:0.56%
controls:0.00%
—
—
cases:1.60%
controls:0.13%
cases:2.08%
controls:0.47%
26
150
3930
39391
65
62
3891
39479
81
5
3875
39536
22
0
3934
39541
—
56
49
3445
38278
57
152
2681
32271
Protein [Mass/volume] in Serum or Plasma
2885-2 [3020630]
5.6e-01
2.0e+00
3.8e+00
—
3.1e+00
1.2e+00
8.5e-01
cases:3.01%
controls:1.74%
cases:5.89%
controls:0.88%
cases:5.33%
controls:0.13%
—
—
cases:3.54%
controls:0.16%
cases:3.06%
controls:0.92%
cases:6.03%
controls:2.66%
119
687
3837
38854
233
348
3723
39193
211
52
3745
39489
—
136
63
3708
39409
107
352
3394
37975
165
863
2573
31560
CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
9728-7 [3025271]
1.2e+00
2.1e+00
—
1.0e+50
—
4.9e+00
3.3e+00
cases:0.33%
controls:0.10%
cases:0.48%
controls:0.06%
—
—
cases:0.96%
controls:0.00%
—
—
cases:4.20%
controls:0.03%
cases:4.09%
controls:0.16%
13
41
3943
39500
19
23
3937
39518
—
38
0
3918
39541
—
147
12
3354
38315
112
53
2626
32370
Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
3216-9 [3020427]
-4.6e-02
1.2e+00
3.1e+00
1.0e+50
4.1e+00
2.2e+00
9.5e-01
cases:0.66%
controls:0.69%
cases:0.76%
controls:0.24%
cases:0.83%
controls:0.04%
cases:0.15%
controls:0.00%
cases:1.20%
controls:0.02%
cases:2.00%
controls:0.23%
cases:2.08%
controls:0.82%
26
272
3930
39269
30
94
3926
39447
33
15
3923
39526
6
0
3950
39541
46
8
3798
39464
70
89
3431
38238
57
265
2681
32158
Other and unspecified hydronephrosis
N13.3 [45553432]
2.7e-01
1.4e+00
3.2e+00
1.0e+50
3.4e+00
2.4e+00
1.1e+00
cases:0.20%
controls:0.15%
cases:0.43%
controls:0.11%
cases:0.73%
controls:0.03%
cases:0.35%
controls:0.00%
cases:0.65%
controls:0.02%
cases:0.97%
controls:0.09%
cases:0.73%
controls:0.23%
8
61
3948
39480
17
42
3939
39499
29
12
3927
39529
14
0
3942
39541
25
9
3819
39463
34
35
3467
38292
20
76
2718
32347
Nonfamilial hypogammaglobulinaemia
D80.1 [45533001]
2.3e+00
2.4e+00
—
—
—
3.0e+00
3.7e+00
cases:0.25%
controls:0.03%
cases:0.23%
controls:0.02%
—
—
—
—
—
—
cases:0.37%
controls:0.02%
cases:0.88%
controls:0.02%
10
10
3946
39531
9
8
3947
39533
—
—
—
13
7
3488
38320
24
7
2714
32416
Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
50797-0 [3029379]
6.5e-01
2.0e+00
3.7e+00
1.0e+50
3.1e+00
1.0e+00
8.7e-01
cases:1.21%
controls:0.64%
cases:2.43%
controls:0.33%
cases:1.90%
controls:0.05%
cases:0.33%
controls:0.00%
cases:1.40%
controls:0.06%
cases:0.94%
controls:0.33%
cases:1.97%
controls:0.84%
48
252
3908
39289
96
131
3860
39410
75
18
3881
39523
13
0
3943
39541
54
25
3790
39447
33
128
3468
38199
54
272
2684
32151
Panorama tomography of teeth and jaws or similar X-ray examination
EB1HA [2001301913]
-1.4e-02
2.9e-01
2.1e+00
4.6e+00
2.9e+00
1.2e+00
6.2e-01
cases:8.01%
controls:8.12%
cases:3.13%
controls:2.35%
cases:1.97%
controls:0.26%
cases:1.69%
controls:0.02%
cases:3.12%
controls:0.17%
cases:6.60%
controls:2.08%
cases:12.97%
controls:7.43%
317
3209
3639
36332
124
931
3832
38610
78
102
3878
39439
67
7
3889
39534
120
67
3724
39405
231
799
3270
37528
355
2410
2383
30013
CD3+CD4+ (T4 helper) cells [#/volume] in Blood
24467-3 [3028167]
1.1e+00
2.2e+00
—
1.0e+50
—
4.7e+00
3.4e+00
cases:0.43%
controls:0.14%
cases:0.56%
controls:0.06%
—
—
cases:0.33%
controls:0.00%
—
—
cases:4.40%
controls:0.04%
cases:4.24%
controls:0.15%
17
55
3939
39486
22
25
3934
39516
—
13
0
3943
39541
—
154
16
3347
38311
116
50
2622
32373
Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2865-4 [3015322]
6.4e-01
2.0e+00
3.8e+00
1.0e+50
3.0e+00
1.1e+00
8.6e-01
cases:1.54%
controls:0.82%
cases:3.08%
controls:0.43%
cases:2.53%
controls:0.06%
cases:0.48%
controls:0.00%
cases:1.61%
controls:0.08%
cases:1.29%
controls:0.45%
cases:2.70%
controls:1.17%
61
323
3895
39218
122
171
3834
39370
100
24
3856
39517
19
0
3937
39541
62
31
3782
39441
45
173
3456
38154
74
378
2664
32045
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
47598-8 [3048816]
1.9e-01
8.9e-01
3.6e+00
—
3.8e+00
2.0e+00
1.0e+00
cases:1.95%
controls:1.62%
cases:2.30%
controls:0.96%
cases:4.63%
controls:0.14%
—
—
cases:5.44%
controls:0.13%
cases:6.57%
controls:0.92%
cases:6.68%
controls:2.47%
77
640
3879
38901
91
379
3865
39162
183
54
3773
39487
—
209
50
3635
39422
230
354
3271
37973
183
802
2555
31621
Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32730-4 [3043723]
6.5e-01
2.0e+00
3.7e+00
1.0e+50
3.1e+00
1.0e+00
8.2e-01
cases:1.67%
controls:0.88%
cases:3.26%
controls:0.46%
cases:2.65%
controls:0.07%
cases:0.48%
controls:0.00%
cases:1.77%
controls:0.08%
cases:1.37%
controls:0.49%
cases:2.92%
controls:1.31%
66
347
3890
39194
129
180
3827
39361
105
26
3851
39515
19
0
3937
39541
68
32
3776
39440
48
189
3453
38138
80
425
2658
31998
Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2868-8 [3005229]
6.5e-01
2.0e+00
3.7e+00
1.0e+50
3.1e+00
1.0e+00
8.1e-01
cases:1.67%
controls:0.88%
cases:3.29%
controls:0.46%
cases:2.65%
controls:0.07%
cases:0.48%
controls:0.00%
cases:1.74%
controls:0.08%
cases:1.37%
controls:0.49%
cases:2.92%
controls:1.32%
66
347
3890
39194
130
180
3826
39361
105
26
3851
39515
19
0
3937
39541
67
32
3777
39440
48
189
3453
38138
80
427
2658
31996
Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32731-2 [3043747]
6.3e-01
2.0e+00
3.7e+00
1.0e+50
3.1e+00
1.0e+00
8.1e-01
cases:1.64%
controls:0.88%
cases:3.29%
controls:0.46%
cases:2.65%
controls:0.07%
cases:0.48%
controls:0.00%
cases:1.74%
controls:0.08%
cases:1.37%
controls:0.49%
cases:2.92%
controls:1.32%
65
347
3891
39194
130
180
3826
39361
105
26
3851
39515
19
0
3937
39541
67
32
3777
39440
48
189
3453
38138
80
427
2658
31996
Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2874-6 [3023465]
6.7e-01
2.1e+00
3.6e+00
1.0e+50
3.1e+00
1.0e+00
8.6e-01
cases:1.62%
controls:0.84%
cases:3.08%
controls:0.41%
cases:2.22%
controls:0.06%
cases:0.38%
controls:0.00%
cases:1.53%
controls:0.07%
cases:1.23%
controls:0.44%
cases:2.67%
controls:1.14%
64
331
3892
39210
122
161
3834
39380
88
24
3868
39517
15
0
3941
39541
59
29
3785
39443
43
170
3458
38157
73
370
2665
32053
Carbon dioxide [Partial pressure] in Venous blood
2021-4 [3021447]
-1.1e-01
5.1e-01
2.5e+00
4.1e+00
2.8e+00
1.4e+00
2.2e-01
cases:1.54%
controls:1.72%
cases:1.77%
controls:1.07%
cases:1.87%
controls:0.15%
cases:0.73%
controls:0.01%
cases:2.73%
controls:0.17%
cases:4.54%
controls:1.22%
cases:4.93%
controls:4.00%
61
680
3895
38861
70
425
3886
39116
74
60
3882
39481
29
5
3927
39536
105
67
3739
39405
159
466
3342
37861
135
1296
2603
31127
pH of Venous blood
2746-6 [3012544]
-9.3e-02
5.1e-01
2.5e+00
4.1e+00
2.8e+00
1.4e+00
2.4e-01
cases:1.62%
controls:1.77%
cases:1.77%
controls:1.07%
cases:1.85%
controls:0.15%
cases:0.76%
controls:0.01%
cases:2.65%
controls:0.17%
cases:4.57%
controls:1.22%
cases:5.08%
controls:4.05%
64
701
3892
38840
70
424
3886
39117
73
61
3883
39480
30
5
3926
39536
102
66
3742
39406
160
469
3341
37858
139
1313
2599
31110
Base excess in Venous blood by calculation
1927-3 [3002032]
-1.2e-01
5.3e-01
2.5e+00
4.1e+00
2.8e+00
1.4e+00
2.4e-01
cases:1.54%
controls:1.74%
cases:1.79%
controls:1.07%
cases:1.79%
controls:0.15%
cases:0.73%
controls:0.01%
cases:2.65%
controls:0.17%
cases:4.54%
controls:1.21%
cases:4.93%
controls:3.91%
61
688
3895
38853
71
422
3885
39119
71
60
3885
39481
29
5
3927
39536
102
67
3742
39405
159
462
3342
37865
135
1268
2603
31155
Subcutaneous
ZX112 [2001311492]
5.2e-01
8.2e-01
—
1.0e+50
4.1e+00
4.4e+00
2.8e+00
cases:0.35%
controls:0.21%
cases:0.18%
controls:0.08%
—
—
cases:0.28%
controls:0.00%
cases:1.87%
controls:0.03%
cases:4.54%
controls:0.06%
cases:2.08%
controls:0.13%
14
83
3942
39458
7
31
3949
39510
—
11
0
3945
39541
72
13
3772
39459
159
23
3342
38304
57
43
2681
32380
CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
20607-8 [3020073]
1.9e+00
—
1.0e+50
—
—
5.2e+00
4.1e+00
cases:0.25%
controls:0.04%
—
—
cases:0.48%
controls:0.00%
—
—
—
—
cases:3.63%
controls:0.02%
cases:3.29%
controls:0.06%
10
15
3946
39526
—
19
0
3937
39541
—
—
127
8
3374
38319
90
19
2648
32404
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
-4.3e-02
4.8e-01
2.7e+00
4.6e+00
2.4e+00
9.6e-01
1.8e-01
cases:8.87%
controls:9.23%
cases:7.25%
controls:4.62%
cases:8.67%
controls:0.61%
cases:1.47%
controls:0.02%
cases:6.22%
controls:0.61%
cases:11.63%
controls:4.80%
cases:16.80%
controls:14.48%
351
3648
3605
35893
287
1825
3669
37716
343
242
3613
39299
58
6
3898
39535
239
241
3605
39231
407
1840
3094
36487
460
4696
2278
27727
Calcium [Moles/volume] corrected for albumin in Serum or Plasma
29265-6 [3020059]
1.0e-01
9.9e-01
3.8e+00
—
3.6e+00
1.9e+00
7.8e-01
cases:4.30%
controls:3.90%
cases:4.80%
controls:1.84%
cases:11.07%
controls:0.28%
—
—
cases:9.76%
controls:0.29%
cases:12.77%
controls:2.08%
cases:12.93%
controls:6.39%
170
1544
3786
37997
190
729
3766
38812
438
111
3518
39430
—
375
114
3469
39358
447
796
3054
37531
354
2072
2384
30351
Sicca syndrome [Sjögren]
M35.0 [45562711]
1.2e+00
1.9e+00
2.0e+00
1.0e+50
2.3e+00
1.9e+00
1.7e+00
cases:0.91%
controls:0.27%
cases:0.91%
controls:0.13%
cases:0.30%
controls:0.04%
cases:0.33%
controls:0.00%
cases:0.47%
controls:0.05%
cases:1.03%
controls:0.15%
cases:1.39%
controls:0.26%
36
105
3920
39436
36
52
3920
39489
12
17
3944
39524
13
0
3943
39541
18
18
3826
39454
36
57
3465
38270
38
85
2700
32338
Ultrasound examination of upper part of abdomen
JN1AE [2001305517]
2.2e-01
1.4e+00
3.5e+00
1.0e+50
3.3e+00
1.7e+00
1.2e+00
cases:1.24%
controls:0.99%
cases:1.31%
controls:0.33%
cases:0.81%
controls:0.03%
cases:0.35%
controls:0.00%
cases:0.49%
controls:0.02%
cases:1.40%
controls:0.26%
cases:2.99%
controls:0.96%
49
393
3907
39148
52
130
3904
39411
32
10
3924
39531
14
0
3942
39541
19
7
3825
39465
49
99
3452
38228
82
312
2656
32111
Treponema pallidum Ab [Presence] in Serum
22587-0 [3019832]
-2.7e-02
7.6e-01
3.1e+00
—
3.3e+00
2.8e+00
1.1e+00
cases:0.76%
controls:0.78%
cases:0.68%
controls:0.32%
cases:0.48%
controls:0.02%
—
—
cases:0.55%
controls:0.02%
cases:4.03%
controls:0.25%
cases:2.92%
controls:1.00%
30
308
3926
39233
27
127
3929
39414
19
9
3937
39532
—
21
8
3823
39464
141
97
3360
38230
80
323
2658
32100
Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
62424-7 [40765161]
4.5e-01
1.0e+00
3.4e+00
—
—
3.9e+00
2.6e+00
cases:0.43%
controls:0.27%
cases:0.43%
controls:0.15%
cases:0.51%
controls:0.02%
—
—
—
—
cases:4.97%
controls:0.10%
cases:4.46%
controls:0.35%
17
108
3939
39433
17
60
3939
39481
20
7
3936
39534
—
—
174
40
3327
38287
122
112
2616
32311
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
-8.3e-02
6.4e-01
2.3e+00
4.0e+00
2.3e+00
1.3e+00
4.0e-01
cases:8.27%
controls:8.92%
cases:8.52%
controls:4.70%
cases:5.97%
controls:0.66%
cases:1.24%
controls:0.02%
cases:6.35%
controls:0.67%
cases:14.85%
controls:4.63%
cases:18.08%
controls:12.87%
327
3526
3629
36015
337
1858
3619
37683
236
259
3720
39282
49
9
3907
39532
244
265
3600
39207
520
1774
2981
36553
495
4174
2243
28249
Sepsis, unspecified
A41.9 [45585911]
1.5e-01
8.9e-01
2.8e+00
—
3.8e+00
3.1e+00
1.3e+00
cases:0.33%
controls:0.28%
cases:0.25%
controls:0.10%
cases:0.28%
controls:0.02%
—
—
cases:0.86%
controls:0.02%
cases:3.08%
controls:0.14%
cases:1.61%
controls:0.45%
13
112
3943
39429
10
41
3946
39500
11
7
3945
39534
—
33
8
3811
39464
108
55
3393
38272
44
147
2694
32276
Troponin I.cardiac [Mass/volume] in Serum or Plasma
10839-9 [3021337]
7.9e-02
7.3e-01
2.7e+00
3.6e+00
2.6e+00
1.3e+00
2.1e-01
cases:4.83%
controls:4.48%
cases:4.80%
controls:2.36%
cases:4.15%
controls:0.29%
cases:0.71%
controls:0.02%
cases:4.40%
controls:0.33%
cases:7.97%
controls:2.36%
cases:8.47%
controls:6.97%
191
1771
3765
37770
190
934
3766
38607
164
116
3792
39425
28
8
3928
39533
169
132
3675
39340
279
906
3222
37421
232
2260
2506
30163
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
-3.8e-02
6.9e-01
2.3e+00
4.0e+00
2.3e+00
1.3e+00
3.8e-01
cases:7.10%
controls:7.36%
cases:7.94%
controls:4.16%
cases:5.38%
controls:0.58%
cases:1.19%
controls:0.02%
cases:5.70%
controls:0.61%
cases:13.62%
controls:4.27%
cases:16.69%
controls:12.10%
281
2909
3675
36632
314
1644
3642
37897
213
228
3743
39313
47
9
3909
39532
219
240
3625
39232
477
1635
3024
36692
457
3924
2281
28499
General Surgery
2 [38004447]
1.9e-02
9.4e-01
2.8e+00
4.7e+00
1.6e+00
5.9e-01
3.2e-01
cases:18.81%
controls:18.52%
cases:13.52%
controls:5.74%
cases:11.50%
controls:0.81%
cases:3.13%
controls:0.03%
cases:3.17%
controls:0.68%
cases:8.71%
controls:5.01%
cases:19.39%
controls:14.91%
744
7322
3212
32219
535
2270
3421
37271
455
319
3501
39222
124
12
3832
39529
122
267
3722
39205
305
1920
3196
36407
531
4834
2207
27589
Immunoglobulin light chains.free panel - Serum
57778-3 [40760888]
6.1e-01
2.3e+00
3.6e+00
—
2.1e+00
1.1e+00
1.2e+00
cases:0.99%
controls:0.54%
cases:2.38%
controls:0.25%
cases:1.74%
controls:0.05%
—
—
cases:0.57%
controls:0.07%
cases:0.80%
controls:0.27%
cases:2.15%
controls:0.67%
39
212
3917
39329
94
98
3862
39443
69
20
3887
39521
—
22
27
3822
39445
28
103
3473
38224
59
217
2679
32206
Leukocytes [#/volume] in Urine
30405-5 [3018095]
-1.6e-02
6.8e-01
2.2e+00
4.2e+00
2.2e+00
1.2e+00
3.6e-01
cases:7.86%
controls:7.98%
cases:8.92%
controls:4.74%
cases:5.79%
controls:0.67%
cases:1.19%
controls:0.02%
cases:5.96%
controls:0.72%
cases:14.48%
controls:4.95%
cases:18.81%
controls:13.91%
311
3154
3645
36387
353
1876
3603
37665
229
264
3727
39277
47
7
3909
39534
229
284
3615
39188
507
1899
2994
36428
515
4509
2223
27914
Radiotherapy with large shaped fields - isocentric therapy
ZX012 [2001311468]
4.3e-02
2.2e-01
2.3e+00
—
3.3e+00
3.5e+00
1.7e+00
cases:0.66%
controls:0.63%
cases:0.30%
controls:0.24%
cases:0.25%
controls:0.03%
—
—
cases:0.86%
controls:0.03%
cases:4.74%
controls:0.15%
cases:1.79%
controls:0.35%
26
249
3930
39292
12
96
3944
39445
10
10
3946
39531
—
33
12
3811
39460
166
57
3335
38270
49
113
2689
32310
Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
27811-9 [3000515]
2.8e-01
9.0e-01
3.0e+00
1.0e+50
3.8e+00
1.9e+00
1.2e+00
cases:0.73%
controls:0.56%
cases:0.56%
controls:0.23%
cases:0.63%
controls:0.03%
cases:0.15%
controls:0.00%
cases:0.88%
controls:0.02%
cases:1.23%
controls:0.19%
cases:1.90%
controls:0.57%
29
220
3927
39321
22
90
3934
39451
25
13
3931
39528
6
0
3950
39541
34
8
3810
39464
43
71
3458
38256
52
185
2686
32238
Chromosome analysis panel by Banding
62355-3 [40765096]
1.7e+00
3.9e+00
1.0e+50
1.0e+50
1.0e+50
3.3e+00
3.6e+00
cases:0.15%
controls:0.03%
cases:1.11%
controls:0.02%
cases:3.26%
controls:0.00%
cases:0.15%
controls:0.00%
cases:0.68%
controls:0.00%
cases:0.49%
controls:0.02%
cases:1.28%
controls:0.04%
6
11
3950
39530
44
9
3912
39532
129
0
3827
39541
6
0
3950
39541
26
0
3818
39472
17
7
3484
38320
35
12
2703
32411
CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
54218-3 [40757349]
1.2e+00
2.2e+00
1.0e+50
—
—
4.9e+00
3.6e+00
cases:0.13%
controls:0.04%
cases:0.20%
controls:0.02%
cases:0.30%
controls:0.00%
—
—
—
—
cases:1.71%
controls:0.01%
cases:2.19%
controls:0.06%
5
15
3951
39526
8
9
3948
39532
12
0
3944
39541
—
—
60
5
3441
38322
60
19
2678
32404
lipegfilgrastim; parenteral
L03AA14 [43534819]
6.9e-01
1.9e+00
—
—
—
5.8e+00
3.0e+00
cases:0.23%
controls:0.11%
cases:0.33%
controls:0.05%
—
—
—
—
—
—
cases:7.77%
controls:0.03%
cases:1.21%
controls:0.06%
9
45
3947
39496
13
20
3943
39521
—
—
—
272
10
3229
38317
33
19
2705
32404
Haptoglobin [Mass/volume] in Serum or Plasma
4542-7 [3012336]
3.3e-01
1.7e+00
3.4e+00
1.0e+50
3.4e+00
1.3e+00
8.5e-01
cases:1.29%
controls:0.93%
cases:2.45%
controls:0.46%
cases:1.79%
controls:0.06%
cases:0.20%
controls:0.00%
cases:1.12%
controls:0.04%
cases:1.66%
controls:0.47%
cases:3.29%
controls:1.43%
51
368
3905
39173
97
181
3859
39360
71
23
3885
39518
8
0
3948
39541
43
15
3801
39457
58
181
3443
38146
90
465
2648
31958
Bronchial lavation
TGC00 [2001303585]
8.1e-01
1.5e+00
2.8e+00
—
—
3.6e+00
2.6e+00
cases:0.51%
controls:0.23%
cases:0.30%
controls:0.07%
cases:0.25%
controls:0.02%
—
—
—
—
cases:2.37%
controls:0.07%
cases:2.96%
controls:0.22%
20
89
3936
39452
12
26
3944
39515
10
6
3946
39535
—
—
83
25
3418
38302
81
71
2657
32352
General anesthesia, balanced
WX408 [2001310808]
-1.6e-03
1.4e+00
4.0e+00
1.0e+50
2.7e+00
1.4e+00
1.1e+00
cases:4.75%
controls:4.76%
cases:4.58%
controls:1.16%
cases:5.01%
controls:0.10%
cases:0.88%
controls:0.00%
cases:0.96%
controls:0.06%
cases:2.80%
controls:0.72%
cases:5.66%
controls:2.01%
188
1882
3768
37659
181
457
3775
39084
198
39
3758
39502
35
0
3921
39541
37
25
3807
39447
98
277
3403
38050
155
653
2583
31770
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
D38.1 [45605357]
9.6e-03
2.3e+00
3.8e+00
1.0e+50
2.7e+00
1.8e+00
7.6e-01
cases:0.25%
controls:0.25%
cases:1.06%
controls:0.11%
cases:0.99%
controls:0.02%
cases:0.28%
controls:0.00%
cases:0.23%
controls:0.02%
cases:0.60%
controls:0.10%
cases:0.69%
controls:0.33%
10
99
3946
39442
42
43
3914
39498
39
9
3917
39532
11
0
3945
39541
9
6
3835
39466
21
40
3480
38287
19
106
2719
32317
Emergency Medicine
93 [38004510]
-5.8e-02
5.9e-01
2.4e+00
4.3e+00
1.9e+00
1.0e+00
2.6e-01
cases:14.18%
controls:14.90%
cases:14.36%
controls:8.52%
cases:12.11%
controls:1.21%
cases:3.01%
controls:0.04%
cases:8.27%
controls:1.31%
cases:21.91%
controls:9.33%
cases:31.15%
controls:25.83%
561
5892
3395
33649
568
3370
3388
36171
479
477
3477
39064
119
16
3837
39525
318
516
3526
38956
767
3576
2734
34751
853
8375
1885
24048
levofloxacin; inhalant, oral, parenteral
J01MA12 [21603019]
2.8e-01
9.7e-01
2.4e+00
—
3.3e+00
2.7e+00
1.1e+00
cases:3.36%
controls:2.56%
cases:2.20%
controls:0.85%
cases:1.01%
controls:0.09%
—
—
cases:2.39%
controls:0.09%
cases:10.54%
controls:0.75%
cases:8.80%
controls:3.23%
133
1014
3823
38527
87
335
3869
39206
40
36
3916
39505
—
92
35
3752
39437
369
289
3132
38038
241
1046
2497
31377
Thorax CT examination
GD1AD [2001303618]
4.4e-01
1.4e+00
3.4e+00
1.0e+50
2.5e+00
2.0e+00
1.2e+00
cases:0.66%
controls:0.42%
cases:0.86%
controls:0.21%
cases:0.86%
controls:0.03%
cases:0.38%
controls:0.00%
cases:0.29%
controls:0.02%
cases:1.69%
controls:0.24%
cases:3.58%
controls:1.07%
26
168
3930
39373
34
85
3922
39456
34
12
3922
39529
15
0
3941
39541
11
9
3833
39463
59
91
3442
38236
98
346
2640
32077
Extensive CT examination of arteria pulmonalis
FB1BD [2001302407]
2.4e-01
1.0e+00
3.0e+00
1.0e+50
2.8e+00
2.3e+00
1.3e+00
cases:1.14%
controls:0.90%
cases:0.81%
controls:0.29%
cases:0.91%
controls:0.05%
cases:0.46%
controls:0.00%
cases:0.39%
controls:0.02%
cases:2.29%
controls:0.23%
cases:2.67%
controls:0.77%
45
356
3911
39185
32
115
3924
39426
36
18
3920
39523
18
0
3938
39541
15
9
3829
39463
80
87
3421
38240
73
249
2665
32174
Very extensive body CT
JN4CD [2001310902]
5.1e-01
1.9e+00
4.8e+00
1.0e+50
—
2.1e+00
1.7e+00
cases:0.83%
controls:0.50%
cases:1.06%
controls:0.15%
cases:1.44%
controls:0.01%
cases:0.56%
controls:0.00%
—
—
cases:0.80%
controls:0.10%
cases:1.17%
controls:0.23%
33
199
3923
39342
42
61
3914
39480
57
5
3899
39536
22
0
3934
39541
—
28
37
3473
38290
32
73
2706
32350
Lysozyme [Mass/volume] in Serum or Plasma
2589-0 [3012110]
3.8e-01
1.7e+00
3.4e+00
—
3.1e+00
9.9e-01
1.3e+00
cases:0.78%
controls:0.54%
cases:1.44%
controls:0.26%
cases:1.09%
controls:0.04%
—
—
cases:0.55%
controls:0.03%
cases:0.69%
controls:0.26%
cases:2.08%
controls:0.58%
31
213
3925
39328
57
102
3899
39439
43
15
3913
39526
—
21
10
3823
39462
24
98
3477
38229
57
187
2681
32236
Morphology [Interpretation] in Bone marrow Narrative
51628-6 [3042111]
1.5e+00
2.9e+00
—
1.0e+50
—
3.7e+00
2.4e+00
cases:1.31%
controls:0.31%
cases:2.50%
controls:0.15%
—
—
cases:2.65%
controls:0.00%
—
—
cases:4.74%
controls:0.13%
cases:4.78%
controls:0.43%
52
121
3904
39420
99
58
3857
39483
—
105
0
3851
39541
—
166
48
3335
38279
131
141
2607
32282
Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
2532-0 [3016436]
7.5e-01
2.2e+00
3.4e+00
—
—
2.9e+00
1.9e+00
cases:0.18%
controls:0.08%
cases:0.40%
controls:0.05%
cases:0.38%
controls:0.01%
—
—
—
—
cases:0.63%
controls:0.03%
cases:0.95%
controls:0.14%
7
33
3949
39508
16
18
3940
39523
15
5
3941
39536
—
—
22
13
3479
38314
26
45
2712
32378
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
-5.7e-03
4.1e-01
2.4e+00
4.1e+00
2.5e+00
8.2e-01
2.8e-01
cases:38.07%
controls:38.20%
cases:39.41%
controls:30.18%
cases:38.42%
controls:5.49%
cases:10.11%
controls:0.19%
cases:39.46%
controls:5.20%
cases:51.56%
controls:31.83%
cases:61.98%
controls:55.16%
1506
15106
2450
24435
1559
11935
2397
27606
1520
2171
2436
37370
400
76
3556
39465
1517
2052
2327
37420
1805
12201
1696
26126
1697
17885
1041
14538
valaciclovir; oral
J05AB11 [21603137]
4.4e-01
8.2e-01
1.6e+00
—
3.2e+00
2.8e+00
1.6e+00
cases:2.68%
controls:1.74%
cases:1.47%
controls:0.65%
cases:0.68%
controls:0.14%
—
—
cases:2.97%
controls:0.13%
cases:11.31%
controls:0.75%
cases:9.39%
controls:2.13%
106
688
3850
38853
58
258
3898
39283
27
57
3929
39484
—
114
50
3730
39422
396
286
3105
38041
257
690
2481
31733
25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
68438-1 [40771025]
2.4e-02
4.0e-01
2.7e+00
4.6e+00
2.1e+00
3.6e-01
2.3e-01
cases:8.29%
controls:8.11%
cases:7.03%
controls:4.84%
cases:7.23%
controls:0.52%
cases:1.29%
controls:0.01%
cases:4.27%
controls:0.57%
cases:7.43%
controls:5.31%
cases:18.63%
controls:15.43%
328
3207
3628
36334
278
1914
3678
37627
286
205
3670
39336
51
5
3905
39536
164
224
3680
39248
260
2037
3241
36290
510
5003
2228
27420
CT examination of mouth and soft tissues of neck
EN1AD [2001302280]
1.8e+00
2.6e+00
—
1.0e+50
—
3.9e+00
2.0e+00
cases:0.38%
controls:0.06%
cases:0.20%
controls:0.02%
—
—
cases:0.33%
controls:0.00%
—
—
cases:1.06%
controls:0.02%
cases:1.10%
controls:0.15%
15
24
3941
39517
8
6
3948
39535
—
13
0
3943
39541
—
37
8
3464
38319
30
48
2708
32375
Epithelial cells [#/volume] in Urine
30383-4 [3000850]
-1.1e-01
7.1e-01
2.3e+00
3.2e+00
2.3e+00
1.3e+00
5.0e-01
cases:4.58%
controls:5.06%
cases:4.68%
controls:2.36%
cases:3.19%
controls:0.32%
cases:0.38%
controls:0.02%
cases:3.10%
controls:0.33%
cases:8.05%
controls:2.24%
cases:10.23%
controls:6.44%
181
2002
3775
37539
185
932
3771
38609
126
126
3830
39415
15
6
3941
39535
119
131
3725
39341
282
857
3219
37470
280
2089
2458
30334
Neutrophil count
30630007 [4148615]
1.5e+00
1.9e+00
—
—
—
4.7e+00
2.2e+00
cases:0.33%
controls:0.08%
cases:0.25%
controls:0.04%
—
—
—
—
—
—
cases:2.34%
controls:0.02%
cases:1.02%
controls:0.11%
13
30
3943
39511
10
15
3946
39526
—
—
—
82
8
3419
38319
28
36
2710
32387
Other transplanted organ and tissue status
Z94.8 [45600381]
—
1.5e+00
—
—
2.3e+00
3.9e+00
4.1e+00
—
—
cases:0.13%
controls:0.03%
—
—
—
—
cases:0.13%
controls:0.01%
cases:1.46%
controls:0.03%
cases:2.26%
controls:0.04%
—
5
11
3951
39530
—
—
5
5
3839
39467
51
11
3450
38316
62
13
2676
32410
Kappa light chains/Lambda light chains [Mass Ratio] in Serum
15189-4 [3007778]
5.1e-01
2.3e+00
3.7e+00
—
2.4e+00
9.7e-01
9.9e-01
cases:1.09%
controls:0.65%
cases:3.19%
controls:0.33%
cases:2.15%
controls:0.06%
—
—
cases:1.04%
controls:0.10%
cases:1.03%
controls:0.39%
cases:2.78%
controls:1.05%
43
258
3913
39283
126
129
3830
39412
85
22
3871
39519
—
40
39
3804
39433
36
151
3465
38176
76
339
2662
32084
Lambda light chains.free [Mass/volume] in Serum or Plasma
33944-0 [3047169]
5.1e-01
2.3e+00
3.6e+00
—
2.4e+00
1.0e+00
9.8e-01
cases:1.11%
controls:0.67%
cases:3.34%
controls:0.35%
cases:2.40%
controls:0.07%
—
—
cases:1.14%
controls:0.11%
cases:1.20%
controls:0.43%
cases:3.10%
controls:1.19%
44
264
3912
39277
132
140
3824
39401
95
26
3861
39515
—
44
43
3800
39429
42
165
3459
38162
85
386
2653
32037
CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
14135-8 [3001405]
1.0e+00
2.0e+00
—
1.0e+50
—
5.0e+00
3.3e+00
cases:0.33%
controls:0.12%
cases:0.46%
controls:0.06%
—
—
cases:0.81%
controls:0.00%
—
—
cases:4.00%
controls:0.03%
cases:4.16%
controls:0.17%
13
47
3943
39494
18
24
3938
39517
—
32
0
3924
39541
—
140
11
3361
38316
114
54
2624
32369
Kappa light chains.free [Mass/volume] in Serum
36916-5 [3034860]
5.4e-01
2.3e+00
3.6e+00
—
2.4e+00
1.0e+00
9.8e-01
cases:1.14%
controls:0.67%
cases:3.34%
controls:0.36%
cases:2.40%
controls:0.07%
—
—
cases:1.17%
controls:0.11%
cases:1.17%
controls:0.43%
cases:3.10%
controls:1.19%
45
263
3911
39278
132
142
3824
39399
95
26
3861
39515
—
45
43
3799
39429
41
166
3460
38161
85
385
2653
32038
Gastroenterology
10 [38004455]
1.9e-01
9.9e-01
2.3e+00
3.4e+00
1.7e+00
1.1e+00
8.0e-01
cases:6.98%
controls:5.82%
cases:6.04%
controls:2.34%
cases:3.72%
controls:0.40%
cases:0.81%
controls:0.03%
cases:2.29%
controls:0.44%
cases:7.20%
controls:2.42%
cases:14.10%
controls:6.84%
276
2300
3680
37241
239
927
3717
38614
147
158
3809
39383
32
11
3924
39530
88
172
3756
39300
252
929
3249
37398
386
2218
2352
30205
Anaemia, unspecified
D64.9 [45600610]
1.9e-01
1.6e+00
3.2e+00
—
2.8e+00
2.1e+00
4.1e-01
cases:1.72%
controls:1.43%
cases:3.29%
controls:0.65%
cases:2.25%
controls:0.09%
—
—
cases:1.59%
controls:0.09%
cases:5.63%
controls:0.72%
cases:3.43%
controls:2.32%
68
564
3888
38977
130
257
3826
39284
89
36
3867
39505
—
61
37
3783
39435
197
277
3304
38050
94
751
2644
31672
Other and unspecified abdominal pain
R10.4 [45568113]
8.3e-02
1.3e+00
3.0e+00
3.6e+00
1.6e+00
7.0e-01
2.2e-01
cases:5.56%
controls:5.14%
cases:5.71%
controls:1.66%
cases:3.64%
controls:0.18%
cases:0.56%
controls:0.02%
cases:0.99%
controls:0.20%
cases:3.06%
controls:1.55%
cases:6.76%
controls:5.47%
220
2032
3736
37509
226
658
3730
38883
144
72
3812
39469
22
6
3934
39535
38
78
3806
39394
107
593
3394
37734
185
1775
2553
30648
Thorax X-ray examination
GD1AA [2001303617]
1.8e-01
9.7e-01
2.8e+00
—
3.0e+00
2.2e+00
1.2e+00
cases:12.66%
controls:10.82%
cases:10.29%
controls:4.15%
cases:7.79%
controls:0.52%
—
—
cases:8.45%
controls:0.47%
cases:25.65%
controls:3.86%
cases:29.51%
controls:11.61%
501
4279
3455
35262
407
1640
3549
37901
308
205
3648
39336
—
325
186
3519
39286
898
1479
2603
36848
808
3764
1930
28659
Abnormal findings on diagnostic imaging of lung
R91 [45548995]
3.9e-01
1.9e+00
3.4e+00
1.0e+50
2.0e+00
1.8e+00
1.1e+00
cases:1.90%
controls:1.29%
cases:3.26%
controls:0.52%
cases:2.76%
controls:0.10%
cases:0.40%
controls:0.00%
cases:0.65%
controls:0.09%
cases:3.00%
controls:0.51%
cases:4.78%
controls:1.60%
75
510
3881
39031
129
206
3827
39335
109
38
3847
39503
16
0
3940
39541
25
34
3819
39438
105
195
3396
38132
131
518
2607
31905
Inpatient Visit
IP [9201]
-2.5e-02
8.1e-01
3.0e+00
—
3.8e+00
2.0e+00
5.3e-01
cases:7.81%
controls:7.99%
cases:7.91%
controls:3.67%
cases:7.71%
controls:0.40%
—
—
cases:16.52%
controls:0.43%
cases:21.37%
controls:3.54%
cases:18.15%
controls:11.60%
309
3159
3647
36382
313
1450
3643
38091
305
159
3651
39382
—
635
170
3209
39302
748
1357
2753
36970
497
3760
2241
28663
Cytology report of Tissue fine needle aspirate Cyto stain
33718-8 [3043109]
6.4e-01
3.1e+00
—
—
3.0e+00
2.1e+00
1.4e+00
cases:0.86%
controls:0.46%
cases:3.72%
controls:0.18%
—
—
—
—
cases:0.26%
controls:0.01%
cases:0.89%
controls:0.11%
cases:1.75%
controls:0.46%
34
180
3922
39361
147
70
3809
39471
—
—
10
5
3834
39467
31
42
3470
38285
48
149
2690
32274
ABO and Rh group [Type] in Blood
882-1 [3003694]
7.0e-02
1.1e+00
4.3e+00
—
3.7e+00
1.2e+00
5.4e-02
cases:5.01%
controls:4.68%
cases:5.01%
controls:1.75%
cases:9.98%
controls:0.16%
—
—
cases:4.94%
controls:0.13%
cases:4.37%
controls:1.38%
cases:5.95%
controls:5.66%
198
1852
3758
37689
198
693
3758
38848
395
62
3561
39479
—
190
53
3654
39419
153
530
3348
37797
163
1834
2575
30589
Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
40987-0 [3043924]
-1.4e-01
5.6e-01
3.1e+00
—
3.5e+00
2.3e+00
7.3e-01
cases:1.34%
controls:1.54%
cases:1.69%
controls:0.97%
cases:2.25%
controls:0.11%
—
—
cases:3.46%
controls:0.11%
cases:9.94%
controls:1.08%
cases:8.77%
controls:4.41%
53
609
3903
38932
67
384
3889
39157
89
42
3867
39499
—
133
43
3711
39429
348
414
3153
37913
240
1431
2498
30992
Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34487-9 [3044938]
3.3e-02
6.4e-01
3.0e+00
—
3.4e+00
2.3e+00
8.3e-01
cases:2.30%
controls:2.23%
cases:2.43%
controls:1.29%
cases:3.11%
controls:0.16%
—
—
cases:4.47%
controls:0.15%
cases:13.14%
controls:1.54%
cases:12.31%
controls:5.75%
91
881
3865
38660
96
512
3860
39029
123
65
3833
39476
—
172
59
3672
39413
460
592
3041
37735
337
1863
2401
30560
Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
40982-1 [3038288]
-3.6e-02
5.3e-01
3.0e+00
—
3.5e+00
2.4e+00
7.9e-01
cases:1.54%
controls:1.60%
cases:1.62%
controls:0.96%
cases:2.10%
controls:0.11%
—
—
cases:3.38%
controls:0.11%
cases:9.94%
controls:1.04%
cases:8.80%
controls:4.18%
61
632
3895
38909
64
379
3892
39162
83
43
3873
39498
—
130
42
3714
39430
348
399
3153
37928
241
1356
2497
31067
Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
3209-4 [3019250]
1.7e-01
9.5e-01
2.8e+00
1.0e+50
3.7e+00
1.6e+00
1.0e+00
cases:0.63%
controls:0.54%
cases:0.56%
controls:0.21%
cases:0.56%
controls:0.03%
cases:0.13%
controls:0.00%
cases:0.73%
controls:0.02%
cases:0.89%
controls:0.18%
cases:1.46%
controls:0.54%
25
212
3931
39329
22
85
3934
39456
22
13
3934
39528
5
0
3951
39541
28
7
3816
39465
31
69
3470
38258
40
174
2698
32249
Infiltration anesthesia
WX110 [2001310767]
4.4e-02
5.1e-01
2.5e+00
4.1e+00
1.7e+00
8.3e-01
5.0e-01
cases:20.07%
controls:19.37%
cases:11.96%
controls:7.51%
cases:9.76%
controls:0.91%
cases:2.17%
controls:0.04%
cases:4.66%
controls:0.92%
cases:15.51%
controls:7.39%
cases:30.31%
controls:20.90%
794
7661
3162
31880
473
2969
3483
36572
386
358
3570
39183
86
14
3870
39527
179
364
3665
39108
543
2832
2958
35495
830
6776
1908
25647
tinzaparin; parenteral
B01AB10 [21600981]
1.1e-01
6.9e-01
2.5e+00
—
3.5e+00
2.6e+00
8.5e-01
cases:1.04%
controls:0.93%
cases:0.94%
controls:0.47%
cases:1.39%
controls:0.12%
—
—
cases:3.72%
controls:0.12%
cases:6.37%
controls:0.48%
cases:4.02%
controls:1.76%
41
367
3915
39174
37
186
3919
39355
55
47
3901
39494
—
143
48
3701
39424
223
184
3278
38143
110
572
2628
31851
Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
33762-6 [3029187]
3.3e-02
3.1e-01
2.0e+00
3.9e+00
2.4e+00
1.1e+00
4.2e-01
cases:6.90%
controls:6.69%
cases:5.33%
controls:3.97%
cases:3.59%
controls:0.51%
cases:0.99%
controls:0.02%
cases:5.41%
controls:0.54%
cases:12.03%
controls:4.22%
cases:17.79%
controls:12.39%
273
2647
3683
36894
211
1568
3745
37973
142
201
3814
39340
39
8
3917
39533
208
212
3636
39260
421
1618
3080
36709
487
4018
2251
28405
Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
34645-2 [3031478]
4.5e-01
1.1e+00
3.1e+00
—
—
3.6e+00
2.3e+00
cases:0.33%
controls:0.21%
cases:0.33%
controls:0.11%
cases:0.46%
controls:0.02%
—
—
—
—
cases:3.40%
controls:0.10%
cases:4.05%
controls:0.43%
13
83
3943
39458
13
43
3943
39498
18
8
3938
39533
—
—
119
38
3382
38289
111
139
2627
32284
Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
2742-5 [3034780]
3.4e-01
1.7e+00
3.6e+00
—
2.7e+00
8.6e-01
1.1e+00
cases:1.19%
controls:0.85%
cases:1.97%
controls:0.35%
cases:1.52%
controls:0.04%
—
—
cases:0.44%
controls:0.03%
cases:0.86%
controls:0.36%
cases:2.81%
controls:0.93%
47
336
3909
39205
78
139
3878
39402
60
16
3896
39525
—
17
12
3827
39460
30
139
3471
38188
77
301
2661
32122
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
6.3e-02
4.2e-01
2.3e+00
3.9e+00
2.3e+00
7.6e-01
4.2e-01
cases:28.49%
controls:27.22%
cases:33.19%
controls:24.69%
cases:35.11%
controls:5.21%
cases:10.47%
controls:0.24%
cases:34.24%
controls:5.05%
cases:43.33%
controls:26.35%
cases:55.59%
controls:45.13%
1127
10762
2829
28779
1313
9763
2643
29778
1389
2059
2567
37482
414
95
3542
39446
1316
1993
2528
37479
1517
10098
1984
28229
1522
14632
1216
17791
Ultrasound examination of lower leg veins
PH2AE [2001309451]
4.0e-01
1.1e+00
2.9e+00
1.0e+50
3.1e+00
1.8e+00
7.4e-01
cases:2.20%
controls:1.49%
cases:1.26%
controls:0.45%
cases:0.94%
controls:0.05%
cases:0.81%
controls:0.00%
cases:0.91%
controls:0.04%
cases:2.77%
controls:0.45%
cases:3.40%
controls:1.65%
87
589
3869
38952
50
176
3906
39365
37
21
3919
39520
32
0
3924
39541
35
16
3809
39456
97
172
3404
38155
93
536
2645
31887
dexamethasone; oral, parenteral
H02AB02 [21602730]
8.9e-02
8.3e-01
2.6e+00
—
3.4e+00
2.3e+00
8.8e-01
cases:2.48%
controls:2.27%
cases:2.58%
controls:1.14%
cases:2.35%
controls:0.18%
—
—
cases:5.12%
controls:0.17%
cases:9.11%
controls:0.99%
cases:8.22%
controls:3.60%
98
898
3858
38643
102
451
3854
39090
93
73
3863
39468
—
197
68
3647
39404
319
381
3182
37946
225
1166
2513
31257
PET-CT of upper body metabolism
JN5DR [2001310926]
7.6e-01
2.4e+00
—
1.0e+50
1.0e+50
4.8e+00
2.7e+00
cases:0.25%
controls:0.12%
cases:0.58%
controls:0.05%
—
—
cases:1.01%
controls:0.00%
cases:0.86%
controls:0.00%
cases:5.14%
controls:0.04%
cases:1.94%
controls:0.13%
10
47
3946
39494
23
20
3933
39521
—
40
0
3916
39541
33
0
3811
39472
180
17
3321
38310
53
42
2685
32381
Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13317-3 [3019902]
-1.9e-02
7.0e-01
3.0e+00
—
3.5e+00
1.8e+00
8.4e-01
cases:2.30%
controls:2.34%
cases:2.30%
controls:1.15%
cases:3.06%
controls:0.15%
—
—
cases:3.51%
controls:0.11%
cases:6.17%
controls:1.04%
cases:6.32%
controls:2.82%
91
927
3865
38614
91
455
3865
39086
121
59
3835
39482
—
135
42
3709
39430
216
397
3285
37930
173
915
2565
31508
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
-3.3e-02
3.9e-01
2.4e+00
3.9e+00
2.4e+00
7.0e-01
2.1e-01
cases:37.77%
controls:38.53%
cases:40.62%
controls:31.57%
cases:41.15%
controls:6.12%
cases:15.19%
controls:0.37%
cases:40.35%
controls:5.82%
cases:50.19%
controls:33.30%
cases:60.30%
controls:55.18%
1494
15237
2462
24304
1607
12484
2349
27057
1628
2420
2328
37121
601
145
3355
39396
1551
2298
2293
37174
1757
12761
1744
25566
1651
17892
1087
14531
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
6.4e-04
4.0e-01
2.2e+00
4.0e+00
2.2e+00
7.7e-01
4.1e-01
cases:26.52%
controls:26.50%
cases:30.49%
controls:22.80%
cases:32.43%
controls:5.28%
cases:12.77%
controls:0.27%
cases:31.89%
controls:4.94%
cases:40.53%
controls:24.00%
cases:50.69%
controls:40.59%
1049
10480
2907
29061
1206
9017
2750
30524
1283
2087
2673
37454
505
106
3451
39435
1226
1950
2618
37522
1419
9198
2082
29129
1388
13161
1350
19262
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
-3.0e-02
3.9e-01
2.4e+00
3.9e+00
2.4e+00
6.9e-01
2.1e-01
cases:38.17%
controls:38.87%
cases:40.90%
controls:32.01%
cases:41.33%
controls:6.28%
cases:15.14%
controls:0.37%
cases:40.43%
controls:5.93%
cases:50.47%
controls:33.78%
cases:60.63%
controls:55.51%
1510
15370
2446
24171
1618
12657
2338
26884
1635
2485
2321
37056
599
145
3357
39396
1554
2339
2290
37133
1767
12948
1734
25379
1660
17999
1078
14424
Treatment plan or consultation
WZC00 [2001310885]
7.0e-02
6.0e-01
2.2e+00
—
3.7e+00
2.4e+00
1.1e+00
cases:6.09%
controls:5.70%
cases:4.04%
controls:2.27%
cases:2.35%
controls:0.28%
—
—
cases:9.21%
controls:0.25%
cases:18.54%
controls:2.12%
cases:17.46%
controls:6.84%
241
2255
3715
37286
160
896
3796
38645
93
110
3863
39431
—
354
97
3490
39375
649
812
2852
37515
478
2219
2260
30204
Medical doctor
Z2221 [2001311556]
2.7e-01
1.1e+00
2.7e+00
—
3.0e+00
1.6e+00
1.2e+00
cases:6.70%
controls:5.20%
cases:3.64%
controls:1.29%
cases:2.60%
controls:0.17%
—
—
cases:3.15%
controls:0.16%
cases:5.37%
controls:1.14%
cases:7.38%
controls:2.36%
265
2057
3691
37484
144
512
3812
39029
103
69
3853
39472
—
121
62
3723
39410
188
436
3313
37891
202
766
2536
31657
Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
54067-4 [3051552]
6.1e-02
7.1e-01
2.3e+00
—
3.1e+00
2.5e+00
1.2e+00
cases:1.24%
controls:1.17%
cases:1.04%
controls:0.51%
cases:0.78%
controls:0.08%
—
—
cases:1.87%
controls:0.08%
cases:7.26%
controls:0.66%
cases:5.81%
controls:1.83%
49
461
3907
39080
41
202
3915
39339
31
30
3925
39511
—
72
33
3772
39439
254
253
3247
38074
159
594
2579
31829
Social worker
Z2446 [2001311559]
3.1e-02
5.4e-01
3.1e+00
1.0e+50
4.2e+00
2.6e+00
5.1e-01
cases:0.73%
controls:0.71%
cases:0.30%
controls:0.18%
cases:0.43%
controls:0.02%
cases:0.86%
controls:0.00%
cases:1.30%
controls:0.02%
cases:1.43%
controls:0.11%
cases:0.62%
controls:0.37%
29
281
3927
39260
12
70
3944
39471
17
8
3939
39533
34
0
3922
39541
50
8
3794
39464
50
41
3451
38286
17
121
2721
32302
Other autoimmune haemolytic anaemias
D59.1 [45566703]
2.3e+00
2.6e+00
—
1.0e+50
—
2.8e+00
2.1e+00
cases:0.25%
controls:0.03%
cases:0.28%
controls:0.02%
—
—
cases:0.15%
controls:0.00%
—
—
cases:0.29%
controls:0.02%
cases:0.37%
controls:0.04%
10
10
3946
39531
11
8
3945
39533
—
6
0
3950
39541
—
10
7
3491
38320
10
14
2728
32409
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]
-1.2e-02
8.9e-01
3.4e+00
—
3.0e+00
1.9e+00
6.2e-01
cases:4.73%
controls:4.78%
cases:5.36%
controls:2.26%
cases:6.62%
controls:0.25%
—
—
cases:5.52%
controls:0.28%
cases:12.14%
controls:1.99%
cases:11.25%
controls:6.37%
187
1891
3769
37650
212
895
3744
38646
262
97
3694
39444
—
212
112
3632
39360
425
762
3076
37565
308
2066
2430
30357
Very extensive MRI examination of brain with high intensity magnet
AA1DG [2001300120]
-1.8e-01
1.5e+00
—
1.0e+50
3.0e+00
3.3e+00
2.0e+00
cases:0.18%
controls:0.21%
cases:0.35%
controls:0.08%
—
—
cases:0.18%
controls:0.00%
cases:0.31%
controls:0.02%
cases:1.40%
controls:0.05%
cases:1.53%
controls:0.22%
7
84
3949
39457
14
30
3942
39511
—
7
0
3949
39541
12
6
3832
39466
49
21
3452
38306
42
71
2696
32352
CD3-CD19+ cells/cells in Blood
15196-9 [3006245]
1.1e+00
1.9e+00
—
1.0e+50
—
4.9e+00
3.0e+00
cases:0.20%
controls:0.07%
cases:0.23%
controls:0.04%
—
—
cases:0.73%
controls:0.00%
—
—
cases:2.14%
controls:0.02%
cases:1.94%
controls:0.10%
8
28
3948
39513
9
14
3947
39527
—
29
0
3927
39541
—
75
6
3426
38321
53
33
2685
32390
Clinic/Center
261Q00000X [38004207]
-1.4e-01
4.8e-01
1.7e+00
—
3.6e+00
2.9e+00
1.6e+00
cases:0.76%
controls:0.87%
cases:0.56%
controls:0.34%
cases:0.40%
controls:0.07%
—
—
cases:2.26%
controls:0.07%
cases:4.37%
controls:0.26%
cases:2.63%
controls:0.53%
30
343
3926
39198
22
136
3934
39405
16
29
3940
39512
—
87
26
3757
39446
153
101
3348
38226
72
172
2666
32251
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
-6.7e-02
5.3e-01
2.1e+00
3.5e+00
2.1e+00
1.1e+00
3.5e-01
cases:16.91%
controls:17.88%
cases:15.14%
controls:9.52%
cases:9.98%
controls:1.39%
cases:1.62%
controls:0.05%
cases:10.87%
controls:1.44%
cases:24.94%
controls:9.69%
cases:31.15%
controls:24.09%
669
7068
3287
32473
599
3763
3357
35778
395
551
3561
38990
64
19
3892
39522
418
568
3426
38904
873
3712
2628
34615
853
7811
1885
24612
EKG study
11524-6 [3013512]
-9.7e-02
4.1e-01
2.6e+00
3.9e+00
2.1e+00
4.8e-01
2.2e-01
cases:7.91%
controls:8.65%
cases:7.33%
controls:5.01%
cases:7.81%
controls:0.62%
cases:1.19%
controls:0.03%
cases:5.41%
controls:0.67%
cases:8.60%
controls:5.48%
cases:16.73%
controls:13.89%
313
3419
3643
36122
290
1980
3666
37561
309
245
3647
39296
47
10
3909
39531
208
264
3636
39208
301
2101
3200
36226
458
4504
2280
27919
Thrombin time
3243-3 [3036489]
2.3e-01
8.6e-01
2.7e+00
1.0e+50
3.7e+00
1.5e+00
9.1e-01
cases:0.88%
controls:0.70%
cases:0.61%
controls:0.26%
cases:0.58%
controls:0.04%
cases:0.15%
controls:0.00%
cases:0.78%
controls:0.02%
cases:1.03%
controls:0.22%
cases:1.90%
controls:0.77%
35
278
3921
39263
24
102
3932
39439
23
15
3933
39526
6
0
3950
39541
30
8
3814
39464
36
86
3465
38241
52
250
2686
32173
Ultrasound examination of scrotum
KF8AE [2001306187]
7.4e-01
1.9e+00
—
1.0e+50
3.3e+00
2.9e+00
1.6e+00
cases:0.43%
controls:0.20%
cases:0.46%
controls:0.07%
—
—
cases:0.43%
controls:0.00%
cases:0.34%
controls:0.01%
cases:0.71%
controls:0.04%
cases:1.13%
controls:0.23%
17
81
3939
39460
18
28
3938
39513
—
17
0
3939
39541
13
5
3831
39467
25
15
3476
38312
31
73
2707
32350
Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection
6521-9 [3009595]
1.0e+00
1.4e+00
2.6e+00
—
1.0e+50
3.9e+00
3.1e+00
cases:0.28%
controls:0.10%
cases:0.18%
controls:0.04%
cases:0.18%
controls:0.01%
—
—
cases:0.31%
controls:0.00%
cases:2.46%
controls:0.05%
cases:3.47%
controls:0.16%
11
39
3945
39502
7
17
3949
39524
7
5
3949
39536
—
12
0
3832
39472
86
19
3415
38308
95
53
2643
32370
Oral Surgery
19 [38004464]
1.9e-01
1.2e+00
2.1e+00
—
2.8e+00
2.2e+00
1.3e+00
cases:0.94%
controls:0.77%
cases:0.96%
controls:0.30%
cases:0.46%
controls:0.06%
—
—
cases:0.86%
controls:0.05%
cases:2.20%
controls:0.26%
cases:2.78%
controls:0.74%
37
306
3919
39235
38
117
3918
39424
18
22
3938
39519
—
33
20
3811
39452
77
98
3424
38229
76
239
2662
32184
Complement C4 [Mass/volume] in Serum or Plasma
4498-2 [3017766]
2.1e-01
1.2e+00
3.2e+00
—
2.9e+00
1.3e+00
9.9e-01
cases:0.71%
controls:0.57%
cases:0.73%
controls:0.21%
cases:0.48%
controls:0.02%
—
—
cases:0.36%
controls:0.02%
cases:0.86%
controls:0.22%
cases:1.68%
controls:0.63%
28
227
3928
39314
29
84
3927
39457
19
8
3937
39533
—
14
8
3830
39464
30
86
3471
38241
46
204
2692
32219
Complement C3 [Mass/volume] in Serum or Plasma
4485-9 [3000620]
1.3e-01
1.2e+00
3.1e+00
—
3.0e+00
1.3e+00
1.0e+00
cases:0.68%
controls:0.60%
cases:0.73%
controls:0.22%
cases:0.48%
controls:0.02%
—
—
cases:0.36%
controls:0.02%
cases:0.86%
controls:0.22%
cases:1.75%
controls:0.64%
27
237
3929
39304
29
88
3927
39453
19
9
3937
39532
—
14
7
3830
39465
30
86
3471
38241
48
208
2690
32215
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
-2.5e-02
3.7e-01
2.3e+00
3.8e+00
2.2e+00
6.6e-01
2.9e-01
cases:40.50%
controls:41.09%
cases:44.44%
controls:35.57%
cases:44.51%
controls:7.68%
cases:15.34%
controls:0.40%
cases:42.79%
controls:7.35%
cases:53.61%
controls:37.36%
cases:65.01%
controls:58.22%
1602
16248
2354
23293
1758
14065
2198
25476
1761
3036
2195
36505
607
160
3349
39381
1645
2903
2199
36569
1877
14319
1624
24008
1780
18876
958
13547
nystatin; oral
A07AA02 [21600604]
3.7e-01
6.6e-01
1.7e+00
—
3.6e+00
3.2e+00
1.2e+00
cases:1.31%
controls:0.91%
cases:0.61%
controls:0.31%
cases:0.30%
controls:0.06%
—
—
cases:2.26%
controls:0.07%
cases:7.43%
controls:0.33%
cases:3.47%
controls:1.09%
52
359
3904
39182
24
124
3932
39417
12
22
3944
39519
—
87
26
3757
39446
260
126
3241
38201
95
355
2643
32068
Extensive high resolution CT examination of lungs
GD1ED [2001303637]
5.6e-01
1.7e+00
2.5e+00
—
—
3.1e+00
2.3e+00
cases:0.61%
controls:0.35%
cases:0.35%
controls:0.07%
cases:0.15%
controls:0.01%
—
—
—
—
cases:1.26%
controls:0.05%
cases:1.39%
controls:0.14%
24
137
3932
39404
14
26
3942
39515
6
5
3950
39536
—
—
44
21
3457
38306
38
46
2700
32377
Adjuvant radiotherapy
WF003 [2001310702]
-4.7e-01
—
—
—
3.0e+00
5.1e+00
1.5e+00
cases:0.25%
controls:0.40%
—
—
—
—
—
—
cases:0.39%
controls:0.02%
cases:7.40%
controls:0.05%
cases:1.02%
controls:0.22%
10
159
3946
39382
—
—
—
15
8
3829
39464
259
19
3242
38308
28
71
2710
32352
Neoplasm of uncertain or unknown behaviour: Other digestive organs
D37.7 [45552349]
9.5e-02
1.7e+00
3.6e+00
—
2.8e+00
1.4e+00
6.6e-01
cases:0.28%
controls:0.25%
cases:0.83%
controls:0.15%
cases:1.14%
controls:0.03%
—
—
cases:0.42%
controls:0.03%
cases:0.57%
controls:0.14%
cases:0.66%
controls:0.34%
11
100
3945
39441
33
59
3923
39482
45
12
3911
39529
—
16
10
3828
39462
20
55
3481
38272
18
111
2720
32312
Telephone, letter or other consultation without direct patient contact
ZY020 [2001311600]
3.3e-01
1.1e+00
3.0e+00
—
2.8e+00
1.5e+00
1.2e+00
cases:1.31%
controls:0.95%
cases:0.81%
controls:0.28%
cases:0.58%
controls:0.03%
—
—
cases:0.73%
controls:0.05%
cases:1.00%
controls:0.23%
cases:1.79%
controls:0.52%
52
374
3904
39167
32
112
3924
39429
23
12
3933
39529
—
28
18
3816
39454
35
87
3466
38240
49
169
2689
32254
Paranasal sinuses X-ray examination without contrast
DM1AA [2001301740]
8.4e-01
2.2e+00
—
—
—
3.8e+00
2.7e+00
cases:0.61%
controls:0.26%
cases:0.40%
controls:0.05%
—
—
—
—
—
—
cases:2.37%
controls:0.05%
cases:2.85%
controls:0.20%
24
104
3932
39437
16
18
3940
39523
—
—
—
83
21
3418
38306
78
64
2660
32359
immunoglobulins, normal human, for intravascular adm.
J06BA02 [21601257]
1.8e+00
2.2e+00
2.3e+00
—
—
2.5e+00
2.9e+00
cases:0.20%
controls:0.03%
cases:0.20%
controls:0.02%
cases:0.13%
controls:0.01%
—
—
—
—
cases:0.23%
controls:0.02%
cases:0.58%
controls:0.03%
8
13
3948
39528
8
9
3948
39532
5
5
3951
39536
—
—
8
7
3493
38320
16
10
2722
32413
immunoglobulins, normal human, for extravascular adm.
J06BA01 [21601256]
1.8e+00
2.2e+00
2.3e+00
—
—
2.5e+00
2.9e+00
cases:0.20%
controls:0.03%
cases:0.20%
controls:0.02%
cases:0.13%
controls:0.01%
—
—
—
—
cases:0.23%
controls:0.02%
cases:0.58%
controls:0.03%
8
13
3948
39528
8
9
3948
39532
5
5
3951
39536
—
—
8
7
3493
38320
16
10
2722
32413
Bilirubin.conjugated [Moles/volume] in Serum or Plasma
29760-6 [3005772]
2.3e-01
1.3e+00
3.1e+00
—
2.6e+00
1.7e+00
7.9e-01
cases:2.78%
controls:2.22%
cases:3.26%
controls:0.93%
cases:2.78%
controls:0.13%
—
—
cases:1.77%
controls:0.13%
cases:5.00%
controls:0.96%
cases:6.43%
controls:3.02%
110
879
3846
38662
129
367
3827
39174
110
50
3846
39491
—
68
53
3776
39419
175
368
3326
37959
176
980
2562
31443
Pathologist interpretation of Cerebral spinal fluid tests
21024-5 [3012320]
1.9e+00
—
1.0e+50
—
1.0e+50
4.0e+00
3.5e+00
cases:0.18%
controls:0.03%
—
—
cases:0.48%
controls:0.00%
—
—
cases:1.04%
controls:0.00%
cases:0.83%
controls:0.02%
cases:1.06%
controls:0.03%
7
10
3949
39531
—
19
0
3937
39541
—
40
0
3804
39472
29
6
3472
38321
29
10
2709
32413
Intubation
WX704 [2001310820]
-2.3e-02
9.2e-01
4.0e+00
1.0e+50
3.0e+00
1.5e+00
3.6e-01
cases:0.91%
controls:0.93%
cases:0.88%
controls:0.35%
cases:1.26%
controls:0.02%
cases:0.48%
controls:0.00%
cases:0.44%
controls:0.02%
cases:1.49%
controls:0.32%
cases:1.75%
controls:1.23%
36
368
3920
39173
35
140
3921
39401
50
9
3906
39532
19
0
3937
39541
17
9
3827
39463
52
124
3449
38203
48
398
2690
32025
Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
21363-7 [3020565]
1.2e-02
1.1e+00
3.5e+00
1.0e+50
1.0e+50
3.7e+00
2.3e+00
cases:0.20%
controls:0.20%
cases:0.30%
controls:0.11%
cases:0.51%
controls:0.02%
cases:0.13%
controls:0.00%
cases:0.81%
controls:0.00%
cases:3.28%
controls:0.09%
cases:3.29%
controls:0.35%
8
79
3948
39462
12
42
3944
39499
20
6
3936
39535
5
0
3951
39541
31
0
3813
39472
115
33
3386
38294
90
115
2648
32308
MCH [Entitic mass]
28539-5 [3035941]
-2.4e-02
3.8e-01
2.2e+00
3.8e+00
2.2e+00
6.2e-01
2.2e-01
cases:42.29%
controls:42.88%
cases:46.51%
controls:37.30%
cases:45.96%
controls:8.44%
cases:17.37%
controls:0.46%
cases:43.39%
controls:8.14%
cases:54.50%
controls:39.12%
cases:65.30%
controls:60.08%
1673
16957
2283
22584
1840
14748
2116
24793
1818
3339
2138
36202
687
182
3269
39359
1668
3213
2176
36259
1908
14995
1593
23332
1788
19481
950
12942
Leukocytes [#/volume] in Blood
26464-8 [3010813]
-2.0e-02
3.9e-01
2.2e+00
3.8e+00
2.2e+00
6.2e-01
2.3e-01
cases:42.49%
controls:42.99%
cases:46.74%
controls:37.34%
cases:45.90%
controls:8.46%
cases:17.37%
controls:0.46%
cases:43.39%
controls:8.17%
cases:54.58%
controls:39.19%
cases:65.41%
controls:60.14%
1681
17000
2275
22541
1849
14765
2107
24776
1816
3346
2140
36195
687
183
3269
39358
1668
3224
2176
36248
1911
15020
1590
23307
1791
19499
947
12924
Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
9654-5 [3007847]
9.4e-01
2.4e+00
3.4e+00
1.0e+50
—
2.2e+00
1.5e+00
cases:0.28%
controls:0.11%
cases:0.56%
controls:0.05%
cases:0.38%
controls:0.01%
cases:0.15%
controls:0.00%
—
—
cases:0.43%
controls:0.05%
cases:0.77%
controls:0.17%
11
43
3945
39498
22
21
3934
39520
15
5
3941
39536
6
0
3950
39541
—
15
19
3486
38308
21
56
2717
32367
Platelets [#/volume] in Blood
26515-7 [3007461]
-2.3e-02
3.8e-01
2.2e+00
3.8e+00
2.2e+00
6.2e-01
2.3e-01
cases:42.29%
controls:42.85%
cases:46.51%
controls:37.30%
cases:45.96%
controls:8.43%
cases:17.37%
controls:0.47%
cases:43.39%
controls:8.13%
cases:54.47%
controls:39.12%
cases:65.30%
controls:60.04%
1673
16944
2283
22597
1840
14750
2116
24791
1818
3335
2138
36206
687
184
3269
39357
1668
3208
2176
36264
1907
14994
1594
23333
1788
19466
950
12957
Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
76080-1 [46235759]
1.8e-01
8.2e-01
2.4e+00
1.0e+50
3.1e+00
2.1e+00
1.0e+00
cases:0.66%
controls:0.55%
cases:0.63%
controls:0.28%
cases:0.63%
controls:0.06%
cases:0.20%
controls:0.00%
cases:0.78%
controls:0.04%
cases:2.86%
controls:0.38%
cases:3.10%
controls:1.16%
26
217
3930
39324
25
110
3931
39431
25
22
3931
39519
8
0
3948
39541
30
14
3814
39458
100
144
3401
38183
85
377
2653
32046
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
-2.4e-02
3.8e-01
2.2e+00
3.8e+00
2.2e+00
6.2e-01
2.2e-01
cases:42.37%
controls:42.96%
cases:46.61%
controls:37.35%
cases:45.93%
controls:8.45%
cases:17.37%
controls:0.46%
cases:43.39%
controls:8.16%
cases:54.47%
controls:39.17%
cases:65.34%
controls:60.11%
1676
16985
2280
22556
1844
14770
2112
24771
1817
3340
2139
36201
687
183
3269
39358
1668
3219
2176
36253
1907
15012
1594
23315
1789
19488
949
12935
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
-2.4e-02
3.8e-01
2.2e+00
3.8e+00
2.2e+00
6.2e-01
2.2e-01
cases:42.37%
controls:42.96%
cases:46.64%
controls:37.37%
cases:45.96%
controls:8.46%
cases:17.37%
controls:0.46%
cases:43.39%
controls:8.16%
cases:54.50%
controls:39.20%
cases:65.38%
controls:60.13%
1676
16986
2280
22555
1845
14775
2111
24766
1818
3344
2138
36197
687
183
3269
39358
1668
3221
2176
36251
1908
15026
1593
23301
1790
19495
948
12928
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
-2.4e-02
3.8e-01
2.2e+00
3.8e+00
2.2e+00
6.2e-01
2.3e-01
cases:42.37%
controls:42.96%
cases:46.64%
controls:37.36%
cases:45.96%
controls:8.47%
cases:17.37%
controls:0.46%
cases:43.39%
controls:8.16%
cases:54.50%
controls:39.19%
cases:65.38%
controls:60.11%
1676
16985
2280
22556
1845
14771
2111
24770
1818
3350
2138
36191
687
183
3269
39358
1668
3220
2176
36252
1908
15022
1593
23305
1790
19490
948
12933
CD3+CD8+ (T8 suppressor) cells/cells in Blood
8101-8 [3007449]
1.1e+00
1.7e+00
—
1.0e+50
—
4.7e+00
3.0e+00
cases:0.20%
controls:0.07%
cases:0.23%
controls:0.04%
—
—
cases:0.73%
controls:0.00%
—
—
cases:2.14%
controls:0.02%
cases:1.86%
controls:0.09%
8
28
3948
39513
9
16
3947
39525
—
29
0
3927
39541
—
75
8
3426
38319
51
30
2687
32393
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
-2.4e-02
3.8e-01
2.2e+00
3.8e+00
2.2e+00
6.2e-01
2.2e-01
cases:42.42%
controls:43.01%
cases:46.61%
controls:37.42%
cases:45.96%
controls:8.47%
cases:17.37%
controls:0.47%
cases:43.39%
controls:8.20%
cases:54.50%
controls:39.22%
cases:65.38%
controls:60.18%
1678
17005
2278
22536
1844
14795
2112
24746
1818
3350
2138
36191
687
185
3269
39356
1668
3235
2176
36237
1908
15032
1593
23295
1790
19513
948
12910
Simple therapy of methastized malignancy with biomodifiers
WD305 [2001310685]
—
4.8e-01
—
1.0e+50
3.3e+00
3.7e+00
2.4e+00
—
—
cases:0.13%
controls:0.08%
—
—
cases:0.43%
controls:0.00%
cases:0.78%
controls:0.03%
cases:2.31%
controls:0.06%
cases:1.42%
controls:0.14%
—
5
31
3951
39510
—
17
0
3939
39541
30
11
3814
39461
81
23
3420
38304
39
44
2699
32379
pH of Specimen
17433-4 [3019225]
3.1e-02
7.5e-01
3.4e+00
—
3.2e+00
1.3e+00
7.8e-01
cases:2.55%
controls:2.48%
cases:2.78%
controls:1.33%
cases:5.69%
controls:0.20%
—
—
cases:4.45%
controls:0.20%
cases:4.60%
controls:1.34%
cases:6.17%
controls:2.92%
101
979
3855
38562
110
525
3846
39016
225
80
3731
39461
—
171
77
3673
39395
161
513
3340
37814
169
947
2569
31476

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
1673
6718
3.57
322.23
7.2
3.3
0.81
0.81
mmol/l
2.46
1622
6310
3220
19603
4.36
316.72
17.0
6.8
10.99
12.27
umol/l
5.19
3183
18714
464
673
7.67
309.38
5.1
3.6
1.72
1.68
%
0.08
445
590
419
179
26.04
307.65
3.1
2.3
231.00
223.91
e6/l
0.15
359
152
3325
20348
4.85
307.65
27.7
9.5
3.57
4.26
e9/l
63.46
3083
17498
884
411
27.36
307.65
1.6
1.3
—
—
—
0
0
3119
16751
4.98
307.65
12.5
6.6
0.68
0.67
%
0.76
3055
15619
1257
3987
4.15
307.65
4.0
2.5
69.69
68.91
e9/l
0.27
1014
2933
3250
18104
5.33
307.65
11.8
6.2
0.62
0.62
e9/l
0.09
2952
15296
555
624
10.17
307.65
1.4
1.4
—
—
—
0
0
3131
16760
5.07
307.65
12.4
6.5
2.59
2.87
%
10.02
3069
15627
495
541
10.31
307.65
1.4
1.4
129.78
155.42
au/ml
2.97
138
165
3089
16726
4.78
307.65
11.7
6.4
56.55
58.22
%
9.18
3047
15910
3274
18685
5.24
307.65
12.7
6.4
0.16
0.20
e9/l
28.10
3000
16050
379
307
13.54
307.65
1.6
1.8
3.90
4.56
mg/l
1.48
366
296
294
105
30.15
307.65
1.2
1.1
—
—
—
0
0
241
88
29.09
307.65
2.4
1.9
10.80
11.75
%
0.18
211
80
3140
17033
4.99
307.65
12.6
6.5
26.90
26.41
%
1.22
3087
16063
374
191
21.51
307.65
3.2
2.1
0.45
0.68
e9/l
3.43
352
179
1146
3450
4.26
307.65
6.8
4.3
1.12
0.94
%
1.42
840
1069
312
112
30.14
307.65
2.2
1.9
40.27
28.58
%
11.75
312
112
535
190
32.37
307.65
2.3
2.0
16.01
15.88
%
0.05
517
183
405
170
26.41
307.65
3.6
2.4
33.37
40.27
%
3.63
285
87
544
621
9.99
307.65
1.4
1.4
28.41
15.33
u/ml
—
7
12
1466
5077
3.99
307.65
3.9
2.5
1.81
1.79
%
0.24
1387
4493
1481
2642
8.33
307.65
4.5
2.8
8.81
10.77
g/l
33.71
1435
2419
2573
9838
5.57
307.65
6.3
2.9
317.96
357.43
umol/l
61.25
2508
8499
985
265
49.06
307.65
1.4
1.2
—
—
—
0
0
2030
3578
10.54
307.65
1.6
1.6
—
—
—
0
0
655
263
29.61
307.65
2.7
2.1
1075.34
1113.34
e6/l
0.24
592
227
1908
3099
10.90
307.65
1.5
1.6
—
—
—
0
0
242
89
28.89
307.65
2.4
2.0
36.15
25.38
%
7.98
223
82
424
178
26.54
307.65
2.8
2.2
197.83
158.50
e6/l
0.24
417
168
399
184
23.99
307.65
2.9
2.2
575.72
485.91
e6/l
0.75
318
144
2094
4123
9.61
307.65
1.6
1.7
—
—
—
0
0
1072
2112
6.58
307.65
3.4
1.9
1.59
1.26
g/l
1.97
1015
1926
3262
18467
5.24
307.65
12.0
6.3
1.86
1.88
e9/l
0.18
3011
16004
1588
3249
7.47
307.65
1.8
1.4
—
—
—
0
0
1808
1989
15.82
307.65
1.4
1.4
—
—
—
0
0
3141
16786
5.13
307.65
12.7
6.6
9.76
9.12
%
19.15
3076
15655
3250
18170
5.30
307.65
11.8
6.2
0.04
0.04
e9/l
12.89
2954
15370
896
668
17.02
307.65
1.8
1.6
—
—
—
0
0
550
205
30.97
307.65
2.3
1.9
73.44
70.38
%
1.53
527
190
2951
17234
3.75
302.15
9.3
5.3
33.89
35.00
g/l
20.54
2867
16126
1052
3278
4.00
293.10
6.8
4.2
0.79
0.71
%
0.77
741
1009
1023
3307
3.82
267.95
7.0
4.4
0.20
0.11
%
3.44
716
925
147
25
61.02
264.28
1.8
2.5
—
—
—
0
0
167
58
30.01
251.99
2.5
1.8
0.47
0.22
e9/l
0.30
55
22
1349
5463
3.22
244.52
7.2
6.2
1.04
1.04
mmol/l
0.30
1307
5078
2169
11634
2.90
233.67
8.3
4.5
—
—
—
0
0
355
555
6.92
219.39
1.3
1.2
277.41
262.93
u/ml
0.29
213
323
429
810
5.82
219.34
1.3
1.2
—
—
—
0
0
1021
3711
3.36
218.53
2.9
2.7
64.15
66.08
g/l
9.42
977
3377
950
3319
3.45
216.54
7.3
4.5
0.18
0.13
%
0.50
637
869
2980
19549
3.09
209.97
13.7
7.7
1.22
1.21
mmol/l
10.10
2612
16848
2754
17617
2.83
197.62
11.9
7.0
1.22
1.21
mmol/l
6.82
2677
16226
1500
7351
2.67
181.20
10.3
4.9
—
—
—
0
0
273
402
7.22
177.79
5.3
4.0
—
—
—
0
0
2051
11773
2.53
176.55
8.5
4.4
7.41
7.40
ph
14.17
1556
8583
279
443
6.70
169.20
5.1
3.6
53.90
58.17
%
1.99
262
370
2182
13063
2.48
168.89
7.6
3.6
2.35
2.35
mmol/l
0.57
2080
11778
1320
6256
2.66
168.40
2.7
1.5
1.99
2.67
g/l
19.64
1085
3661
403
936
4.68
161.10
1.4
1.7
—
—
—
0
0
215
285
7.92
153.42
2.6
2.3
21.06
31.46
iu/ml
0.60
41
43
277
484
6.08
152.54
1.7
1.4
—
—
—
0
0
277
484
6.08
152.54
1.7
1.4
—
—
—
0
0
277
484
6.08
152.54
1.7
1.4
—
—
—
0
0
277
484
6.08
152.54
1.7
1.4
—
—
—
0
0
110
56
20.17
143.12
1.5
1.3
—
—
—
0
0
2506
16766
2.34
139.75
4.8
2.9
—
—
estimate
—
0
0
314
668
5.02
139.11
2.8
2.1
0.97
0.90
%
0.91
254
457
231
383
6.34
133.93
1.2
1.2
—
—
—
0
0
1449
7832
2.34
132.88
5.1
3.1
2.48
2.46
mmol/l
5.77
1399
7009
1955
11996
2.24
131.64
4.7
2.6
—
—
—
0
0
543
1839
3.26
125.41
2.6
1.9
2.75
2.61
ug/l
0.06
506
1625
2330
15588
2.19
123.29
23.1
12.5
0.01
0.00
e9/l
0.73
1978
12653
535
1823
3.24
122.17
2.6
2.5
4.01
4.20
g/l
5.93
510
1658
535
1824
3.23
122.05
2.6
2.5
7.17
7.42
g/l
2.42
509
1656
533
1821
3.22
121.13
2.6
2.5
3.64
3.76
g/l
0.44
509
1656
3291
25661
2.63
117.60
7.8
4.5
16.78
13.44
mm/h
20.65
3195
23852
2623
18676
2.19
114.56
17.2
18.3
1.26
1.32
inr
8.20
2217
15764
472
1548
3.32
114.46
2.8
3.6
38.19
63.87
mg/l
1.52
398
1315
499
1696
3.22
114.08
2.7
2.5
3.10
2.91
g/l
3.21
474
1531
472
1551
3.32
114.08
2.8
3.6
57.36
56.37
mg/l
0.05
401
1315
3426
27394
2.80
113.41
22.5
8.7
84.54
81.24
u/l
3.42
3371
25979
306
762
4.27
110.98
2.0
1.4
7224.55
753.34
e6/l
0.48
262
595
331
877
4.03
110.38
1.9
1.3
698.56
564.82
mg/l
2.57
322
826
435
1397
3.37
108.92
2.8
3.4
4.28
3.04
ratio
0.59
251
820
1087
5601
2.29
107.61
2.1
2.1
—
—
—
0
0
299
755
4.20
106.37
1.9
1.4
39.36
25.35
e6/l
0.29
244
557
466
1587
3.19
105.86
2.7
2.5
9.51
10.33
g/l
2.83
438
1405
1175
6310
2.22
104.78
3.2
2.1
29.50
29.84
s
1.05
1147
6139
1532
9196
2.08
101.79
4.4
2.6
—
—
—
0
0
290
775
3.96
95.30
1.8
1.3
3.68
3.83
mmol/l
1.21
276
724
1533
9462
2.01
92.04
6.2
4.4
85.13
85.35
%
0.14
1505
9285
532
2130
2.73
89.48
2.1
1.7
1.55
1.55
g/l
0.03
451
1844
238
580
4.30
88.51
2.1
2.8
—
—
—
0
0
222
513
4.52
88.39
1.1
1.1
—
—
—
0
0
235
568
4.33
88.34
1.3
1.3
120.17
215.70
miu/ml
2.42
37
214
2022
13908
1.92
86.61
2.7
2.3
—
—
—
0
0
268
728
3.87
85.92
5.9
3.2
56.41
58.24
%
1.11
268
728
341
1090
3.33
85.43
3.4
2.4
3.74
3.57
g/l
1.05
332
1041
1470
9325
1.91
78.34
1.6
1.3
—
—
—
0
0
2828
22120
1.96
77.99
8.7
5.4
6.69
6.84
mmol/l
4.15
2772
21129
81
75
11.00
75.71
2.3
1.9
—
—
—
0
0
180
400
4.67
75.15
1.2
1.1
—
—
—
0
0
821
4295
2.15
74.82
4.7
2.9
8.59
9.29
umol/l
0.38
747
3818
1054
6062
2.00
74.25
2.6
2.8
23.75
22.10
%
2.31
1000
5647
393
1493
2.81
72.49
1.5
1.6
—
—
—
0
0
1105
6514
1.96
72.18
2.6
2.7
2.15
2.26
g/l
8.03
1041
6025
1151
6916
1.93
70.82
2.6
2.8
12.70
12.39
umol/l
0.57
1094
6450
1622
10880
1.83
70.53
17.8
6.4
—
—
—
0
0
218
588
3.86
70.43
5.7
6.4
11.47
12.31
mg/l
2.03
203
552
808
4341
2.08
67.96
2.5
4.3
9.71
19.32
ug/l
1.49
574
3614
819
4448
2.06
66.77
4.5
3.3
4.99
4.86
e9/l
0.10
718
3768
1846
13062
1.77
65.55
3.9
3.3
1844.94
1583.04
ng/l
1.68
1695
11434
272
907
3.15
63.16
2.0
1.9
12.20
12.27
mg/l
0.04
261
833
196
535
3.80
62.20
1.1
1.0
—
—
—
0
0
1529
10434
1.76
60.07
4.0
3.5
0.20
326.73
estimate
—
5
47
1600
11087
1.74
59.35
4.1
3.5
0.48
0.45
e6/l
0.13
1227
8295
157
379
4.27
58.95
1.8
1.4
—
—
—
0
0
52
35
15.04
58.81
1.7
2.5
1.51
1.27
mg/l
0.14
33
29
81
105
7.85
58.68
1.3
1.2
—
—
—
0
0
1792
12849
1.72
58.48
4.2
3.7
31.19
79.89
e6/l
5.78
1421
9968
1508
10345
1.74
57.49
2.4
2.4
3.17
2.87
mg/l
3.86
1330
8914
2862
23419
1.79
57.08
6.0
5.2
1265.69
1546.79
e6/l
0.12
52
370
774
4358
1.96
55.94
1.7
1.5
—
—
—
0
0
1919
14128
1.69
55.91
5.0
4.3
132.52
108.89
e6/l
0.28
1460
10287
114
230
5.07
53.34
3.0
1.7
—
—
—
0
0
675
3715
1.98
51.74
8.8
8.9
—
—
—
0
0
701
4010
1.91
47.58
7.8
7.4
10.41
10.65
mmol/l
0.36
688
3831
128
316
4.15
46.65
1.1
1.1
—
—
—
0
0
529
2769
2.05
46.32
4.7
3.9
7.43
7.42
ph
8.37
461
2311
727
4246
1.87
46.14
5.8
3.8
1.91
1.87
mmol/l
0.10
646
3697
540
2854
2.03
46.02
4.7
3.9
5.02
5.14
kpa
3.23
527
2729
741
4359
1.86
45.95
5.8
3.8
5.70
5.83
kpa
3.32
731
4242
746
4418
1.85
45.21
5.8
3.8
7.39
7.38
ph
3.93
452
2559
568
3147
1.94
42.04
10.4
4.1
1.23
1.22
mmol/l
1.82
549
2751
63
93
6.87
40.69
1.6
1.3
—
—
—
0
0
1283
9046
1.62
40.51
3.3
2.8
4.18
4.83
e6/l
1.28
1199
8253
1971
15413
1.55
39.37
3.6
3.1
371.76
150.22
ug/l
23.33
1850
14191
1585
11826
1.57
38.91
3.1
2.7
56.33
67.51
u/l
0.95
1482
10948
56
77
7.36
38.56
1.0
1.1
—
—
—
0
0
330
1551
2.23
37.88
2.1
3.5
262.40
3563.11
u/ml
1.16
267
1347
578
3328
1.86
37.75
2.2
2.4
381.21
378.45
nmol/l
0.12
555
3066
1121
7755
1.62
37.72
3.4
3.1
527.02
536.37
mosm/kgh2o
0.87
1030
6816
346
1669
2.18
37.22
1.4
1.3
—
—
—
0
0
958
6412
1.65
36.64
3.6
3.4
1.72
1.99
e6/l
0.51
492
3265
1021
6946
1.63
36.58
3.5
3.2
1.01
1.11
e6/l
0.37
557
3811
1121
7835
1.60
35.81
4.5
4.3
319.83
517.09
ng/l
0.50
975
6656
644
3895
1.78
35.62
8.2
7.6
1.50
1.34
mmol/l
2.04
634
3820
1097
7660
1.60
35.04
2.2
1.8
1.98
1.46
mg/l
2.15
905
6053
378
1936
2.05
34.68
5.1
4.1
—
—
—
0
0
2809
24086
1.56
34.65
5.9
4.9
2.01
2.83
—
6
32
58
97
6.05
33.24
1.9
1.5
3380.00
3632.00
titre
0.08
20
15
632
3885
1.75
32.82
2.3
2.2
0.19
0.20
g/l
5.46
589
3615
56
97
5.84
30.98
1.4
1.2
20.78
27.27
%
0.25
18
15
1856
14811
1.47
30.64
5.0
4.2
37.67
89.66
ng/l
1.10
1593
11452
757
4970
1.65
30.53
1.4
1.4
—
—
—
0
0
1970
15918
1.47
30.43
2.7
2.5
78.07
78.75
nmol/l
0.48
1847
14134
72
159
4.59
30.33
1.5
1.2
65.60
65.00
%
0.02
15
21
250
1151
2.25
30.06
6.8
3.4
1.57
1.69
mg/l
1.35
234
1033
112
343
3.33
29.87
1.5
1.4
2.10
3.02
g/l
6.08
82
249
112
343
3.33
29.87
1.5
1.4
5.94
6.86
g/l
1.26
80
250
112
343
3.33
29.87
1.5
1.4
0.32
0.41
g/l
2.09
80
250
1521
11724
1.48
29.63
3.9
3.5
—
—
—
0
0
154
569
2.78
29.63
1.6
1.6
0.48
0.88
g/l
6.59
113
448
173
686
2.59
28.96
1.7
1.5
31.61
31.69
g/l
0.03
165
618
166
646
2.64
28.87
1.1
1.2
—
—
—
0
0
115
369
3.18
28.43
1.4
2.1
1574.68
3583.14
u/l
0.54
30
144
676
4389
1.65
28.28
1.9
1.8
—
—
—
0
0
109
341
3.26
28.10
1.6
1.4
—
—
—
0
0
272
1349
2.09
27.08
3.0
2.0
21.98
21.26
s
0.77
256
1235
149
576
2.65
26.27
1.8
2.7
—
—
—
0
0
106
341
3.17
26.12
2.4
1.5
—
—
—
0
0
291
1505
2.01
25.82
5.5
4.2
25.62
24.80
mmol/l
4.46
276
1379
748
5115
1.57
24.93
9.6
7.7
7.43
7.42
ph
2.96
422
2817
587
3809
1.63
24.32
7.6
4.7
7.39
7.35
ph
5.95
529
2720
740
5090
1.56
23.93
9.4
7.6
1.16
0.97
mmol/l
0.62
604
4183
133
512
2.65
23.67
1.6
1.6
—
—
—
0
0
1473
11642
1.42
23.57
6.3
3.3
36.34
37.38
u/l
0.19
1408
10962
678
4615
1.57
22.87
9.7
7.8
96.08
95.37
%
3.33
651
4457
737
5123
1.54
22.59
9.6
7.6
12.54
12.09
kpa
1.30
711
4927
737
5124
1.54
22.57
9.6
7.6
4.98
5.09
kpa
2.69
706
4925
60
148
4.10
22.01
1.2
1.1
1667.77
366.92
ng/l
1.02
30
39
41
74
5.59
21.77
1.7
1.3
39.88
144.25
titre
—
8
8
541
3549
1.61
21.25
2.5
2.5
38.19
52.86
u/l
0.53
462
2975
129
522
2.52
20.77
1.7
1.5
—
—
—
0
0
283
1561
1.88
20.71
3.2
3.1
24.48
24.76
mmol/l
0.57
278
1540
549
3637
1.59
20.66
5.5
3.2
4.68
4.49
kpa
1.10
538
3533
101
363
2.83
20.54
1.4
1.3
29.48
11.82
u/l
1.43
96
331
621
4248
1.55
20.28
10.8
8.4
112.42
120.82
g/l
19.85
604
4149
3511
32765
1.61
20.17
43.9
18.8
25.57
26.78
mg/l
1.53
3347
27615
197
973
2.08
19.82
1.7
1.5
0.22
0.24
g/l
1.87
179
928
201
1004
2.06
19.62
1.7
1.5
1.11
1.18
g/l
2.15
195
956
259
1413
1.89
19.60
2.8
3.8
99.13
82.03
u/ml
0.33
250
1361
2185
18809
1.36
19.37
4.7
4.2
2.70
3.20
estimate
0.06
549
4123
715
5091
1.49
19.25
1.4
1.3
—
—
—
0
0
119
481
2.52
19.22
1.5
1.4
6.06
6.37
mmol/l
0.64
113
452
1784
14912
1.36
19.02
4.1
3.6
6.25
6.25
ph
0.08
945
8189
85
292
2.95
18.79
1.4
1.2
—
—
—
0
0
254
1396
1.88
18.79
1.2
1.2
—
—
—
0
0
71
221
3.25
18.56
1.2
1.1
71.47
40.19
mg/l
2.29
58
177
2157
18604
1.35
18.49
4.7
4.1
0.00
0.00
estimate
1.08
539
4009
135
596
2.31
17.97
1.6
1.5
1956.07
3516.49
e6/l
0.51
94
417
124
533
2.37
17.56
1.5
1.4
22179.17
76103.73
e6/l
2.08
70
295
43
98
4.42
17.51
1.0
1.0
—
—
—
0
0
68
215
3.20
17.35
1.2
1.0
430.32
297.47
mg/l
1.73
60
179
2181
18953
1.33
17.19
4.8
4.2
0.01
0.09
estimate
0.51
519
3819
185
957
1.98
16.41
4.0
4.2
—
—
—
0
0
624
4455
1.48
16.34
1.4
1.3
687.48
490.86
titre
1.34
139
983
41
96
4.30
16.16
1.4
1.1
—
—
—
0
0
145
691
2.14
16.06
1.7
1.4
10.74
9.68
u/l
0.47
124
556
1421
11696
1.33
15.89
1.8
1.8
19.41
20.07
nmol/l
0.92
1241
9804
181
946
1.96
15.59
2.3
3.5
539.87
879.09
u/ml
0.24
163
867
22
10
22.11
15.52
1.0
1.1
—
—
—
0
0
2401
21361
1.31
14.97
4.2
3.4
61.94
55.54
u/l
1.90
2268
19761
27
47
5.78
14.91
12.5
3.2
44.56
40.02
umol/l
0.45
21
38
107
466
2.33
14.76
1.9
2.1
—
—
—
0
0
309
1939
1.64
14.36
4.1
3.5
25.12
25.17
mmol/l
0.11
303
1874
417
2819
1.54
14.11
5.1
4.3
—
—
—
0
0
23
36
6.42
14.09
1.3
1.1
—
—
—
0
0
23
36
6.42
14.09
1.3
1.1
—
—
—
0
0
23
36
6.42
14.09
1.3
1.1
—
—
—
0
0
401
2691
1.55
14.03
10.8
6.7
24.75
24.48
mmol/l
0.66
380
2580
401
2693
1.54
13.98
5.2
3.2
119.69
128.13
g/l
10.10
396
2610
62
212
2.95
13.91
1.5
1.8
—
—
—
0
0
160
851
1.92
13.13
4.2
4.9
2.74
2.69
mmol/l
0.08
123
592
20
12
16.75
12.96
1.5
1.0
1.27
1.23
iu/ml
—
13
6
375
2524
1.54
12.92
14.0
10.1
15.13
15.90
%
6.55
357
2438
50
158
3.19
12.85
33.9
29.0
104.20
117.73
ug/l
0.87
41
133
70
267
2.65
12.84
1.4
1.4
7.41
7.40
ph
0.05
57
181
2881
26555
1.31
12.35
48.8
23.3
14.53
13.80
%
108.74
2871
26184
442
3108
1.47
12.33
3.9
4.1
87.29
96.32
ng/l
1.17
371
2649
44
132
3.36
12.30
2.0
1.2
1.38
0.10
g/l
—
9
9
63
233
2.73
12.29
1.4
1.6
—
—
—
0
0
1442
12210
1.28
12.19
2.3
2.3
159.77
214.24
u/l
2.63
1375
11528
34
86
3.98
12.17
1.2
1.2
4.11
2.01
mmol/l
0.58
27
58
1200
14264
0.77
12.03
2.0
2.0
1.38
1.33
mmol/l
1.10
977
11794
104
489
2.16
12.01
1.5
1.5
—
—
—
0
0
85
368
2.34
11.96
1.2
1.1
—
—
—
0
0
49
161
3.07
11.83
1.3
1.2
0.53
0.51
ratio
0.29
26
89
264
1680
1.61
11.60
1.3
1.2
—
—
—
0
0
33
85
3.91
11.53
1.6
1.4
—
—
—
0
0
24
48
5.02
11.46
1.9
1.2
73.16
107.70
ng/l
0.26
19
33
183
1066
1.75
11.24
3.9
3.6
2.56
1.82
index
0.78
96
539
62
241
2.60
11.01
1.1
1.1
—
—
—
0
0
20
35
5.74
11.00
1.0
1.0
—
—
—
0
0
18
13
13.90
10.95
1.0
1.0
—
—
—
0
0
120
618
1.97
10.88
1.8
1.9
5.36
4.61
mmol/24h
1.26
105
535
1260
10606
1.28
10.86
5.1
4.3
0.01
0.00
estimate
0.44
494
3631
29
71
4.11
10.86
1.7
1.4
—
—
—
0
0
46
155
2.99
10.67
1.9
1.5
1.93
2.67
%
0.29
40
135
142
782
1.85
10.53
1.3
1.2
—
—
—
0
0
143
792
1.84
10.42
1.3
1.3
84.09
40.91
u/l
1.91
126
685
36
106
3.42
10.40
2.1
1.6
1.34
5.92
ug/l
1.09
25
77
281
1863
1.55
10.37
2.6
3.4
4.26
4.42
pmol/l
1.81
255
1635
22
27
8.19
10.30
1.7
1.2
—
—
—
0
0
50
181
2.78
10.21
1.9
1.5
69.02
67.54
%
0.11
43
150
17
13
13.13
10.14
1.0
1.0
—
—
—
0
0
17
13
13.13
10.14
1.0
1.0
—
—
—
0
0
17
13
13.13
10.14
1.0
1.0
—
—
—
0
0
17
13
13.13
10.14
1.0
1.0
—
—
—
0
0
130
706
1.87
10.09
1.8
1.4
27.86
29.06
iu/l
0.14
105
595
47
167
2.84
9.94
1.5
5.0
66.72
62.45
mg/l
0.10
39
119
479
3553
1.40
9.91
3.3
3.1
268.91
215.51
ng/l
1.47
445
3279
879
7143
1.30
9.84
1.8
1.8
1204.86
1163.97
nmol/l
0.62
700
5362
31
86
3.63
9.80
1.1
1.1
—
—
—
0
0
213
1345
1.62
9.69
1.7
1.7
6.56
6.32
iu/ml
0.05
50
311
41
140
2.95
9.33
35.4
35.7
6.83
7.24
ug/l
0.59
33
123
18
19
9.51
9.25
3.1
1.6
1.72
1.50
mpas
—
8
10
200
1264
1.61
9.09
10.8
5.9
1.31
1.33
mmol/l
0.09
173
1123
2644
24473
1.24
8.99
5.6
4.6
0.33
1554.51
—
6
65
20
27
7.44
8.91
4.0
6.3
10.20
8.33
%
0.42
20
27
20
27
7.44
8.91
2.0
3.1
35.85
37.22
%
0.07
20
27
22
51
4.33
8.86
2.0
2.3
111.16
113.45
ng/l
0.03
13
23
284
1960
1.48
8.69
10.1
5.1
1.55
1.60
%
0.48
264
1856
295
2056
1.47
8.59
1.3
1.3
82.12
60.52
au/ml
0.56
17
146
540
4174
1.34
8.57
1.4
1.4
—
—
—
0
0
207
1339
1.58
8.55
3.0
3.2
683.29
411.43
mg/l
0.58
104
600
158
957
1.68
8.50
1.4
1.2
42.54
35.20
u/ml
0.18
17
43
31
95
3.28
8.47
1.2
1.2
1.37
1.60
mmol/l
0.73
25
62
151
912
1.68
8.22
1.4
1.2
—
—
—
0
0
1039
8786
1.25
8.15
4.4
4.0
0.00
0.14
—
5
109
150
909
1.68
8.07
1.4
1.2
1.94
3.43
u/ml
1.41
20
73
268
1863
1.47
7.92
2.4
2.2
0.02
0.47
estimate
0.50
55
553
315
2259
1.43
7.89
2.5
2.4
27.05
20.73
au/ml
0.32
23
182
165
1033
1.62
7.83
3.0
2.3
117.98
128.36
g/l
5.83
123
807
14
13
10.80
7.78
1.2
1.2
—
—
—
0
0
149
911
1.66
7.77
1.4
1.2
2.77
5.67
u/ml
1.25
29
132
24
66
3.65
7.73
1.1
1.1
433.33
886.67
titre
—
6
15
1911
17283
1.20
7.54
2.3
2.2
92.21
94.35
pmol/l
1.19
1123
9202
149
919
1.65
7.52
2.4
2.6
33.68
34.87
umol/l
0.21
141
813
3046
31933
0.80
7.50
5.0
5.4
1.35
1.43
mmol/l
18.14
2753
29227
210
1410
1.52
7.37
4.8
3.7
1.62
1.40
mmol/l
1.05
203
1388
39
149
2.63
7.28
1.5
1.3
1.36
412.91
ug/l
1.35
14
70
27
84
3.23
7.24
1.9
2.0
—
—
—
0
0
37
139
2.68
7.14
1.4
1.4
3.33
3.20
mmol/l
0.09
37
126
35
128
2.75
7.11
1.1
1.0
1106.77
1608.09
miu/ml
1.90
35
128
17
26
6.56
7.10
1.1
1.0
—
—
—
0
0
19
47
4.06
7.07
1.2
1.2
68.36
52.44
%
0.67
11
16
54
246
2.21
6.90
1.1
1.4
—
—
—
0
0
275
1976
1.42
6.84
1.4
1.3
475.29
248.67
u/ml
0.92
237
1826
254
1799
1.44
6.84
11.2
5.3
0.88
0.86
%
0.35
235
1702
3078
32162
0.81
6.81
5.1
5.5
4.40
4.46
mmol/l
2.86
2814
29653
82
442
1.87
6.65
1.1
1.1
—
—
—
0
0
14
18
7.80
6.60
1.4
1.6
—
—
—
0
0
25
79
3.18
6.56
2.0
1.5
4.85
6.85
%
0.53
13
41
75
395
1.92
6.53
1.3
1.2
61.35
57.63
u/ml
—
6
20
113
675
1.69
6.49
1.3
1.2
36.29
47.49
u/ml
0.37
16
69
3020
31578
0.82
6.45
6.6
7.2
40.02
40.14
mmol/mol
0.26
2770
29257
139
886
1.59
6.20
14.1
6.8
10.65
11.37
mmol/l
1.88
122
793
139
886
1.59
6.20
14.1
6.9
105.33
105.10
mmol/l
0.17
122
793
57
278
2.07
6.17
1.6
1.7
2076.35
1864.02
ml
1.06
57
271
15
24
6.27
6.15
1.0
1.1
—
—
—
0
0
34
134
2.55
6.02
1.1
1.1
—
—
—
0
0
26
89
2.93
5.99
2.0
2.3
3.15
403.29
ug/l
0.67
26
89
3155
32776
0.82
5.81
5.7
6.3
2.56
2.57
mmol/l
0.06
2850
30090
3518
34074
1.28
5.74
44.1
22.9
139.30
139.64
mmol/l
12.63
3486
33417
13
19
6.86
5.73
1.4
1.4
—
—
—
0
0
69
371
1.88
5.69
4.1
3.6
15.05
11.34
index
1.91
43
202
81
458
1.78
5.69
1.1
1.1
27.85
23.05
au/ml
—
8
87
91
542
1.69
5.35
2.2
2.4
0.89
1.30
g/24h
0.93
58
319
125
807
1.57
5.33
1.5
1.4
57.73
61.76
mmol/l
0.59
101
654
3518
34124
1.27
5.31
44.8
23.1
4.00
4.00
mmol/l
0.03
3483
33412
78
446
1.76
5.30
1.3
1.4
273.97
275.85
mosm/kgh2o
0.38
71
330
428
3426
1.28
5.22
2.7
2.6
0.46
0.52
e6/l
0.25
418
3300
1093
9645
1.18
5.16
3.4
3.2
0.15
0.05
0.59
20
285
160
1099
1.47
5.13
7.0
2.9
59.39
60.13
%
0.15
152
1066
51
258
1.99
5.07
1.7
1.5
0.21
0.28
nmol/l
1.03
40
187
17
52
3.28
4.74
1.4
1.3
20.73
17.26
%
0.14
11
35
42
206
2.05
4.57
2.1
2.3
14.14
25.07
umol/l
—
5
19
67
384
1.76
4.57
1.3
1.1
—
—
—
0
0
9
11
8.20
4.56
1.0
1.0
—
—
—
0
0
236
1783
1.34
4.42
2.5
2.8
—
—
—
0
0
446
3662
1.25
4.40
2.5
2.2
0.01
0.01
estimate
0.18
78
724
50
266
1.89
4.35
2.1
2.0
8.73
8.30
mmol/l
0.29
50
266
36
170
2.13
4.34
2.0
1.5
39.62
39.91
g/l
0.10
36
170
1518
13887
1.15
4.34
4.9
4.2
0.02
0.22
estimate
0.71
463
3313
66
386
1.72
4.22
1.3
1.1
—
—
—
0
0
76
462
1.66
4.22
1.2
1.2
4.26
5.89
u/ml
0.56
34
214
14
34
4.13
4.20
1.2
1.1
—
—
—
0
0
1210
13346
0.87
4.16
3.6
3.5
53.97
51.22
mg/l
0.16
786
8716
173
2341
0.73
4.08
2.0
2.1
3.55
3.49
ratio
0.28
132
1895
27
116
2.34
4.08
1.2
1.2
10.64
14.08
pmol/l
—
6
42
980
10950
0.86
3.99
3.4
3.5
—
—
—
0
0
49
267
1.85
3.99
5.6
5.6
40.94
43.59
u/ml
0.05
15
80
2953
30617
0.86
3.95
4.4
4.6
1.33
1.29
mmol/l
1.70
2661
27696
37
184
2.02
3.93
6.4
6.9
13.82
123.29
ug/l
0.60
30
113
1076
9663
1.16
3.90
4.4
3.7
0.02
0.20
estimate
0.88
440
3139
164
1196
1.39
3.87
1.5
1.5
256.21
267.80
ug/g
0.29
102
742
48
263
1.84
3.85
2.6
2.3
14.34
16.29
%
4.52
48
263
7
8
8.76
3.77
1.0
1.0
—
—
—
0
0
31
147
2.12
3.74
1.5
2.2
2699.12
5951.62
e6/l
0.26
26
103
1244
13610
0.87
3.70
4.3
4.2
11.45
9.38
mg/mmol
0.46
788
8632
202
1544
1.32
3.55
2.1
2.2
376.05
613.73
ug/l
0.63
190
1469
6
6
10.01
3.49
1.2
1.0
1.17
0.83
u/field
—
6
6
73
466
1.58
3.40
1.3
1.6
22.98
29.60
ng/l
0.93
73
466
57
342
1.68
3.40
2.1
2.3
—
—
—
0
0
44
246
1.80
3.35
1.2
1.2
—
—
—
0
0
74
476
1.57
3.34
5.9
20.3
7.51
7.47
mmol/l
0.04
64
400
2636
25238
1.13
3.34
4.4
4.3
15.06
14.99
pmol/l
0.72
2424
22858
136
988
1.39
3.34
3.1
3.3
0.88
0.81
nmol/l
0.52
101
793
61
375
1.64
3.32
1.1
1.2
—
—
—
0
0
51
299
1.71
3.31
1.4
1.2
122.98
98.91
pmol/l
2.02
51
299
3513
34348
1.19
3.22
27.6
13.2
27.00
26.19
u/l
0.99
3475
33191
163
1231
1.34
3.15
1.4
1.2
5.24
1.00
u/ml
—
9
93
35
186
1.89
3.14
2.1
1.7
1.21
2.49
u/field
1.42
24
132
17
67
2.54
3.12
1.1
1.1
—
—
—
0
0
1266
13721
0.89
3.11
3.6
3.5
6.88
7.42
mmol/l
4.96
1054
11477
27
132
2.05
3.06
1.2
1.6
—
—
—
0
0
17
68
2.51
3.04
1.1
1.1
—
—
—
0
0
430
3662
1.20
2.99
2.3
2.4
7.15
7.32
ug/l
0.04
367
3229
898
8097
1.14
2.99
1.7
1.8
15541020.68
25613671.17
pmol/l
0.27
740
6645
36
197
1.83
2.97
1.3
1.7
15.95
13.57
umol/l
0.09
23
131
130
960
1.37
2.93
1.3
1.2
104.29
104.43
titre
0.00
14
79
45
266
1.70
2.88
1.2
1.2
—
—
—
0
0
12
38
3.16
2.84
1.1
1.1
—
—
—
0
0
10
28
3.58
2.78
1.0
1.0
—
—
—
0
0
10
28
3.58
2.78
1.0
1.0
—
—
—
0
0
25
126
1.99
2.65
1.2
2.0
20185.22
19764.53
e6/l
0.01
18
66
10
30
3.34
2.60
1.0
1.1
—
204.14
—
0
7
22
107
2.06
2.57
1.3
2.1
—
—
—
0
0
129
1648
0.78
2.16
1.8
1.8
3.31
3.45
mmol/l
0.59
86
1199
42
268
1.57
2.08
1.2
1.2
—
115.00
—
0
6
231
1931
1.21
2.04
1.4
1.4
—
—
—
0
0
44
286
1.54
2.02
3.0
2.9
31.66
31.92
mg/l
0.01
29
215
60
419
1.44
1.97
1.3
1.2
—
—
—
0
0
92
1207
0.76
1.91
1.1
1.1
—
—
—
0
0
45
664
0.67
1.90
1.6
1.7
—
—
—
0
0
3537
34821
1.14
1.90
50.7
25.1
84.63
82.97
umol/l
1.52
3507
34377
40
260
1.54
1.86
1.3
1.3
—
—
—
0
0
112
873
1.29
1.86
4.8
3.4
7.01
7.63
mmol/l
2.38
112
848
33
205
1.61
1.85
1.5
1.5
8.49
7.19
u/l
0.24
28
181
36
229
1.58
1.84
1.0
1.1
0.13
10.43
nmol/l
—
6
52
40
264
1.52
1.76
2.3
1.8
—
—
—
0
0
30
185
1.63
1.75
1.2
1.2
—
—
—
0
0
24
140
1.72
1.71
2.5
2.6
0.60
0.61
mmol/l
0.46
24
140
140
1715
0.81
1.69
1.3
1.4
—
—
—
0
0
14
69
2.03
1.64
2.0
1.9
1.80
2.08
ug/l
—
8
38
58
419
1.39
1.63
1.5
1.2
—
—
—
0
0
67
498
1.35
1.59
2.0
2.2
23.37
21.55
mg/l
0.15
30
172
34
223
1.53
1.56
2.3
2.1
512.17
493.29
min
0.53
18
165
287
2517
1.15
1.50
1.2
1.2
—
—
—
0
0
47
335
1.41
1.45
1.1
1.2
—
—
—
0
0
5
16
3.13
1.44
1.2
1.1
198.40
235.50
nmol/l
—
5
16
92
728
1.27
1.42
1.3
1.3
—
—
—
0
0
16
88
1.82
1.41
1.4
1.2
—
—
—
0
0
58
431
1.35
1.41
1.2
1.3
—
—
—
0
0
110
1347
0.81
1.38
1.6
1.6
0.30
0.33
mg/l
0.18
48
623
57
757
0.75
1.37
2.5
1.6
0.97
0.85
nmol/l
0.57
46
633
432
3914
1.12
1.37
2.3
2.3
196.74
154.18
ug/g
1.18
367
3113
9
41
2.20
1.37
1.8
2.2
16.90
18.25
umol/l
—
9
41
31
454
0.68
1.34
1.0
1.1
6.28
2.18
u/ml
0.44
14
268
23
144
1.60
1.31
2.9
1.9
38.30
56.97
ug/l
1.45
23
139
47
637
0.73
1.31
1.1
1.1
0.58
0.65
ratio
—
7
97
24
368
0.65
1.31
1.0
1.1
1.98
1.83
u/ml
—
7
168
27
178
1.52
1.26
1.2
1.2
158.04
352.03
u/l
1.89
27
165
22
339
0.65
1.24
1.0
1.1
10.79
1.52
u/ml
—
5
192
21
131
1.61
1.23
1.7
1.9
—
—
—
0
0
47
348
1.35
1.20
1.4
1.5
34.66
27.90
%
0.58
31
208
54
705
0.76
1.19
1.2
1.2
1.47
1.51
g/l
0.66
54
705
230
2025
1.14
1.18
2.4
2.5
—
—
—
0
0
0
34
0.00
1.16
0.0
1.1
—
31.59
—
0
24
20
126
1.59
1.14
2.8
2.8
24.92
29.33
umol/l
1.06
15
92
316
2847
1.12
1.14
2.8
2.9
6.01
6.05
ph
0.31
219
2019
90
734
1.23
1.13
1.1
1.1
4.54
7.95
eliau/ml
—
10
60
7
31
2.26
1.10
1.0
1.1
—
—
—
0
0
45
337
1.34
1.09
1.0
1.1
1.59
2.72
eliau/ml
1.25
12
116
26
373
0.70
1.06
1.0
1.1
8.77
4.20
u/ml
—
10
198
28
195
1.44
1.04
1.1
1.1
19.18
11.66
iu/ml
—
6
52
14
83
1.69
1.01
1.1
1.0
0.10
3.36
u/ml
—
5
25
5
23
2.18
0.98
1.0
1.2
—
30.82
—
0
11
5
23
2.18
0.98
1.0
1.2
—
24.00
—
0
9
5
23
2.18
0.98
1.0
1.1
—
—
—
0
0
228
2038
1.13
0.97
3.7
3.5
1.02
1.02
ratio
0.60
210
1859
15
92
1.63
0.97
1.2
1.3
27.40
28.47
s
0.34
15
92
18
117
1.54
0.93
1.0
1.0
—
—
—
0
0
18
117
1.54
0.93
1.0
1.0
—
—
—
0
0
18
117
1.54
0.93
1.0
1.0
—
—
—
0
0
6
27
2.22
0.93
1.0
2.3
—
—
—
0
0
9
52
1.73
0.92
6.9
13.9
7.73
5.21
mmol/l
—
9
52
14
86
1.63
0.90
3.4
2.3
6.47
8.08
mmol/l
—
9
48
115
987
1.17
0.89
4.8
4.3
—
—
—
0
0
361
3327
1.09
0.88
2.6
2.3
12.66
13.03
nmol/l
0.36
332
2942
77
924
0.83
0.88
1.6
1.7
—
—
—
0
0
6
30
2.00
0.87
1.0
1.2
—
—
—
0
0
11
64
1.72
0.86
1.3
1.5
—
—
—
0
0
8
45
1.78
0.84
6.4
5.6
40.38
54.13
ug/min
—
8
39
0
24
0.00
0.79
0.0
1.2
—
354.25
—
0
24
5
24
2.08
0.74
1.0
2.6
—
113.55
—
0
13
97
839
1.16
0.72
1.1
1.1
—
—
—
0
0
46
371
1.24
0.71
1.6
1.3
24644.48
126314.55
e6/l
1.98
31
248
7
40
1.75
0.71
1.1
1.0
0.35
8.52
u/ml
—
7
33
40
498
0.80
0.69
3.9
5.1
313.15
347.34
umol/l
0.84
34
435
31
239
1.30
0.69
1.6
1.7
93.16
88.83
umol/l
0.12
31
239
5
27
1.85
0.68
1.2
1.5
—
—
—
0
0
38
473
0.80
0.66
2.9
2.7
—
—
—
0
0
21
155
1.36
0.63
1.4
1.3
5.99
6.14
mmol/l
0.26
21
148
21
280
0.75
0.62
1.6
2.3
—
—
—
0
0
6
104
0.58
0.61
3.0
2.3
125.67
145.53
nmol/l
—
6
92
116
1034
1.13
0.59
2.0
1.9
46.91
42.70
nmol/l
1.01
116
993
54
454
1.19
0.59
1.5
1.5
63.30
60.72
%
0.20
34
278
91
799
1.14
0.59
3.8
3.6
26.12
29.65
mg/l
0.63
73
563
1206
12401
0.96
0.56
4.4
4.9
21.73
22.04
%
0.31
639
6537
22
286
0.77
0.56
1.6
1.6
1161.73
935.70
mu/l
0.46
16
241
39
320
1.22
0.55
2.5
2.0
1.73
1.56
u/field
0.09
22
169
6
37
1.62
0.55
1.2
1.2
—
—
—
0
0
195
1796
1.09
0.55
1.2
1.2
126.70
131.72
u/ml
0.06
58
627
19
142
1.34
0.54
1.1
1.1
133.11
223.10
iu/ml
1.63
19
142
129
1171
1.11
0.51
1.7
1.6
25.87
21.18
u/ml
0.19
24
211
19
247
0.77
0.50
1.0
1.1
0.61
0.32
u/ml
—
5
106
16
213
0.75
0.50
1.5
1.6
—
—
—
0
0
3538
35165
1.05
0.49
59.6
28.3
92.13
91.64
fl
7.88
3513
34715
3538
35166
1.05
0.49
59.5
28.3
30.53
30.46
pg
1.29
3513
34716
24
301
0.80
0.48
2.3
2.5
—
—
—
0
0
3538
35168
1.05
0.48
59.7
28.4
4.15
4.44
e12/l
148.28
3474
34230
57
493
1.16
0.48
1.1
1.1
1.67
1.55
g/l
1.43
57
443
3538
35169
1.05
0.48
60.7
29.0
37.51
40.05
%
140.30
3511
34705
38
317
1.20
0.48
2.5
2.3
807.45
636.79
ml
1.06
22
206
3538
35171
1.05
0.47
59.7
28.4
6.75
6.86
e9/l
1.06
3477
34230
3537
35163
1.05
0.47
59.8
28.4
216.79
242.56
e9/l
76.64
3482
34357
3538
35174
1.05
0.46
60.1
28.6
124.24
134.25
g/l
212.03
3514
34736
5
82
0.61
0.45
1.0
1.7
—
—
—
0
0
24
298
0.80
0.45
1.0
1.1
11.12
2.38
u/ml
—
7
158
51
589
0.86
0.45
1.2
1.8
—
—
—
0
0
52
596
0.87
0.42
1.3
1.9
—
—
—
0
0
15
113
1.33
0.42
1.1
1.1
3.23
1.29
u/ml
—
7
43
5
32
1.56
0.42
1.0
1.2
107.40
148.27
mmol/l
—
5
26
12
87
1.38
0.42
1.2
1.1
—
—
—
0
0
0
15
0.00
0.41
0.0
10.2
—
103.47
—
0
15
3063
30389
1.03
0.40
5.5
5.4
2.05
2.00
mu/l
1.03
2829
27693
26
214
1.22
0.39
2.5
3.0
—
—
—
0
0
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
53
600
0.88
0.38
1.4
1.8
—
—
—
0
0
49
557
0.88
0.37
1.3
1.9
—
—
—
0
0
82
743
1.11
0.37
1.5
1.5
—
1.00
—
0
5
5
37
1.35
0.37
1.6
1.5
—
—
—
0
0
5
37
1.35
0.37
6.6
9.2
0.68
0.20
%
—
5
37
5
37
1.35
0.37
1.8
2.4
0.40
0.54
u/field
—
5
37
53
597
0.89
0.35
1.3
1.9
—
—
—
0
0
218
2303
0.94
0.35
1.2
1.3
—
—
—
0
0
37
426
0.87
0.34
1.4
1.3
1.36
1.53
nmol/l
0.59
32
384
729
7098
1.03
0.34
1.3
1.3
2.78
1.69
u/ml
0.73
158
1803
13
166
0.78
0.33
1.0
1.1
—
—
—
0
0
17
209
0.81
0.32
1.7
1.4
1.28
1.21
nmol/l
—
9
148
27
314
0.86
0.29
1.0
1.0
729.86
708.60
ng/l
0.09
21
208
50
556
0.90
0.29
1.1
1.1
2.00
58.88
iu/ml
—
7
98
101
1085
0.93
0.29
1.2
1.2
—
—
—
0
0
23
270
0.85
0.28
1.0
1.1
1.75
4.17
u/ml
—
7
129
847
8302
1.03
0.26
5.1
4.4
1.02
1.20
kg/l
0.50
623
5664
21
178
1.18
0.26
2.7
3.8
—
—
—
0
0
187
1784
1.05
0.25
2.1
2.1
—
—
—
0
0
12
96
1.25
0.24
7.6
7.4
4.98
5.35
kpa
0.89
12
96
595
5821
1.03
0.22
1.3
1.3
47.32
35.62
iu/ml
0.80
190
1754
5
41
1.22
0.22
1.0
1.2
2.14
1.85
umol/24h
—
5
41
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
2.55
—
0
7
0
12
0.00
0.21
0.0
1.0
—
8.09
—
0
7
0
13
0.00
0.21
0.0
1.1
—
0.05
—
0
13
0
13
0.00
0.21
0.0
1.3
—
1.78
—
0
13
102
1078
0.94
0.20
13.3
11.4
—
—
—
0
0
19
164
1.16
0.20
2.9
3.9
—
—
—
0
0
0
14
0.00
0.20
0.0
1.4
—
495.41
—
0
14
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
6
49
1.22
0.20
1.0
1.0
116.57
42.77
iu/ml
—
6
49
28
312
0.90
0.19
1.0
1.0
343.43
316.84
ng/l
0.25
23
213
17
196
0.87
0.18
1.1
1.0
—
—
—
0
0
12
100
1.20
0.18
4.1
4.7
—
—
—
0
0
10
121
0.83
0.18
2.0
1.4
7.40
7.76
mmol/l
—
10
121
12
142
0.84
0.17
1.5
1.3
101.83
169.87
mmol/24h
2.36
12
142
96
1008
0.95
0.17
1.2
1.1
—
—
—
0
0
22
245
0.90
0.15
1.2
1.3
4.85
1.80
u/ml
0.45
13
143
56
526
1.07
0.15
1.3
1.4
39.71
77.47
mu/l
1.25
49
472
25
276
0.91
0.15
1.3
1.4
1.06
1.13
promille
0.09
20
218
18
159
1.13
0.15
1.4
2.1
99.09
109.43
umol/l
0.12
11
92
13
112
1.16
0.14
1.2
1.3
19.00
10.75
mm/h
0.93
13
112
29
267
1.09
0.13
1.1
1.1
—
—
—
0
0
92
957
0.96
0.12
2.6
2.3
172.34
105.53
ug/min
0.42
59
569
37
347
1.07
0.11
3.5
3.1
22.86
28.39
mg/l
0.23
28
272
3193
32009
0.99
0.11
5.6
5.7
6.00
6.07
mmol/l
2.55
2916
29006
450
4563
0.98
0.11
4.7
5.3
31.64
32.93
%
1.51
304
2914
12
135
0.89
0.09
1.6
1.6
—
—
—
0
0
549
5433
1.01
0.09
1.3
1.3
16.36
13.78
u/ml
0.27
184
1946
6
57
1.05
0.08
1.2
1.4
11.08
168090.08
nmol/l
—
6
47
32
302
1.06
0.08
1.1
1.2
334.85
344.18
nmol/l
0.08
27
247
11
123
0.89
0.08
1.2
1.8
0.00
0.05
estimate
0.80
11
123
6
71
0.84
0.07
1.3
1.1
—
—
—
0
0
103
1005
1.03
0.07
1.8
1.6
16551.51
13288.13
e6/l
0.25
75
696
1547
15409
1.01
0.06
5.4
6.0
2.90
3.50
ug/l
0.77
1384
13893
12
132
0.91
0.06
1.4
1.5
—
—
—
0
0
24
254
0.94
0.06
2.4
2.2
2.01
1.96
ug/l
0.04
19
212
50
517
0.97
0.06
1.4
1.3
0.69
4.11
nmol/l
0.49
50
493
47
485
0.97
0.05
1.2
1.3
280.84
291.63
pmol/l
0.10
38
410
16
171
0.94
0.05
1.5
1.5
73.10
56.93
ug/l
0.26
11
147
2632
26277
1.00
0.04
50.3
24.5
331.00
331.94
g/l
5.76
2620
26118
12
130
0.92
0.04
1.3
1.5
1.21
1.32
mm
—
6
97
21
221
0.95
0.04
1.6
1.5
134.62
201.76
pmol/l
0.84
21
221
26
249
1.04
0.04
1.3
2.0
7.86
6.76
mmol/l
0.76
21
168
11
102
1.08
0.03
2.2
2.0
1.37
1.20
ug/l
0.10
11
94
15
158
0.95
0.02
1.6
1.8
2.29
11.47
nmol/l
1.62
15
136
44
447
0.98
0.01
1.3
1.3
0.18
0.19
nmol/l
0.55
32
371
81
817
0.99
0.01
1.9
1.9
9.05
11.96
iu/l
0.14
25
300
15
149
1.01
0.00
1.0
1.3
—
—
—
0
0
44
444
0.99
0.00
1.3
1.3
—
—
nmol/l
—
0
0
910
9104
1.00
0.00
3.1
3.5
0.79
0.80
ug/l
0.15
644
6358
11
107
1.03
0.00
1.5
1.5
106.09
563.70
nmol/24h
0.94
11
107
20
197
1.02
0.00
1.3
1.2
107.10
138.44
nmol/l
4.84
20
197
9
91
0.99
-0.00
1.1
1.2
136.33
139.00
mmol/l
—
9
70
0
6
0.00
-0.00
0.0
1.2
—
1700.00
—
0
6
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.6
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.0
—
—
—
0
0
7
75
0.93
-0.00
1.3
1.3
68.07
63.43
mu/l
—
7
56
0
6
0.00
-0.00
0.0
1.5
—
1.40
—
0
6
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
5.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
2.0
—
36.50
—
0
8

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: C3_NONFOLLICULAR_LYMPHOMA – Non-follicular lymphoma

GWS hits: 7

This endpoint is excluded (different definition than used in FinnGen).